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Polycyclic aromatic hydrocarbons (PAH) are important environmental pollutants 
originating from a wide variety of natural and anthropogenic sources. Because many of them are 
highly suspect as etiological agents in human cancer, chemical analysis of PAH is of great 
environmental and toxicological importance. Current methodology for PAH follows the classical 
pattern of sample preparation and chromatographic analysis. Sample preparation pre-
concentrates PAH, simplifies matrix composition, and facilitates analytical resolution in the 
chromatographic column. Among the several approaches that exist to pre-concentrate PAH from 
water samples, the Environmental Protection Agency (EPA) recommends the use of solid-phase 
extraction (SPE). High-performance liquid chromatography (HPLC) and gas chromatography-
mass spectrometry (GC-MS) are the basis for standard PAH identification and determination. 
Ultraviolet (UV) absorption and room temperature fluorescence detection are both widely used 
in HPLC, but the specificity of these detectors is modest. Since PAH identification is solely 
based on retention times, unambiguous PAH identification requires complete chromatographic 
resolution of sample components. When HPLC is applied to “unfamiliar” samples, the EPA 
recommends that a supporting analytical technique such as GC-MS be applied to verify 
compound identification and to check peak-purity HPLC fractions. Independent of the volume of 
extracted water, the approximate time required to separate and determine the sixteen “priority 
pollutants” (EPA-PAH) via HPLC is approximately 60min. If additional GC-MS analysis is 
required for unambiguous PAH determination, the total analysis time will reach 2-3 hours per 
sample.  If the concentrations of target species are found to lie outside the detector’s response 
range, the sample must be diluted and the process repeated.  These are important considerations 
iv 
 
when routine analysis of numerous samples is contemplated.  
Parent PAH are relatively inert and need metabolic activation to express their 
carcinogenicity. By virtue of the rich heterogeneous distribution of metabolic products they 
produce, PAH provide a full spectrum of the complexity associated with understanding the initial 
phase of carcinogenesis.  PAH metabolites include a variety of products such as expoxides, 
hydroxyl aromatics, quinines, dihydrodiols, dioepoxides, tetrols and water soluble conjugates. 
During the past decades tremendous efforts have been made to develop bio-analytical techniques 
that possess the selectivity and sensitivity for the problem at hand. Depending on the complexity 
of the sample and the relative concentrations of the targeted metabolites, a combination of 
sample preparation techniques is often necessary to reach the limits of detection of the 
instrumental method of analysis. The numerous preparation steps open ample opportunity to 
metabolite loss and collection of inaccurate data. Separation of metabolites has been 
accomplished via HPLC, capillary electrophoresis (CE) and GC-MS. Unfortunately, the 
existence of chemically related metabolic products with virtually identical fragmentation patterns 
often challenges the specificity of these techniques.  
            This dissertation presents significant improvements in various fronts. Its first original 
component – which we have named solid-phase nano-extraction (SPNE) - deals with the use of 
gold nanoparticles (Au NPs) as extracting material for PAH. The advantages of SPNE are 
demonstrated for the analysis of PAH in water samples via both HPLC1 and Laser-Excited Time-
Resolved Shpol’skii Spectroscopy (LETRSS).2 The same concept is then extended to the analysis 
of monohydroxy-PAH in urine samples via SPE- HPLC3 and In-Capillary SPNE-CE.4 The 
second original component of this dissertation describes the application of Shpol’skii 
Spectroscopy to the analysis of polar PAH metabolites. The outstanding selectivity and 
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sensitivity for the direct analysis of PAH at trace concentration levels has made Shpol’skii 
spectroscopy a leading technique in environmental analysis.5 Unfortunately, the requirement of a 
specific guest-host combination - typically a non-polar PAH dissolved in an n-alkane - has 
hindered its widespread application to the field of analytical chemistry. This dissertation takes 
the first steps in removing this limitation demonstrating its feasibility for the analysis of polar 





Foremost, I would like to express my sincere gratitude to my advisor Prof. Andres D. 
Campiglia for his continuous and enormous support for my Ph.D. study and research with his 
patience, enthusiasm, and immense knowledge. His guidance helped me in all the time of 
research and writing of this thesis. I could not have imagined having a better advisor and mentor 
for my Ph.D. study. I would have been lost without him. 
Besides my advisor, I would like to thank the rest of my thesis committee: Dr. Kevin D. 
Belfield Dr. Robert Igarashi, Dr. Shengli Zou, Dr. Xun Gong. It’s such a privilege to have them 
on my dissertation committee. 
I would also like to thank for the valuable help from my lab mates, Dr. Shenjiang Yu, Dr. 
Matthew Rex, Korina Calimag, Krishnaveni Appalaneni, Gaston Knobel, Walter Brent Wilson 
and Anthony Moore. The friendship, laughs, and yummy food in the lab will never be forgotten. 
My deepest gratitude goes to my wife, Pin Wang, for her unflagging love and support 
throughout my life; this dissertation is simply impossible without her.  Last but not least, I would 
like to thank my parents, for giving me life in the first place, unconditional support, and 







TABLE OF CONTENTS 
LIST OF FIGURES ............................................................................................................................................ xii 
LIST OF TABLES ............................................................................................................................................. xiv 
CHAPTER 1  POLYCYCLIC AROMATIC HYDROCARBONS AND THEIR METABOLIC PRODUCTS .. 1 
1.1  Environmental and Toxicological Relevance of Polycyclic Aromatic Hydrocarbons ..................... 1 
1.2  Solid-Phase Extraction of PAH ........................................................................................................ 3 
1.3  Chromatographic Analysis of EPA-PAH ......................................................................................... 8 
1.4  High Molecular Weight PAH ......................................................................................................... 10 
1.5  Metabolic Products of PAH ........................................................................................................... 11 
1.6  Original Components of this Dissertation ...................................................................................... 15 
CHAPTER 2  HIGH RESOLUTION MOLECULAR SPECTROSCOPY IN LOW-TEMPERATURE 
CRYSTALLINE MATRICES ............................................................................................................................. 16 
2.1  Basic Concepts on Luminescence Phenomena .............................................................................. 17 
2.2  Achieving High-Resolution Spectra under Shpol’skii Conditions ................................................. 21 
2.3  Sample Freezing Procedures .......................................................................................................... 28 
2.4  Instrumentation for Emission Measurements in Shpol’skii Matrixes ............................................ 31 
2.5  Instrumentation for Absorption Measurements in Shpol’skii Matrixes ......................................... 34 
2.6  Applications of the Fiber Optic Probe and the Multidimensional Luminescence System to the 
Environmental Analysis of PAH ................................................................................................................. 38 
CHAPTER 3  INSTRUMENTATION .............................................................................................................. 50 
3.1  Room-Temperature Absorption Measurements with Commercial Instrumentation ...................... 50 
3.2  Room-Temperature and 77 K Fluorescence Measurements with Commercial Instrumentation .... 50 
3.3  Fluorescence and Absorption Measurements at 4.2K .................................................................... 51 
3.4  HPLC Analysis .............................................................................................................................. 53 
3.5  Capillary Electrophoresis (CE) ...................................................................................................... 54 
CHAPTER 4  DETERMINATION OF POLYCYCLIC AROMATIC HYDROCARBONS IN DRINKING 






4.2.3  Sample Mixing and Centrifugation for PAH Extraction with Gold Colloids .......................... 58 
viii 
 
4.2.4  UV-VIS Absorption Spectroscopy ........................................................................................... 58 
4.2.5  RTF Spectroscopy ................................................................................................................... 58 
4.2.6  HPLC Analysis ........................................................................................................................ 58 
4.3  Results and Discussion .................................................................................................................. 59 
4.3.1  Preliminary Studies on the Interaction of PAH with Au NPs .................................................. 59 
4.3.2  Centrifugation Time for Au NPs Precipitation ........................................................................ 60 
4.3.3  PAH Precipitation in the Absence of Au NPs .......................................................................... 61 
4.3.4  Efficiency of PAH Extraction as a Function of Particle Diameter ........................................... 64 
4.3.5  Maximum Amount of Extractable PAH and its Correlation to the Volume of Commercial 
Solution for Complete PAH Extraction .............................................................................................. 66 
4.3.6  Releasing PAH for HPLC Analysis ......................................................................................... 69 
4.3.7  Analytical Figures of Merit ..................................................................................................... 74 
4.3.8  PAH Determination in Tap Water ............................................................................................ 75 
4.4  Conclusions .................................................................................................................................... 77 
CHAPTER 5  SOLID-PHASE NANO-EXTRACTION AND LASER-EXCITED TIME-RESOLVED 
SHPOL’SKII SPECTROSCOPY FOR THE ANALYSIS OF POLYCYCLIC AROMATIC HYDROCARBONS 





5.2.3  SPNE of PAH from Water Samples ......................................................................................... 80 
5.2.4  HPLC Analysis ........................................................................................................................ 80 
5.2.5  Survey of 77K-Excitation and Fluorescence Spectra .............................................................. 81 
5.2.6  Instrumentation for LETRSS Analysis .................................................................................... 81 
5.2.7  Spectral Acquisition with the MLS .......................................................................................... 81 
5.2.8  Lifetime Acquisition with the MLS ......................................................................................... 82 
5.2.9  77K and 4.2K Sample Procedures ........................................................................................... 82 
5.3  Results and Discussion .................................................................................................................. 83 
5.3.1  HPLC Analysis of EPA PAH ................................................................................................... 83 
5.3.2  4.2K LETRSS of EPA-PAH .................................................................................................... 86 
5.3.3  4.2K LETRSS Analytical Figures of Merit ............................................................................. 91 




CHAPTER 6  IMPROVING THE RECOVERY AND THE LIMITS OF DETECTION FOR THE 






6.2.3  Hydrolysis of Urine Samples ................................................................................................. 101 
6.2.4  Solid-Phase Extraction of Urine Samples .............................................................................. 102 
6.2.5  Extraction of OH-PAH with Au NPs ..................................................................................... 102 





6.3  Results and Discussion ................................................................................................................ 104 
6.3.1  Optimization of HPLC Analysis ............................................................................................ 104 
6.3.2  OH-PAH Precipitation in the Absence of Au NPs ................................................................. 107 
6.3.3  Complete Metabolite Extraction ............................................................................................ 109 
6.3.4  Releasing Metabolites from Au NPs ...................................................................................... 112 
6.3.5  Comparison of the Evaporation Step to the Au NPs Procedure ............................................. 115 
6.4  Conclusions .................................................................................................................................. 120 
CHAPTER 7  GOLD NANOPARTICLES DEPOSITED CAPILLARIES AS PRE-CONCENTRATION 
DEVICES FOR IN-CAPILLARY MICRO-EXTRACTION CAPILLARY ELECTROPHORESIS: 




7.2.1  Chemicals and Materials ....................................................................................................... 128 
7.2.2  Solution preparation .............................................................................................................. 129 
7.2.3  Instrumentation ...................................................................................................................... 129 
7.2.4  Fabrication of Au NPs deposited capillaries .......................................................................... 130 
x 
 
7.2.5  In-capillary micro-extraction procedure ................................................................................ 131 
7.2.6  Analysis of Urine Samples .................................................................................................... 131 
7.3  Results and discussion ................................................................................................................. 131 
7.3.1  CZE separation of the studied metabolites ............................................................................ 131 
7.3.2  Characterization of Au NPs deposited capillaries .................................................................. 133 
7.3.3  Sample flow rate for in-capillary pre-concentration of OH-PAH .......................................... 134 
7.3.4  Releasing OH-PAH from Au NPs deposited capillaries ........................................................ 136 
7.3.5  Analytical figures of merit (AFOM) ...................................................................................... 138 
7.3.6  Urine Analysis ....................................................................................................................... 141 
7.4  Conclusion ................................................................................................................................... 145 
CHAPTER 8  ANALYSIS OF POLAR METABOLITES OF POLYCYCLIC AROMATIC 






8.2.3  UV-VIS Absorption Spectroscopy ......................................................................................... 150 
8.2.4  RTF Spectroscopy ................................................................................................................. 150 
8.2.5  Instrumentation for LETRSS Analysis .................................................................................. 150 
8.2.6  Spectral Acquisition with the MLS ........................................................................................ 151 
8.2.7  Lifetime Acquisition with the MLS ....................................................................................... 151 
8.2.8  77K and 4.2K Sample Procedures ......................................................................................... 151 
8.3  Results and Discussion ................................................................................................................ 152 
8.4  Conclusion and Future Studies .................................................................................................... 162 
APPENDIX A: EXCITATION AND FLUORESCENCE SPECTRA OF 15 EPA PAH AT ROOM 
TEMPERATUR ................................................................................................................................................ 165 
APPENDIX B: “TITRATION” CURVE FOR 15 EPA PAH WITH 5% 20-NM AU NPS ............................... 174 
APPENDIX C: EXCITATION AND FLUORESCENCE SPECTRA OF 15 EPA PAH IN N-OCTANE AT 
77K ................................................................................................................................................................... 183 
APPENDIX D: FLUORESCENCE SPECTRA AND LIFETIME DECAY OF 15 EPA PAH IN N-OCTANE 
AT 4.2K ............................................................................................................................................................ 192 
APPENDIX E: LOW CONCENTRATION RANGES OF CALIBRATION CURVES OBTAINED VIA SPNE-
xi 
 
LETRSS FOR 15 EPA PAH .............................................................................................................................. 208 




LIST OF FIGURES 
Figure 1.1 Molecular structures of 16 EPA PAH. ................................................................................................. 2 
Figure 1.2 Overview of B[a]P metabolism. ........................................................................................................ 13 
Figure 2.1 Jablonski diagram. ............................................................................................................................. 18 
Figure 2.2 Cartoon of analyte in amorphous and crystalline matrix and resulting spectral bandwidth. ............. 22 
Figure 2.3 Electron phonon coupling in emission. ............................................................................................. 24 
Figure 2.4 Simple cartoon explaining the occurrence of different sites if the molecule fits in more than one way 
in the crystal. ....................................................................................................................................................... 26 
Figure 2.5 Jablonski diagram illustrating the concept of Shpol’skii spectroscopy (A) and the resulting spectrum 
(B). ...................................................................................................................................................................... 27 
Figure 2.6 Cryogenic fiber optic probes for 77K (A) and 4.2K (B) measurements. ........................................... 30 
Figure 2.7 Instrumentation for multidimensional luminescence spectroscopy. .................................................. 33 
Figure 2.8 (A) Representation of optical phenomena occurring at the irradiated surface of the frozen matrix; (B) 
Schematic diagram of the tip of the cryogenic fiber optic probe. ....................................................................... 36 
Figure 2.9 Experimental data generated at 4.2 K with the FOP and the instrument. .......................................... 37 
Figure 2.10 4.2K absorption spectra recorded with the FOP and the instrument from 0.1μ g.mL-1 naphthalene 
in n-pentane (left side) and 0.1μ g.mL-1 benzo[a]pyrene in n-octane (right side). .............................................. 38 
Figure 2.11 Experimental steps of SPE-LETRSS of liquid samples (drawing is not to scale). .......................... 40 
Figure 2.12 Laser Excited Shpol’skii spectrum of polluted surface water sample showing specific peaks of 15 
PAH. .................................................................................................................................................................... 41 
Figure 2.13 4.2K fluorescence spectra obtained from extracts of reference standard materials CRM 104-100 
(Panel A) and CRM 105-100 (Panel B). ............................................................................................................. 43 
Figure 2.14 4.2 K fluorescence spectra from synthetic mixtures with the five DP isomers. .............................. 48 
Figure 4.1 Absorbance intensity of Au NPs as a function of centrifugation time. .............................................. 61 
Figure 4.2 Fluorescence intensity as a function of PAH concentration (ng.mL-1): (A) = phenanthrene; (B) = 
chrysene; (C) = benzo[a]pyrene; (D) = indeno[1,2,3-cd]pyrene. ........................................................................ 67 
Figure 4.3 Effect of 1-pentanethiol on the releasing efficiency of extracted PAH with 20nm Au NPs. ............. 72 
Figure 5.1 Schematic diagram with the experimental steps of the SPNE procedure for the analysis of PAH in 
drinking water samples. ...................................................................................................................................... 81 
Figure 5.2 Chromatograms of 15 EPA PAH obtained by SPNE-HPLC (A) and HPLC (B). .............................. 85 
Figure 5.3 (A) 4.2 K WTM recorded with the fiber-optic probe and the MLS. (B) Fluorescence spectrum 
extracted from WTM at 5ns delay. (C) Fluorescence decay obtained from fitting the intensity of fluorescence 
xiii 
 
emission at 404 nm as a function of time. ........................................................................................................... 90 
Figure 5.4 Low concentration ranges of calibration curves obtained via SPNE-LETRSS. ................................ 92 
Figure 5.5 4.2 K fluorescence spectrum of PAH spiked drinking water sample submitted to SPNE–LETRSS 
analysis. .............................................................................................................................................................. 96 
Figure 6.1  Excitation and fluorescence spectra in methanol-water 30-70(v/v) (solid line) and 10-90(v/v) 
(dotted line). (A) 2-OHflu; (B) 9-OHphe; (C) 1-OHpyr; (D) 6-OHchr; (E) 4-OHb(a)p; (F) 3-OHb(a)p. ........ 105 
Figure 6.2 Typical HPLC chromatogram of metabolite synthetic mixture containing 50 ng.mL-1 (A) 2-OHflu; 
(B) 9-OHphe; (C) 1-OHpyr; (D) 6-OHchr; (E) 4-OHb(a)p; (F) 3-OHb(a)p. .................................................... 107 
Figure 6.3 Fluorescence intensity as a function of OH-PAH concentration (ng.mL-1): (A) 2-OHflu; (B) 1-
OHpyr; (C) 6-OHchry; (D) 3-OHb(a)p. ............................................................................................................ 111 
Figure 6.4 Effect of 1-pentanethiol on the releasing efficiency of extracted OH-PAH with 20-nm Au NPs; from 
left to right: 0, 0.2, 0.5, 1, 2μL. ......................................................................................................................... 114 
Figure 6.5 Chromatograms recorded from individual aliquots of the same urine sample pre-concentrated with 
Au NPs. ............................................................................................................................................................. 117 
Figure 7.1 UV absorption spectra of Au NPs solution before and after coating to the capillary and SEM images 
of the inner surface of capillary. ....................................................................................................................... 134 
Figure 7.2 Effect of CE pump pressure on the flow rate and extraction efficiency of 3-OHbap. ..................... 136 
Figure 7.3 Electropherogram of a mixture of 5 OH-PAH and 1-pentanethiol. ................................................. 144 
Figure 8.1 4.2K fluorescence emission spectra recorded upon laser excitation at 347.9nm (1-OHpyrene,) 
311.2nm (3-OHB[a]P). ..................................................................................................................................... 154 
Figure 8.2 4.2K fluorescence spectrum of 10ng.mL-1 B[a]P -trans-9,10-dihydrodiol in 1-octanol. ................ 156 
Figure 8.3 4.2K fluorescence emission spectra of anti-BPDE (±) and syn-BPDE (±) in 1-octanol. ................ 159 
Figure 8.4 Effect of delay (200ns) and gate (500ns) times on the 4.2K fluorescence spectra of syn-BPDE (±) (-
---) and anti-BPDE (±) (—) in 1-octanol.  162  
xiv 
 
LIST OF TABLES 
Table 1.1 EPA-PAH Recoveries from Water Samples via SPE-HPLC and SPE-GC-MS. .................................... 7 
Table 1.2 Limits of detection of EPA-PAH via SPE-HPLC and SPE-GC-MS. .................................................... 9 
Table 2.1 PAH recoveries obtained with the screening method. ......................................................................... 45 
Table 2.2 Lifetime analysisa of DBP isomers on extraction membranes spiked with 100 µL of octane. ........... 49 
Table 4.1 Maximum PAH concentration free from precipitation. ....................................................................... 63 
Table 4.2 PAH extraction as a function of Au nanoparticle diameter and total surface area of Au. ................... 65 
Table 4.3 Maximum amount of PAH extracted with 5% (v/v) 20 nm Au NPs. .................................................. 68 
Table 4.4 Recoveries for the three-step SPNE procedure. .................................................................................. 73 
Table 4.5 Analytical figures of merit via SPNE-HPLC. ..................................................................................... 75 
Table 4.6 PAH recoveries from drinking water samples. .................................................................................... 76 
Table 5.1 Overall recoveries for EPA-PAH via SPNE-HPLC of three water sample tested. .............................. 84 
Table 5.2 Excitation and emission of 15 PAH in n-octane at 4.2K. .................................................................... 88 
Table 5.3 Analytical figure of merit of SPNE-LETRSS. .................................................................................... 93 
Table 5.4 Overall recoveries for EPA-PAH via SPNE-LETRSS of three water sample tested. .......................... 95 
Table 6.1 HPLC parameters for the separation of OH-PAH. ............................................................................ 105 
Table 6.2 Concentrations of OH-PAH free from precipitation. ........................................................................ 108 
Table 6.3 Maximum amount of extracted OH-PAH with 100μL commercial 20-nm Au NPs. ......................... 112 
Table 6.4 Overall recovery of SPNE. ................................................................................................................ 115 
Table 6.5 Metabolites recoveries from synthetic urine samples via SPE-HPLC, SPE-evaporation-HPLC and 
SPE-Au NPs-HPLC analysis. ........................................................................................................................... 116 
Table 6.6 Analytical figures of merit of HPLC analysis with previous sample concentration via SPE-
evaporation and SPE-Au NPs procedure. ......................................................................................................... 119 
Table 7.1  Overview of the CE analysis of PAH metabolites. ........................................................................... 126 
Table 7.2 CE separation parameters for the 5 OH-PAH. ................................................................................... 133 
Table 7.3 Overall recovery of in-capillary micro-extraction. ............................................................................ 138 
Table 7.4 Comparison of the analytical figures of merit of the CE method and in-capillary micro-extraction CE 
method. ............................................................................................................................................................. 140 
Table 7.5 Reproducibility of In-Capillary Micro-Extraction CZE for the Analysis of OH-PAH (Absorption 
intensities ×10-4). .............................................................................................................................................. 142 
Table 8.1 77K Fluorescence Intensities of PAH Metabolites in Alcohol and n-Alkane Matrixes. ................... 153 
Table 8.2 Fluorescence Quantum Yields a of anti-BPDE (±) and syn-BPDE (±). ............................................ 157 
xv 
 
Table 8.3 4.2K Fluorescence analytical figures of merita of B[a]P metabolites in 1-Octanol. ......................... 157 




CHAPTER 1 POLYCYCLIC AROMATIC HYDROCARBONS AND 
THEIR METABOLIC PRODUCTS 
 
1.1 Environmental and Toxicological Relevance of Polycyclic Aromatic Hydrocarbons  
Polycyclic Aromatic hydrocarbons (PAH) are important environmental pollutants 
originating from a wide variety of natural and anthropogenic sources. PAH are generally formed 
during incomplete combustion of organic matter containing carbon and hydrogen.7-17 Due to the 
carcinogenic nature of some PAH, their chemical analysis is of great environmental and 
toxicological importance. Among the hundreds of PAH present in the environment, the EPA lists 
the following sixteen as "Consent Decree" priority pollutants: benz[a]anthracene, 
benzo[b]fluoranthene, benzo[k]fluoranthene, benzo[a]pyrene, dibenzo[a,h]anthracene, 
indeno[1,2,3-cd]pyrene, naphthalene, acenaphthylene, acenaphthene, fluorene, phenanthrene, 
anthracene, fluoranthene, pyrene, chrysene, and benzo[g,h,i]perylene. Their molecular structures 
are shown in Figure 1.1. According to the EPA, these PAH should be routinely monitored to 
avoid human exposure to contaminated sites.   
Human exposure to PAH derives from a verity of sources such as air pollution from 
automobile, diesel and industrial or incinerator emissions, which may modulate a spectrum of 
their other combustion, dietary and occupational sources. The primary source of PAH exposure 
in humans is through food consumption.18,19 Cereal and vegetables are the major dietary sources 
of PAH, except when there is a high consumption of meat cooked over an open flame.20 More 
than 150 PAH have been found in tobacco smoke,21 which also contributes significantly to 

















acenaphthene fluoranthene chrysene anthracene 
   
 
acenaphthylene benzo[g,h,i]perylene benzo[a]anthracene benzo[k]fluoranthene 
  
  
phenanthrene benzo[b]fluoranthene indeno[1,2,3-cd]pyrene benzo[a]pyrene 
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A less pervasive source of air pollution leading to PAH exposure involves biomass 
burning from forest fires and peat bogs resulting from incidental incineration, or from deliberate 
forest cleaning strategies that expend beyond planned boundaries.20 Wood combustion as an 
energy source for heating and/or cooking also generates a source of indoor PAH pollution 
leading to health problems.24,25 Occupational exposures may result from daily contact with 
intensive combustion processes such as iron and steel production,26 coke production,27 waste 
incinerators,28 transportation maintenance,29 mining exhaust exposure30 and aluminum 
smelters,31 or from tobacco smoke in commercial venues23 such as bars, restaurants and 
nightclubs. More intensive PAH exposures in occupational environments – relative to the general 
population – have resulted in reports of lung, genitourinary and skin cancers.32  
1.2 Solid-Phase Extraction of PAH  
In addition to inhalation and dermal absorption in occupational environments, a primary 
route of human exposure to PAH is the ingestion of contaminated water.33,34 Current 
methodologies for the analysis of EPA-PAH in public water supplies follows the classical pattern 
of sample preparation and chromatographic analysis. Sample preparation pre-concentrates PAH, 
simplifies matrix composition, and facilitates analytical resolution in the chromatographic 
column. Among the several approaches that exist to pre-concentrate PAH from water samples – 
which include liquid-liquid extraction, solid-phase micro-extraction, open tubular trap, stir bar 
sorptive extraction and enzyme-linked immunesorbent assays (ELISA) – EPA recommends the 
use of solid-phase extraction (SPE).35-39 Typically, 1L of water is processed through the 
extraction membrane in approximately 1 h. This volume of water is recommended to reach 
detectable concentrations by chromatographic techniques, namely high performance liquid 
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chromatography (HPLC) and gas chromatography – mass spectroscopy (GC-MS).  
SPE of PAH is usually carried out with the aid of non-polar sorbents such as octadecyl-
silica particles. The effectiveness of octadecyl-silica sorbents is based on the same sorption-
desorption phenomena as in reversed-phase liquid chromatography. The main mechanism of 
PAH isolation is a non-polar interaction, i.e. Van der Waals forces. PAH will pass into the solid 
surface, and given time, the equilibrium will be established between the two phases. The 
equilibrium for each PAH is described by its partition coefficient, which is simply the ratio of 
PAH concentrations in the two phases. The driving force for the partition mechanism results 
from the difference in the chemical potential of the PAH in the solid (sorbent) and the liquid 
phase (aqueous sample). The chemical potential equation of any given PAH (PAHi) in any given 
phase (p) is given by 
μip = (μ0)ip + RTInCi                  (1.1) 
where μip is the chemical potential of PAHi in phase “p”, (μ0)ip is the standard chemical potential 
of PAHi in phase “p”, and Ci is the PAH concentration in phase “p”. When equilibrium is 
established, the chemical potential of PAHi in the sorbent (s) and aqueous (a) phases reaches the 
same value, i.e.:  
μis = μia                                    (1.2) 
The concentration of PAHi in each phase depends on its partition coefficient. The larger the 
partition coefficient the better the retention of PAHi will be in the solid phase. The partition 
coefficient (K) can be represented by 
Cis/Cia = exp[ -Δμ0i / RT]         (1.3) 
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K = Cis/Cia                             (1.4) 
SPE materials are packed in two formats, discs and cartridges. A SPE cartridge consists 
of a small column (generally an open syringe barrel) containing a sorbent with an average 
particle size of about 40 packed between plastic frits. The sorbent bed occupies about one-third 
of the syringe barrel volume. The remaining volume is used as sample reservoir. SPE discs are 
particle-loaded membranes in the form of flexible discs of various diameters and 0.5-1.0 mm of 
thickness. They are packed in a way that the sorbent is enmeshed into a web of some other inert 
polymer, e.g., Teflon, or is trapped in a glass fiber or paper filter. SPE discs are preferred over 
cartridges because their larger cross-sectional area and shorter bed depth allow higher flow rates 
and shorter analysis time. 
The experimental procedure for SPE consists of four steps: conditioning, retention, 
rinsing and drying. The solid sorbent must undergo proper conditioning to wet the packing 
material before the sample passes through the SPE device. In its dry form, the octadecyl (C18) 
bonded-phase material is randomly oriented on the surface. If the sorbent is placed in contact 
with an aqueous sample, the environment surrounding the bonded organic moiety would be 
highly polar and entirely incompatible with a C18 bonded-phase. The bonded groups try to 
minimize the exposure to the high polarity medium by forming clusters among them that are 
close to each other. In such a configuration, the organic surface that is exposed to the solute is 
very small. This arrangement of the bonded organic groups diminishes the extraction efficiency 
of SPE. The conditioning step “activates” the sorbent by treatment with an organic solvent, 
typically methanol. Under these conditions, the bonded-organic moiety is more open and 
available for interaction with the solute. This process can be determined as one of the most 
important steps for a successful SPE. After conditioning, the sample is loaded to the SPE device 
6 
 
by gravity feed, pumping, or vacuum. Depending on the type of sample, micro-liters to liters of 
liquid sample can be applied through the sorbent phase. During this step, PAH are extracted and 
pre-concentrated in the solid sorbent. Some of the matrix concomitants may also be retained 
along with PAH, making matrix composition more challenging for further PAH analysis. A 
rinsing step is then used to remove potential interferences from the SPE material. For aqueous 
samples, a water-organic-solvent mixture is usually used as the rinsing solvent. The final step is 
the elution of PAH from the sorbent with an appropriate solvent specifically chosen to disrupt the 
PAH-sorbent interaction. The elution solvent should remove as little as possible of the other 
substances sorbed on the column.  
For efficient SPE of PAH, one would desire the capacity factor to be very large in 
aqueous solutions. Similarly, the capacity factor should approach zero in 100% organic eluting 
solvent unless non-reversed-phase interactions were taking place. Unfortunately, non-reversed-
phase interactions in C18 sorbent materials result from the existence of residual silanol groups on 
the surface of silica particles. These groups, which interact with PAH through both hydrogen 
bonding and dipole-dipole interactions, make difficult PAH desorption for subsequent 
chromatographic analysis.40 Table 1.1 summarizes the overall recoveries of EPA-PAH obtained 
from water samples via HPLC41-46 and GC-MS analyses47-51. The large variations observed for 
the recoveries of individual PAH can be partially attributed to the difficulty of PAH desorption 
from C18 sorbents. Although previously reported data on the standard deviations of average 
recoveries of individual PAH is scarce and incomplete, the reported values44,49 show relatively 
high standard deviations that affect both the precision and the accuracy of analysis. It is within 
this context that development of new extraction approaches and instrumental methods become 




Table 1.1 EPA-PAH Recoveries from Water Samples via SPE-HPLC and SPE-GC-MS. 
PAH Recovery (%) 
HPLC GC-MS 
naphthalene (65.5±1.1)
41, 6342, 1043, 
6245, 6446 
6147, 89.548, 10850, 7150, 
89.3851 
acenaphthylene 8142, 3943, 4045, 6746 7647, 91.248, 9750, 6750, 
60.0851 
acenaphthene (65.5±1.8)41, 7942, 2543, 
7545, 7746 
6647, 94.048, 11250, 7150, 
81.0551 
fluorene (58.5±0.3)41, 8242, 5243, 
6845, 7346 
8147, 94.848, 10950, 6850, 
98.5851 
phenanthrene (57.0±0.5)41, 9542, 6943, 
9345, 5646 
7047, 95.648, (51±7)49, 2350, 
5750, 63.9751 
anthracene (67.6±1.6)41, 9742, 7743, 
10245, 7146 
7947, 95.748, , 8550, 5350, 
81.5151 
fluoranthene (65.6±1.2)41, 10142, 9343, 
(85±12)44, 6445, 7546 
10347, 85.848, 7350, 4650, 
83.1151 
pyrene (65.7±1.0)41, 9442, 8843, 
10145, 8946 
9547, 83.848, (73±11)49, 7250, 
4550, 79.0951 
benzo[a]anthracene (67.7±1.7)41, 9142, 9843, 
10745, 9046 
8347, 74.948, 5150, 4650 
chrysene 9642, 9743, 10545, 10246 10947, 78.448, (70±9)49, 6350, 
5450 
benzo[b]fluoranthene (70.6±0.5)41, 9242, 9843, 
(92±15)44, 10045, 6946 
11547, 62.448, (72±11)49, 
5350, 5050, 87.1851 
benzo[k]fluoranthene (68.3±0.3)41, 8942, 9643, 
(86±13)44, 9945, 6946 
8547, 72.548, 2750, 5550 
benzo[a]pyrene 9542, 9743,(86±13)44, 8545, 
4046 
8047, 66.848, (74±11)49, 5750, 
4750, 62.8951 
dibenz[a,h]anthracene 9142, 9543, 7545, 3646 8547, 67.948, 6150, 6150 
benzo[g,h,i]perylene 8842, 9743,(83±11)44, 7145, 
3846 
8247, 78.148, 5350, 5350, 
76.1951 
indeno[1,2,3-cd]pyrene 8742, 9543,(75±15)44, 9145, 
4446 





1.3  Chromatographic Analysis of EPA-PAH 
HPLC and GC-MS are the basis for standard PAH identification and determination. UV 
absorption and room temperature fluorescence detection are both widely used in HPLC, but the 
specificity of these detectors is modest. Since PAH identification is solely based on retention 
times, unambiguous PAH identification requires complete chromatographic resolution of sample 
components. When HPLC is applied to “unfamiliar” samples, EPA recommends that a supporting 
analytical technique such as GC-MS be applied to verify compound identification and to check 
peak-purity HPLC fractions. 
On drinking waters, the EPA recommends the routine monitoring of benzo[a]pyrene. This 
is the most toxic PAH in the EPA list, and its concentration alone is often used as a measure of 
risk. According to the EPA, its maximum contaminant level (MCL) should not exceed 200ng.L-1. 
In addition to benzo[a]pyrene, the European Union and the World Health Organization have 
regulated fluoranthene, benzo[b]fluoranthene, benzo[k]fluoranthene, benzo[g,h,i]perylene, and 
indeno[1,2,3-cd]pyrene, MCL values were set at 10ng.L-1 for the highly toxic benzo[a]pyrene 
and 200ng.L-1 for the remaining PAH.52-54 Table 1.2 summarizes the limits of detection (LOD) of 
EPA-PAH obtained via SPE-HPLC41-46 and SPE-GC-MS49,55-57 analyses. Although a 
straightforward comparison of LOD is difficult as different mathematical and experimental 
approaches have been used for their calculation, most reported values fall within the parts-per-
trillion concentration range. With one exception, 45 the LOD for the regulated PAH are below the 
stipulated MCL values. The volume of water processed through the SPE device varied from 10 to 
1000mL.41-51,55-57 The possibility to adjust the volume of extracted water to reach the low MCL 
values is one of the main advantages of interfacing SPE with chromatographic methods. 
Independent of the volume of extracted water, the approximate time required to separate and 
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determine the 16 EPA-PAH via HPLC is approximately 60min. If additional GC-MS analysis is 
required for unambiguous PAH determination, the total analysis time will reach 2-3 hours per 
sample.  If the concentrations of target species are found to lie outside the detector’s response 
range, the sample must be diluted and the process repeated. These are important considerations 
when routine analysis of numerous samples is contemplated. Our research addresses these 
disadvantages providing PAH monitoring via a simple, cost-effective, and direct method of 
analysis.   
 
Table 1.2 Limits of detection of EPA-PAH via SPE-HPLC and SPE-GC-MS. 
PAH LOD (ng.L-1) 
HPLC GC-MS 
naphthalene 4641, 3643, 20045, 0.5846 4155, 0.6749, 256, 80057
acenaphthylene 10741, 1743, 40045, 0.6746 1155, 0.3349, 956, 280057 
acenaphthene 743, 30045, 0.5246 455, 0.4449, 456,410057
fluorene 1941, 0.443, 50045, 0.5846 1255, 0.3249, 256, 160057 
phenanthrene 541, 0.643, 30045, 0.5246  555, 0.8049, 156, 340057
anthracene 941, 0.143, 30045, 0.6846 155, 0.7549, 756, 420057
fluoranthene 4941, 543, 9.6844, 50045, 0.7846 255, 0.5249, 356, 390057
pyrene 4141, 343, 70044, 0.6546 355, 0.5049, 356, 510057
benzo[a]anthracene 2441, 0.443, 30045, 0.9246 455, 0.2149, 3056, 580057
chrysene 0.443, 30045, 0.7346 1455, 0.2649, 1056, 490057
benzo[b]fluoranthene 1741, 0.443, 0.8444, 80045, 0.7846 1855, 0.3149, 6056, 350057
benzo[k]fluoranthene 3341, 0.0343, 0.8144, 120045, 0.7646 3955, 0.2149, 3056, 360057
benzo[a]pyrene 0.143, 0.6844, 150045, 0.7946 755, 0.3049, 11056, 560057
dibenz[a,h]anthracene 0.243, 60045, 0.9846  355, 0.1649, 15056, 3600057
benzo[g,h,i]perylene 0.743, 0.7844, 250045, 0.9246 2055, 0.1249, 12056, 760057






1.4 High Molecular Weight PAH 
Recent toxicological studies attribute a significant portion of the biological activity of 
PAH contaminated samples to the presence of high molecular weight (HMW) PAH, i.e. PAH 
with MW ≥ 300. The first group of HMW PAH, i.e. the MW 300 and MW 302 isomers, has been 
identified in combustion related samples with high PAH content such as coal tar,58-61 carbon 
black,62-64 and fuel combustion exhaust.65-67 Their presence has also been confirmed in 
environmental samples such as air particulate matter,60,61,68-71 mussels,61 sediments60,61,71-74 and 
soils.73-75 Coronene is generally the only MW 300 isomer measured, even though a number of 
other isomers are possible.65,76 However, only a limited number of studies have reported the 
quantification of individual isomers.59-61,67 The majority of the reports have only been able to 
make a tentative identification of individual isomers or had to report concentrations in terms of a 
total fraction composed of several isomers. Because the carcinogenic properties of HMW PAH 
differ significantly from isomer to isomer, it is of paramount importance to determine the most 
toxic isomers even if they are present at much lower concentrations than their less toxic isomers.  
The need for unambiguous isomer identification is further intensified by recent findings 
showing that some HMW PAH can exhibit far higher carcinogenic properties than EPA-PAH. A 
crucial example is Dibenzo[a,l]pyrene (DB[a,l]P). This compound is the most potent 
carcinogenic PAH known to date.77-79 Its carcinogenic potency is approximately 100 times higher 
than that of B[a]P. There are several more isomers of dybenzopyrene - including 
dibenzo[a,e]pyrene (DB[a,e]P), dibenzo[a,h]pyrene (DB[a,h]P), dibenzo[a,i]pyrene (DB[a,i]P) 
and dibenzo[e,l]pyrene (DB[e,l]P) – which are also carcinogenic, but not to the extent DB[a,l]P 
is. Thus, unambiguous identification of DB[a,l]P in environmental samples is highly relevant 
even if the other isomers are present at 10 to 100 times higher concentrations. Although DB[a,l]P 
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is the most potent carcinogenic PAH known to man, there are only limited data on its formation 
and presence in the environment. Early carcinogenicity studies mistakenly used the relatively 
weaker carcinogen dibenzo[a,e]fluoranthene.80 As a matter of fact, only recently the U.S. 
Department of Health and Human Services listed DB[a,l]P, DB[a,e]P, DB[a,h]P and DB[a,i]P as 
potential carcinogens to humans.81 
Unfortunately, EPA methodology cannot always meet the challenge of specifically 
analyzing structural isomers at the low concentration levels of environmental samples. The main 
problems that confront EPA methodology arise from the relatively low concentration levels and 
the large number of HMW PAH isomers with very similar elution times and similar, possibly 
even virtually identical, fragmentation patterns. An important component of our research, then, 
focuses on developing methods with the ability to efficiently and reliably detect the presence and 
determine the amounts of the most toxic HMW PAH, even if their less toxic isomers are present 
in far higher concentrations.  
 
1.5  Metabolic Products of PAH 
Parent PAH are relatively inert and need metabolic activation to express their 
carcinogenicity. Covalent binding to DNA is believed to be the first critical step in the initiation 
of the tumor formation process.33,34,82 Complex heterogeneity makes the identification of the 
type(s) of chemical lesion(s) an extremely challenging problem. For instance, a given metabolite 
may bind to different bases or different nucleophilic centers of a base and exist in distinctly 
different adduct-DNA conformations.83-86 Metabolism may also lead to a distribution of 
stereoisomeric metabolites and, as a consequence, stereo specific additions to DNA. The 
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complexity of the problem is well illustrated in figure 1.2. In the initial step of the metabolic 
activation of B[a]P, cytochrome P450s A1, 1A2, 1B1, 3A4, and 2C catalyze the formation of 
arene oxides and phenols.87-90 The arene oxides may arrange spontaneously to phenols or 
undergo hydration catalyzed by epoxide hydrolase, leading dihydrodils. 7,8-Dihydro-7,8-
dihydroxybenzo[a]pyrene is further oxidized to anti- and syn-7,8-dihydroxy-7,8,9,10-
tetrahydrobenzo[a]pyrene (BPDE) in a reaction catalyzed by P450s 1A1, 1A2, and 1B1, as well 
as other enzymes.91-93 Among the four BPDE enantiomers produced in these reactions, the 
(7R,8S,9S,10R)-enantiomer of anti-BPDE is generally formed to the greatest extent and shows 
the highest carcinogenic activity.91-94 This diol epoxide reacts with DNA in vitro and in vivo, 
producing a major adduct in which the exocyclic amino group of deoxyguanosine undergoes 
trans addition to carbon 10 of BPDE. Convincing evidence clearly supports the hypothesis that 
the formation of this and related minor DNA adducts is the major metabolic activation pathway 
of B[a]P.91-96 Other pathways of B[a]P metabolism lead predominantly to detoxification. These 
include phenol formation, glutathione conjugation of arene oxides and diol epoxides involving 
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Figure 1.2 Overview of B[a]P metabolism.  
EH, epoxide hydrolase; DHD, dihydrodiol dehydrogenase. Adapted from ref. [91]. 
 
By virtue of the rich heterogeneous distribution of metabolic products they produce, PAH 
provide a full spectrum of the complexity associated with understanding the initial phase of 
carcinogenesis.  During the past decades tremendous efforts have been made to develop bio-
analytical techniques that possess the selectivity and sensitivity for the problem at hand. The 
general scheme consists on sample clean-up and pre-concentration prior to metabolites 
separation and determination.97-100 Depending on the complexity of the sample and the relative 
concentrations of the targeted metabolites, a combination of preparation techniques is often 
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necessary to reach the limits of detection of the instrumental method of analysis.101-104 The 
numerous preparation steps open ample opportunity to metabolite loss and collection of 
inaccurate data. Separation of metabolites has been accomplished via HPLC, capillary 
electrophoresis (CE) and GC. Ultraviolet –visible absorption and room temperature fluorescence 
detection have been widely used with both HPLC and CE.105-110  
Although the strong fluorescence of metabolic products provides these methods with 
excellent LOD, the broad nature of room-temperature fluorescence spectra drastically reduces 
their qualitative potential for unambiguous determination of co-eluted metabolites. Since the 
identification of metabolic products is solely based on retention times, the unambiguous 
determination of closely related metabolites requires complete resolution in the chromatographic 
column. This is not a trivial task as many metabolites often present similar chromatographic 
behaviors. The ultimate specificity belongs to high-resolution MS either coupled to gas 
chromatography (GC-MS) or HPLC (HPLC-MS).97-100,111-113 However, the existence of 
chemically related metabolic products with virtually identical fragmentation patterns often 
challenges the specificity of these techniques. The issue of selectivity becomes even more crucial 
when facing a distribution of stereo-isomeric metabolites and, therefore, stereo-specific additions 
to DNA. The ability to directly determine the presence and the amounts of targeted metabolites 
without the need of extensive sample preparation and/or chromatographic separation, even if 
closely related stereo-isomers are present in far higher concentrations than their most 





1.6 Original Components of this Dissertation  
The research presented here has led to considerable improvements in various fronts. The 
first original component of this dissertation – which we have named solid-phase nano-extraction 
(SPNE) - deals with the use of gold nanoparticles (Au NPs) as extracting material for PAH. The 
advantages of SPNE are demonstrated for the analysis of PAH in water samples via both HPLC 
and Laser-Excited Time-Resolved Shpol’skii Spectroscopy (LETRSS). The same approach is 
then extended to the analysis of monohydroxy-PAH in urine samples via SPE- HPLC and In-
Capillary SPNE-CE.   
The second original component of this dissertation describes the application of Shpol’skii 
Spectroscopy to the analysis of polar PAH metabolites. The outstanding selectivity and 
sensitivity for the direct analysis of PAH at trace concentration levels has made Shpol’skii 
spectroscopy a leading technique in environmental analysis. Unfortunately, the requirement of a 
specific guest-host combination - typically a non-polar PAH dissolved in an n-alkane - has 
hindered its widespread application to the field of analytical chemistry. This dissertation takes 
the first steps in removing this limitation demonstrating its feasibility for the analysis of polar 










CHAPTER 2 HIGH RESOLUTION MOLECULAR SPECTROSCOPY 
IN LOW-TEMPERATURE CRYSTALLINE MATRICES 
 
J. S. de Klerk, H. Wang, A. D. Campiglia, C. Gooijer and F. Ariese; “Lasers in Chemistry”; 
Edited by M. Lackner, Wiley-VCH, Weinheim, 2008; pp 655-695. 
 
Absorption and luminescence spectroscopy of organic molecules in liquid solutions and 
solid matrices are important tools for compound identification and quantitation, structure 
elucidation and for studying reaction chemistry. The simplicity of experimental procedures 
makes room-temperature analyses the most popular approaches. Unfortunately, absorption and 
luminescence (fluorescence and phosphorescence) spectra at room temperature are generally 
very broad and diffuse, with spectral bandwidths ranging from a few hundred to a few thousand 
wave-numbers. As a result, the information content of room-temperature spectra is rather limited. 
This limitation has prompted numerous researches to devote significant efforts on finding 
conditions that would enable one to observe vibrational structure in condensed-phase electronic 
spectra. The most important techniques currently available for high-resolution spectra are 
fluorescence line-narrowing spectroscopy, spectral hole burning spectroscopy and Shpol’skii 
spectroscopy. Their fields of applications range from organic molecules in crystals, polymers and 
glasses, to very complex biological systems, including proteins and nucleic acids containing 
chromophores, as well as reaction-center complexes of photosynthetic units.100,114  
Closely related to this dissertation is Shpol’skii spectroscopy. The name Shpol’skii was 
introduced in honour of the Russian scientist E.V. Shpol’skii, who published an important 
experimental discovery in 1952115 and initiated worldwide research in this field. He found that 
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upon cooling PAH to 77 K in polycrystalline n-alkane solvents the otherwise broad fluorescence 
and absorption spectra showed much narrower spectral bands – denoted as ‘quasi-lines’.  
Although Shpol'skii spectrometry has been recognized as a powerful technique for the 
environmental analysis of PAH, its widespread use has been hampered by several reasons. These 
include inconvenient sample freezing procedures, questions about signal reproducibility for 
calibration purposes, lack of reference databases, and most importantly, lack of selectivity for the 
unambiguous determination of targeted PAH in highly complex samples. In this chapter, we 
review basic principles on luminescence phenomena, homogeneous and inhomogeneous band-
broadening and state-of-the-art research that eliminates most of the limitations of Shpol’skii 
Spectroscopy.  
 
2.1 Basic Concepts on Luminescence Phenomena  
A partial Jablonski diagram, depicting the various activation and deactivation processes 
for an aromatic molecule, is shown in Figure 2.1116. An absorption, or excitation, process (A) can 
occur into the first or higher excited singlet state. Excitations into the first and second singlet 
states (S1 and S2) are shown. This process is relatively fast and occurs on the order of 10-15 s. 
Following excitation, the molecule typically undergoes vibrational relaxation (VR) into the 
ground vibrational level of the electronic excited state. The excess of vibrational energy is 
converted to thermal or translational energy. VR occurs on the order of 10-11 to 10-10 s. If the 
molecule resides in an upper excited singlet state (S2), internal conversion (IC) into the S1 
electronic level can occur. This process is efficient if the ground vibrational level of the S2 state 
has the same energy as an upper vibrational lever of the S1 state. The internal conversion process 
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Figure 2.1 Jablonski diagram.  
A is the absorption, F is the fluorescence, P is the phosphorescence, VR is the vibrational relaxation, IC is the 
internal conversion, and ISC is the intersystem crossing. 
 
From the S1 state, deactivation of the molecule may happen through various processes. 
External conversion (EC) is a non-radiative deactivation process in which the excited molecule 
transfers its excess electronic energy to surrounding molecules or solvent molecules through 
collisions. From the lowest vibrational level of S1, the molecule may also release the excess of 
electronic energy in the form of a photon. This process is known as fluorescence (F) and it 
occurs on the order of 10-10 to 10-6s. Since IC and VR are comparatively rapid process, 
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fluorescence most often occurs from the ground vibrational lever of the first excited single state 
and is of a longer wavelength than absorption. Fluorescence from the S2 state is rare and will 
only occur if the energy gap between the S1 and S2 states is large enough that ic is not favored.  
The S1 state may also be deactivated by a non-radiative process called inter-system 
crossing (ISC). This process involves a crossover of electronic states similar to IC but it occurs 
between states of different spin multiplicity. Population of the upper vibrational levels of the 
triplet state manifold is followed by VR and IC into the ground vibrational level of the first 
triplet excited state (T1). Deactivation of T1 via the emission of a photon is called 
phosphorescence (P) and it occurs on the order of 10-3 to 103 s. Since phosphorescence occurs on 
a relatively long time scale, T1 is particularly susceptible to collisional deactivations. 117 Non-
radiative deactivation of T1, or quenching, can be a particular problem in the presence of oxygen. 
Molecular oxygen resides naturally in a ground triplet configuration possessing two low-lying 
singlet states with excitation energies of approximately 23 and 38 kcal/mol. Any species having 
excitation energy as low as 23 kcal/mol may be quenched by oxygen via energy transfer. Excited 
singlet states may also be affected by oxygen, but since oxygen quenching is diffusion controlled, 
a high oxygen concentration is necessary to quench the relatively short-lived excited singlet state. 
The removal of oxygen is often accomplished through de-oxygenation of sample solution or 
purging the sample compartment with inert gasses. Similar to phosphorescence, fluorescence is 
always in competition with the various non-radiative deactivation processes of the excited state. 
As a result, fluorescence and phosphorescence intensities intrinsically depend on the relative 
efficiencies of all competing processes affecting their respective excited states. The efficiencies 
of fluorescence and phosphorescence are often expressed in terms of quantum yield (φ ).  
The quantum yield for fluorescence, Fφ , is the ratio of the rate of fluorescence with the 
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rate of absorption, ΦF/ФA, where ΦF = kFnS1V and ФA = kAnS0V. V is the volume of sample 
illuminated; nSx.is the number of molecules occupying the given electronic state x; and kF and kA 
are the rate of fluorescence and absorption, respectively. Under steady state conditions, we can 
assume that nS1 = nS0kA/ (kF + knr), where knr is the sum of rates for the non-radiative processes 
(external conversion, kec; internal conversion, kic; and inter-system crossing, kisc). Using these 
relationships, the fluorescence quantum yield in terms of the rates of the various activation and 






=φ                            (2.1) 
which shows that, in order to improve the fluorescence quantum yield, and hence the 
fluorescence intensity, one needs to minimize the rate contributions from non-radiative 
processes .A similar situation arises for phosphorescence. The phosphorescence quantum yield 












=φ              (2.2) 
Note that the first term in equation (2.2) takes into account the efficiency of inter-system 
crossing. Therefore, to maximize the phosphorescence efficiency, hence the phosphorescence 
intensity, minimization of both non-radiative processes and fluorescence relative to inter-system 
crossing becomes evident. 
Because the excited states (S1 and T1) are often deactivated by first-order processes, the 
decay of either fluorescence or phosphorescence can be described by equation (2.3): 
Lt
t eII
τ/0 −=                      (2.3) 
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Where I0 is the luminescence intensity at time zero and τL is the luminescence lifetime. The 
lifetime is defined as the time it takes for the luminescence to decay to 1/e of its initial value. The 
lifetimes for fluorescence and phosphorescence are related to the rate constant for deactivation 
by equations (2.4) and (2.5): 
1)( −+= nrFF kkτ                       (2.4) 
1)( −+= nrPP kkτ                       (2.5) 
 
Equation (2.1), (2.2), (2.4) and (2.5) indicate that non-radiative decay processes decrease the 
fluorescence and phosphorescence intensities and lifetimes by the same factor. In other words, 
the lifetime and the quantum efficiency are proportional to (kL + knr)-1. 
 
2.2 Achieving High-Resolution Spectra under Shpol’skii Conditions 
Apart from possible instrumental contributions, the spectral line-width in condensed-
phase electronic spectra is determined by inhomogeneous and homogeneous broadening effects. 
Inhomogeneous broadening is related to the fact that in a sample we are usually studying a large 
ensemble of molecules that – although chemically identical – may still show slightly different 
spectra. That is mainly the result of differences in the structure of the solvation shell surrounding 
the chromophore molecules: each individual molecule will experience a slightly different 
interaction with the solvent, resulting in a Gaussian distribution of transition energies (as 
illustrated in Figure 2.2a). In flexible molecules the occurrence of different conformations may 
also play a role. However, when solute molecules adopt the same conformation and experience 
exactly the same environment, like in a theoretically perfect crystalline matrix, their transition 
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Figure 2.2 Cartoon of analyte in amorphous and crystalline matrix and resulting spectral bandwidth. 
 
In practice, the inhomogeneous broadening can be strongly reduced but not completely 
removed. Typical bandwidths in Shpol’skii experiments carried out in n-alkane matrices at 
temperatures of 20 K or lower are 1-3 cm-1. That is sufficient to obtain vibrational resolved 
spectra, but in low-temperature single-molecule experiments thousand-fold narrower transitions 
have been observed.118 Homogeneous broadening factors affect each individual molecule to the 
same extent. In condensed-phase spectroscopy it originates mostly from electron-phonon 
interactions. A phonon is a quantized lattice vibration of the matrix. During an electronic 
transition one or several lattice vibrations can be simultaneously excited. 
The homogeneous spectrum will therefore consist of a superposition of a narrow zero-






2.3. In emission the PW appears as a broad continuum at the low-energy side of the ZPL and in 
absorption at the high-energy side. In a low-temperature environment this phonon sideband is 
often well distinguishable from the ZPL, as shown in Figure 2.3. For most applications one 
would like to obtain strong ZPLs, which means that the temperature should be as low as 
practically possible and solute-matrix interactions should be weak. Both requirements are usually 
met when working under cryogenic conditions with non-polar compounds in an n-alkane matrix, 
but other solute-matrix combinations have also shown Shpol’skii-type spectral narrowing.119  
The intensity I of the profile in 3 may be described in the form:  
),(),(),( TITITI PWZPL ννν +=  (2.6) 







=α  (2.7)  
where S, the so-called Huang-Rhys parameter, is a dimensionless quantity that indicates the 


























Figure 2.3 Electron phonon coupling in emission. 
On the left side three of the many possible phonons are shown, present in a number of overtones. The zero 
phonon transitions for all phonons coincide, resulting in a sharp zero-phonon line (ZPL). The phonons and 
their overtones do not overlap exactly and show up as a broad phonon side band (PSB), red-shifted in 
emission. In practice, excitation into a PSB results in additional broad red shifted emission from an 
inhomogeneous distribution of ZPLs. 
 
 
Ultimately, the remaining source of homogeneous broadening is mainly determined by 
the lifetimes of the different states involved in the transitions. The shorter the lifetime, the less 
precise its energy and the broader the corresponding spectral lines will be. This so-called lifetime 
broadening is a quantum mechanical effect related to Heisenberg’s uncertainty principle,121 and 
is defined as follows:  
  τ ·δE ≈ ħ/2             (2.8)  
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where h is Planck’s constant, δE is the uncertainty in energy and τ is the lifetime of the state 
involved.  When higher excited states are involved, and vibrational relaxation and internal 
conversion are fast, the corresponding spectral broadening is readily observed. In contrast, from 
relatively long-living states such as the first excited state S1 the broadening effect is often 
negligible.118 Thus, the higher-energy transitions observed in Shpol’skii excitation or absorption 
spectra tend to be broader than S0-S1 transitions.122  
In order to obtain a Shpol’skii spectrum the solvent should form a poly-crystalline matrix 
at low temperature. In practice, mostly n-alkane solvents are used. Finding the most appropriate 
solvent is not always evident and may involve some trial and error. Secondly, the analyte should 
fit well into this matrix. In this regard, the three-dimensional shape, polarity, rigidity and the 
number of substituents of the fluorophore are very important. Ideally, the analyte molecule 
displaces a distinct number of solvent molecules in the lattice and will only fit in a single, well-
defined manner in the available space. In that case, the molecules will experience exactly the 
same interaction with the crystalline matrix, which means that the S0-S1 energy differences will 
be identical. However, sometimes there are two or several ways in which the molecule fits in the 
matrix; the molecule is said to occupy different sites (see Figure 2.4). For each site the S0-S1 
energy difference is likely to be different. As a result, a multiplet will appear in the spectrum, 
both in absorption and emission and for every vibronic transition. In other words, two or more 
identical spectra are observed, but shifted over a small amount of energy. The intensity ratio, 
which reflects the relative populations of each site, is constant for every multiplet. By using a 
tuneable laser, one of these subpopulations can be selectively excited in the 0-0 transition or in a 






Figure 2.4 Simple cartoon explaining the occurrence of different sites if the molecule fits in more than one 
way in the crystal.  
The relative line intensities in the spectrum reflect the respective populations. 
 
A laser is not strictly needed to obtain high resolution spectra in Shpol’skii spectroscopy.  
Literature reports show that high quality Shpol’skii spectra can be recorded with a standard 
spectrofluorimeter equipped with a broad-band, continuous wave xenon arc lamp.123,124 The main 
pre-requisite in Shpol’skii spectroscopy is that the solvent forms a regular poly-crystalline matrix 
upon cooling. In the ideal situation the analyte molecule displaces a distinct number of solvent 
molecules in a lattice and fits in a well-defined manner in the available space thus provided. 
Under excellent host-guest compatibility conditions, all solute molecules experience the same 
interactions with the environment and the broadening due to matrix inhomogeneity is reduced to 
about 1cm-1. In the absence of instrumental contributions, that is often also the total spectral 
bandwidth observed which – as shown in Figure 2.5 – it results in vibrational spectral 





Figure 2.5 Jablonski diagram illustrating the concept of Shpol’skii spectroscopy (A) and the resulting 
spectrum (B). 
 Only five vibrations are shown; in the absence of reorientation during the fluorescence lifetime. 
   
            Significant extra broadening can be observed if one of the states involved in excitation or 
emission has a lifetime shorter than approximately one picosecond. The origin of this so-called 
lifetime broadening is the time-energy uncertainty relationship, i.e. when the time of the 
transition can be determined accurately its energy cannot and vice versa. From the broadened 







                       (2.9)
 
where τ is the lifetime of the short-living state, Δυ the homogeneous broadening (in cm-1) and c 
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the speed of light (in cm/s). Usually, in Shpol’skii spectroscopy these effects are only observed in 
excitation when higher electronic states (S2, S1, ...) are involved, since subsequent vibrational 
relaxation and/or internal conversion is fast. As a result, the bands observed in the excitation 
and/or absorption spectrum tend to be broader at shorter wavelengths.122,125 That is the main 
reason selective excitation is bets accomplished within the S1 band. 
 
2.3 Sample Freezing Procedures 
The classic sample preparation procedure for 77 K measurements consists of immersing a 
solution-filled small-diameter tube into an optical dewar filled with liquid nitrogen. The fragility 
of the dewar flask, bubbling in the cryogen at irregular intervals from small ice particles that act 
as nucleation sites, and condensation (frosting) on the outside of the Dewar are nuisances. But 
scattering at each of the air/glass, glass/liquid nitrogen or glass/matrix interfaces can also be a 
severe problem, as stray light usually determines the spectral background and the limit of 
detection. Options to reach temperatures of 5-20 K include using closed-cycle helium 
refrigerators or Joule-Thomson miniature refrigerators. The trade-offs include higher cost and 
reduced sample throughput. Depending on the cooling device, sample size and final temperature, 
the procedure can take between 40 and 100 min. Ariese et al. developed a sample holder that 
strongly improved the user friendliness of the closed-cycle helium refrigerator. It enables the 
simultaneous cooling down of four 10-μl samples in shallow depressions in a gold-plated copper 
sample holder, covered with sapphire windows. These materials guarantee high thermal 
conductivity and therefore fast sample solidification, which is a main condition to obtain good-
quality Shpol’skii spectra. 126 
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Our approach to low-temperature analysis eliminates the need for an optical dewar and/or 
helium cryostats. It consists of a bifurcated fiber-optic probe (FOP) that delivers the excitation 
light directly into the frozen sample. The FOP can simply be lowered into the liquid cryogen for 
fast and reproducible freezing. All interfaces that could scatter exciting light into the detection 
system have been removed from the optical path, providing high quality spectra and excellent 
reproducibility of measurements. A schematic diagram of the FOP is shown in Figure 2.6. The 
probe typically incorporates one delivery and six silica-clad silica collection fibers. A section of 
copper tubing provides mechanical support for lowering the probe into the liquid cryogen. At the 
sample end, the excitation and emission fibers are bundled in a six-around-one configuration 
with vacuum epoxy and fed into a metal sleeve for mechanical support. A sample vial can be 
screwed onto the probe head, assuring a fixed distance from the sample to the tip of the fibers. At 
the instrument end, the collection fibers are bundled with vacuum epoxy in a slit configuration 












Figure 2.6 Cryogenic fiber optic probes for 77K (A) and 4.2K (B) measurements. 
 
After the sample is introduced into the sample vial, it is screwed onto the probe head. The 
tip of the FOP is positioned either above or below the solution surface, and the sample tube is 
lowered into a container filled with liquid cryogen. The cell is allowed to cool for 90 s prior to 
fluorescence measurement to ensure complete sample freezing. If the probe comes into physical 
contact with the sample, the approximately one-minute probe clean up procedure involves 
removing the probe head from the liquid cryogen, melting the frozen matrix and warming the 
resulting solution to approximately room temperature with a heat gun, rinsing the fiber tip with 




2.4 Instrumentation for Emission Measurements in Shpol’skii Matrixes 
The transition wavelengths for many PAH often require frequency doubling or mixing 
techniques to shift the visible laser light into the ultraviolet range. The linewidths of most 
Shpol'skii samples at 77 K are on the order of 20-40 cm-1; even at liquid helium temperature, 
linewidths of less than 1 cm-1 are comparatively rare. Therefore, the 0.1 cm-1 linewidth of high 
performance commercial dye lasers or OPO (optical parametric oscillator) systems is not a 
critical factor, neither is their ability to generate hundreds of mJ in the visible and tens of mJ in 
the ultraviolet. In our lab, we have acquired high quality 77 K and 4.2 K spectra with a very 
compact tuneable dye laser with specifications that are well matched for Shpol’skii spectroscopy. 
Its scanning capability (0.01 nm/step) and its narrow excitation bandwidth (<0.03 nm) allow one 
to record high-resolution excitation spectra or site-selective excitation. Its excitation energy (5 
mJ at the peak of Rhodamine 6G) usually induces sufficient fluorescence so that spectra can be 
recorded with optimum spectrograph slit widths and maximum spectral resolution.  
As for detection, high-resolution Shpol'skii spectra have been recorded with single- and 
multi-channel detection systems.70,127-132 Multi-channel detectors such as a diode arrays131 or 
charge-coupled devices (CCD)70 can acquire emission spectra much faster than is possible with a 
scanning monochromator and a single photomultiplier detector, as was commonly done in earlier 
studies. Collecting the entire emission spectrum at once also avoids problems associated with 
pulse-to-pulse fluctuation, laser intensity drift, and photodecomposition. Pulsed excitation 
sources offer prospects for time-resolved detection in order to improve signal-to-background 
ratios and reduce spectral interference.70,128-132 Early reports on laser-excited Shpols'kii 
spectrometry (LESS) implemented time-resolution at fixed delay time intervals using laboratory-
constructed gated integrators or commercial boxcar averages.127-131 More recently, commercially 
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available delay generators and gated intensified linear photodiode arrays have come into use.70  
Our group has developed instrumentation to efficiently collect multidimensional data 
formats during the lifetime decays of fluorescence (nanoseconds to microseconds) or 
phosphorescence (milliseconds to seconds).133-135 Figure 2.7 shows a schematic diagram of the 
multidimensional luminescence instrument, which integrates a pulsed tuneable dye laser, a delay 
generator, a spectrograph and an intensifier-charged coupled device (ICCD). By setting the 
ICCD gate step parameter, this system automatically increments the time interval between 
successive scans to collect emission spectra at different delay times between the laser firing and 
the opening of the intensifier gate. The series of spectra can be assembled into a wavelength-time 
matrix (WTM), analogous to an excitation-emission matrix (EEM).  The tuning of the dye-laser 
is computer controlled, which facilitates the collection of EEM and time-resolved excitation-
emission matrices (TREEM) in short analysis time. A mechanical shutter facilitates 
phosphorescence spectra and lifetime acquisition over much longer time scales. The shutter is 
controlled either manually (always open or always closed) or programmed through the digital 












Figure 2.7 Instrumentation for multidimensional luminescence spectroscopy. 
FOP: fiber optic probe. ICCD: intensified charge coupled device. Fluorescence measurements are performed 




Multidimensional formats - such as wavelength-time matrices (WTM) and time-resolved 
excitation-emission matrices (TREEM) - combine spectral and lifetime information with 
tremendous potential for the direct analysis of target compounds in complex matrixes. The raw 
data of such formats provide at least five sets of qualitative parameters for compound 
determination, namely excitation, fluorescence and phosphorescence wavelengths and two 
lifetimes. Lifetime analysis from WTMs provides information on spectral peak purity for 
accurate quantitative determination. TREEMs give the analyst the opportunity to select the best 
time window for minimum overlap in highly complex spectra. Applications of this approach, 
which we have named Laser-Excited Time-Resolved Shpol’skii Spectroscopy (LETRSS), have 
focused on the direct analysis of PAH in water and soil samples.  
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2.5 Instrumentation for Absorption Measurements in Shpol’skii Matrixes  
Recording absorption spectra via transmittance through frozen matrixes is a challenging 
task. The main reason is the difficulty to overcome the strong scattering light reaching the 
detector. This is particularly true when thick samples are necessary for recording absorption 
spectra of weak oscillators. In the case of strongly fluorescent (and/or phosphorescent 
compounds), additional errors in absorbance measurements arise from the luminescence reaching 
the detector, which might have an intensity comparable to that of the transmitted light. 
Commercial double-beam spectrophotometers – which afford a very low stray light level – meet 
the requirement for accurate transmittance measurements through highly scattering media but 
fall short with regard to high spectral resolution. 
Nakhimovsky et al. designed the first scanning spectrophotometer for high-resolution 
absorption measurements of PAH and some hetero-PAHs in highly scattering frozen matrices.122 
Their instrument consisted of a double-beam spectrometer using two Czerny-Turner 
monochromators and a continuous-wave xenon lamp as the excitation source. The light selected 
by the first monochromator was alternately sent by rotating mirrors toward the sample and the 
reference. Subsequently the beams were focussed on the second monochromator. Both 
monochromators -which were equipped with 1200 lines/mm gratings- were set at the same 
wavelength and scanned synchronously. To minimize the effect of a possible drift of the 
wavelength drive, a larger bandwidth was used for the first monochromator. A photomultiplier 
was used for sample (IS) and reference (IR) signal detection. Both signals were integrated over a 
certain number of mirror cycles, digitally converted and sent to a computer that calculated the 
absorbance (log(IR/IS)) as a function of excitation wavelength. The inherent disadvantage of this 
system was the time it needed to record a spectrum, which was typically 30 minutes. 
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In 2003 Banasiewicz et al. reported high-resolution Shpol’skii absorption spectra of 
pentacene using a single-beam absorption setup.136 A tungsten lamp was used as the light source, 
which was transmitted alternatively through the solid sample and the solid blank solution. The 
authors used a homemade sample cuvette comprising two quartz windows separated by a 1.5-
mm Teflon ring. A scanning monochromator and photomultiplier operating in the photon-
counting mode was used for detection. In 2008 de Klerk et al. developed an easy-to-use home-
made absorption spectrometer set-up based on transmission measurement that can handle highly 
scattering solid solutions.137 As light source a D2-lamp and white 1 Watt LED was used, together 
covering the whole UV/visible range. This white light – without applying wavelength selection – 
was focussed on the sample, consisting of two cylindrical cells with a 7-mm diameter and 1-mm 
or 5-mm optical path length and sapphire windows on both sides. They were used for the sample 
and the solvent blank (reference), respectively. The samples were cooled by a closed-cycle 
helium refrigerator to 14 K. Detection was performed with a 30-cm monochromator and a CCD 
camera. The monochromator is equipped with 300, 1200 and 2400 l/mm gratings. The spectra 
were corrected for lamp profile and background scatter (we are dealing with strong scatter in the 
case of frozen polycrystalline solvents) by consecutive measurements of the sample and the 
blank. The advantage of this setup is that an absorption spectrum can be measured at once 
without monochromator scanning; the time to record a full spectrum is less than 1 minute. Its 









 Figure 2.8 (A) Representation of optical phenomena occurring at the irradiated surface of the frozen matrix; 
(B) Schematic diagram of the tip of the cryogenic fiber optic probe.  
Where I0 = incident radiation; IT = transmitted radiation; IS = scattered radiation; IPL = photoluminescence 
(fluorescence and/or phosphorescence); IRFL = reflected radiation. 
 
 
Our approach to low-temperature measurements is fundamentally different as the sought 
for information is the intensity of the laser excitation returning from the frozen sample to the 
detector device125. The basis of our approach is illustrated in Figure 2.8. Laser excitation 
returning from the sample is collected with the emission fibers of the cryogenic probe located 
above the surface (~1 cm) of the frozen matrix. Equation (2.10) is the basis for generating 
absorption spectra in the backscattering mode: 
I0 (λ0) = IA (λ0) + IRR (λ0)    (2.10) 
where I0, IA and IRR represent the radiant powers of laser excitation, absorption and returning 
intensities at the wavelength of excitation (λ0), respectively. The experimental procedure is 
straightforward. IRR is monitored as a function of excitation wavelength for both blank (IRRB) and 
analyte (IRRAn+B) solutions. The absorption spectrum of the analyte is then obtained from the 





Figure 2.9 Experimental data generated at 4.2 K with the FOP and the instrument.  
Data was generated from 10μg.mL-1 pyrene solution in n-octane. Curves I and II represent the intensities of 
the excitation energies monitored from the blank [IRRB(λ0)] and analyte [IRRAn+B(λ0)] solutions. Curve III 
represents the net PAH signal. Each data point in the graphs corresponds to the accumulation of 100 laser 
pulses. Delay and gate times were 0 and 10ns, respectively. Slit width of the spectrograph, 40μm.  
 
Figure 2.9 illustrates the type of data generated with the cryogenic probe and the laser 
system in Figure 2.7. Curves I and II represent the intensities of excitation energies returning 
from n-octane (IRRB) and PAH/n-octane (IRRAn+B), respectively. As expected, the relatively lower 
absorption of n-octane provides a higher signal than the PAH. Curve III represents the net PAH 










Figure 2.10 4.2K absorption spectra recorded with the FOP and the instrument from 0.1μ g.mL-1 naphthalene 
in n-pentane (left side) and 0.1μ g.mL-1 benzo[a]pyrene in n-octane (right side). 
Spectra were generated recording laser scatter at 0.1nm excitation steps. Signal intensity at each excitation 
wavelength results from 100 laser pulses. The ICCD was operated at 0 and 10 ns delay and gate times, 




Figure 2.10 shows the 4.2 K absorption spectra of naphthalene in n-pentane and 
benzo[a]pyrene in n-octane. These PAH/n-alkane combinations are well known examples of 
single-site and multisite systems, respectively. Both spectra compare well to previously reported 
spectra at 5 K. A peculiar feature of these spectra is the presence of featureless absorption bands 
underlying the quasi-line absorption spectra. The broad absorption bands have been attributed to 
the presence of disordered groups of solute molecules or pre-aggregates in the frozen matrix.100  
 
2.6 Applications of the Fiber Optic Probe and the Multidimensional Luminescence 
System to the Environmental Analysis of PAH 
The fiber optic probe shown in Figure 2.6 and Figure 2.7 provides a simple way to 
combine sample extraction and spectroscopic analysis. We have taken advantage of this feature 
interfacing LETRSS to SPE and solid-liquid extraction for the analysis of liquid and solid 
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samples, respectively.134,138-151 Figure 2.11depicts the procedure for SPE-LETRSS analysis of 
liquid samples, including SPE extracts of water samples and HPLC fractions. The experimental 
procedure is straightforward. After passing the water sample through the SPE cartridge, the 
extraction membrane is placed in the sample vial and micro-liters of Shpol’skii solvent are 
spiked on its surface. A fraction of non-polar analytes such as PAH will partition into the n-
alkane solvent. The sample is allowed to equilibrate at room-temperature for approximately 5 
min, then the vial is attached to the FOP and the fiber assembly is lowered into the liquid 
cryogen for LETRSS measurements. PAH fitting the polycrystalline matrix will provide quasi-
line Shpol’skii spectra for direct fingerprint determination. Peak assignment is carried out via 
spectral comparison to standards in the pure Shpol’skii solvent. Spectral purity of target peaks is 
tested via WTM collection. A single exponential decay indicates the presence of a single 
component. Further comparison of the fluorescence lifetime to the lifetime of the standard 
provides additional information for unambiguous determination. Figure 2.12 shows the direct 
spectral identification (without prior HPLC separation) of 15 EPA-PAH listed as priority 
pollutants from a contaminated water sample at the parts-per-trillion level. The analysis was 


























Figure 2.12 Laser Excited Shpol’skii spectrum of polluted surface water sample showing specific peaks of 15 
PAH. 
I = Fluorene; II = Benzo[k]fluoranthene;  III = Anthracene; IV = Indeno[1,2,3-cd]pyrene; V = 
Benzo[a]pyrene;  VI = Dibenz[a,h]anthracene; VII = Acenaphthene;  VIII = Benzo[b]fluoranthene;  IX = 
Fluoranthene;  X = Benzo[a]anthracene;  XI = Phenanthrene;  XII = Chrysene; XIII = Benzo[g,h,i]perylene;  
XIV = Naphthalene;  XV = Pyrene. 
 
 
Quantitative analysis can be done either by the calibration curve or the multiple standard 
additions method. There is a linear relationship between the PAH concentration in the Shpol’skii 
layer and its concentration in the liquid sample that follows the relationship below:134,135 
 
CH2O = (VSS/f1VH2O + KdVSLE/f1VH2O)CSS,   (2.11) 

















































where f1 is the isomer fraction extracted from the water sample, Kd is the distribution coefficient 
between the membrane and the Shpol’skii solvent, and VSS, VSLE, and VH2O are the volumes of 
Shpol’skii solvent, extraction membrane, and water, respectively. Equation (2.11) predicts a 
linear relationship between CH2O and CSS upon constant f1, Kd, VSS, VH2O, and VSLE. The analyst 
sets constant values for VSS, VH2O, VSLE, and f1. In our case, VSS = 100 μL, VH2O = 10 mL, and 
VSLE = 23.8 μL. VSLE is calculated using the standard formula of a cylinder V = πr2h, where r is 
the average radius of a disk (0.275 cm) and h is its average thickness (0.1 cm). 
  The main advantages of SPE-LETRSS include short analysis time (~ 10 min per 
sample), reduced solvent consumption (100 μL per sample) and lower limits of detection (LOD). 
Depending on the compound, the LETRSS method was one to two orders of magnitude better 
than HPLC with fluorescence detection.144,148 
We developed a similar approach to screen PAH in soil samples.144 A known amount of 
soil sample (0.0025-0.05 g) is mixed with 0.25 mL of Shpol’skii solvent in the sample vial and 
the mixture is sonicated at room temperature for 30 min in a sonication bath. After 5 min of 
settling time, the vial is coupled to the copper tubing of the FOP, keeping the tip of the fiber 
assembly at a fixed distance above the surface of the liquid layer. LETRSS measurements are 
then performed after lowering the copper tubing into the liquid cryogen. Figure 2.13 shows 
examples of Shpol’skii spectra generated with the screening method. The 15 EPA-PAH are 
clearly identified in both types of soils with no apparent matrix interference. PAH partition into 
the layer of extracting solvent to provide highly resolved spectra and distinct lifetime values for 







Figure 2.13 4.2K fluorescence spectra obtained from extracts of reference standard materials CRM 104-100 
(Panel A) and CRM 105-100 (Panel B). 
Identified PAH are the following: I = flourene, II = naphthalene, III = acenaphthene, IV = phenanthrene, V = 
chrysene, VI = pyrene, VII = anthracene, VIII = benzo[a]anthracene, IX = dibenz[a,h]anthracene, X = 
benzo[b]fluoranthene, XI = benzo[a]pyrene, XII = fluoranthene, XIII = benzo[g,h,i]perylene, XIV= 
benzo[k]fluoranthene, XV = indeno[1,2,3-cd]pyrene.   Portions of spectra within dashed vertical lines 
represent magnifications of entire fluorescence spectrum. Compounds II and III were determined using 





PAH recoveries are reported in Table 2.1. As individual PAH are present in soils at the 
ng.g-1 level, the direct determination of nanogram of PAH in mg of soil sample – i.e. sub-ng.g-1 
to pg.g-1 - with no need for sample pre-concentration, clean up steps and previous PAH 
separation demonstrates the remarkable potential of the screening method. Using the same 
solvent (n-octane) for PAH extraction and LETRSS analysis leads to acceptable PAH recoveries 
with minimum sample handling.  The entire LETRSS analysis takes less than 10 min per sample 
and it consumes 250 μL of organic solvent. These facts make this approach environmentally 





















Table 2.1 PAH recoveries obtained with the screening method.  
PAH 









Naphthalene 44.01 ± 5.07 16.9 ± 2.0 52.27 ± 4.20 20.5 ± 1.5 
Acenaphthene 40.23 ± 2.35 15.5 ± 0.9 53.45 ± 4.63 856.5 ± 74.2 
Fluorene 48.27 ± 1.25 15.9 ± 0.4 48.87 ± 3.26 449.6 ± 30.0 
Phenanthrene 41.90 ± 9.46 121.3 ± 27.4 49.57 ± 3.77 1425.1 ± 108.3 
Anthracene 42.08 ± 6.76 30.3 ± 4.9 44.79 ± 4.45 464.7 ± 46.2 
Fluoranthene 21.52 ± 1.51 264.7 ± 18.6 53.67 ± 2.80 1891.8 ± 98.7 
Pyrene 30.79 ± 1.89 230.9 ± 14.2 57.49 ± 3.94 1523.5 ± 104.4 
Benzo[a]anthracene 30.93 ± 3.04 123.4 ± 12.1 48.75 ± 3.63 305.9 ± 22.8 
Chrysene 51.84 ± 3.67 222.9 ± 15.8 51.63 ± 6.48 409.2 ± 51.4 
Benzo[b]fluoranthene 52.94 ± 8.85 256.5 ± 42.9 54.36 ± 2.91 135.9 ± 7.3 
Benzo[k]fluoranthene 41.75±4.86 106.5 ± 12.4 53.74 ± 1.90 87.1 ± 3.1 
Benzo[a]pyrene 48.88 ± 1.91 124.4 ± 4.9 52.86 ± 6.62 111.0 ± 13.9 
Indeno[1,2,3-cd]pyrene 42.11 ± 3.08 93.9 ± 6.9 49.95 ± 4.12 26.8 ± 2.2 
Dibenzo[a,h]anthracene 48.39 ± 3.77 37.5 ± 2.9 51.48 ± 5.98 14.0 ± 1.6 
Benzo[g,h,i]perylene 32.36 ± 2.57 57.9 ± 4.6 53.90 ± 3.73 30.5 ± 2.1 
     
a
 PAH recoveries were calculated according to the equation: Recovery (%) = [mass of PAH 
in extract / mass of PAH in soil sample] x 100; where mass of PAH in extract (ng)  = C PAH in 
EXTRACT (ng/mL) x 0.25mL  and mass of PAH in soil sample (ng) =  CPAH in SOIL (ng/g) x 
weight of soil sample (g). The PAH concentration in the soil extract (C PAH in EXTRACT) was 
determined via multiple standard additions. The PAH concentration in soil (CPAH in SOIL) is 
the certified PAH concentration of the reference standard. Reported values are an average of 
three soil extractions. b Mass of PAH in soil extract,  calculated by multiplying the PAH 








As previously noted, the carcinogenic potency of DB[a,l]P is approximately 100 times 
higher than that of B[a]P. Several of its isomers - including DB[a,e]P, DB[a,h]P, DB[a,i]P and 
DB[e,l]P –are also carcinogenic, but to a lesser extent than DB[a,l]P. Thus, isomer-specific 
determination of DB[a,l]P in environmental samples is highly relevant, even when present at 
relatively low concentrations. Until recently, analysis was hampered by chromatographic 
interference and the large number of isomers. Using a Shpol’skii approach, however, Kozin and 
coworkers were able to identify and quantitate DB[a,l]P in river sediment extracts.74 In an n-
octane matrix the compound occurs in two distinct sites, which could each be selectively excited 
with a laser for its unambiguous identification. For these experiments the use of time-resolved 
detection with a relatively long delay was also crucial to reduce interference from other 
compounds with shorter fluorescence lifetimes. Although its concentration was typically two 
orders of magnitude lower than that of B[a]P in the samples analyzed, combined with its 100 
times higher potency it is nevertheless highly relevant. Although in recent years there has been 
some effort trying to improve analytical methodology for DB[a,l]P,152 there are still only very 
limited data on its formation and presence in the environment.  
Our group developed a method for determining the five DBP isomers in water 
samples.141,142 The method is based on SPE-LETRSS and follows the experimental procedure 
shown in Figure 2.11. Once extracted on the membrane, DBP isomers partition into the spiked 
layer of Shpol’skii solvent (n-octane) to provide highly resolved spectra and distinct lifetime 
values for unambiguous isomer determination. Figure 2.14 shows the fluorescence spectra of five 
synthetic mixtures containing the DBP isomers. Each mixture was prepared with the target 
isomer at a concentration 100 × lower than the concentrations of the other isomers. Each 
spectrum corresponds to the first spectrum of a WTM. Each WTM was collected at the 
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maximum excitation wavelength of the target isomer using its optimum delay and gate times. 
Spectral comparison to individual standards provided a minimum of two peaks per isomer with 
no spectral overlapping from concomitants. The fluorescence decays  also stripped from the 
WTM at the target fluorescence wavelength of each isomer  were single-exponential decays 























Figure 2.14 4.2 K fluorescence spectra from synthetic mixtures with the five DP isomers. 
Each mixture contained the target isomer at 0.1 µg·mL-1 concentration and the other four isomers at 10 
µgmL-1 concentration. In each mixture, the target isomer was the following: (A) DB[a,l]P; (B) DB[a,e]P; (C) 
DB[a,h]P; (D) DB[a,i]P; (E) DB[e,l]P. Experimental parameters were the following: (A) λexc = 323 nm, td/tg = 
10/250ns; (B) λexc = 310 nm, td/tg = 10/150 ns; (C) λexc = 316.5 nm, td/tg = 0/15 ns; (D) λexc = 304 nm, td/tg = 
10/650 ns; (E) λexc = 288 nm, td/tg =10/150 ns. In all cases, spectrograph slits were 40 µm. All spectra 





Table 2.2 compares fluorescence intensities and lifetimes of standards and mixtures. The 
intensity ratios recorded from standards (IS) and mixtures (IM) are close to unity showing that no 
inner filter effects deteriorate the accuracy of analysis at these concentration levels (data not 
shown). The statistical equivalence of fluorescence lifetimes (N1 = N2 = 6; α =0.05) shows no 
synergistic effects and confirms unambiguous isomer determination without previous separation. 
 
Table 2.2 Lifetime analysisa of DBP isomers on extraction membranes spiked with 100 µL of octane. 
PAH Lifetime of standards (ns) Lifetimes from mixtures (ns) 
DB[a,l]P 78.0±2.9 77.1±1.6 
DB[a,e]P 55.6±1.4 53.8±1.2 
DB[a,h]P 5.9±0.2 6.0±0.2 
DB[a,i]P 214.2±6.9 220.1±5.0 
DB[e,l]P 53.2±1.2 50.5±2.7 
 
a Lifetimes and standard deviations are based on six replicate measurements from 











CHAPTER 3 INSTRUMENTATION 
This chapter presents the instrumentation used to collect the experimental data that is common to 
all subsequent chapters of this dissertation. 
 
3.1 Room-Temperature Absorption Measurements with Commercial Instrumentation 
Absorbance measurements were carried out with a single-beam spectrophotometer 
(model Cary 50, Varian) equipped with a 75-W pulsed xenon lamp, 2-nm fixed bandpass, ±0.1 
nm wavelength precision, and 24 000 nm.min-1 maximum scan rate. All measurements were 
made by pouring liquid solutions into 1 cm ×1 cm quartz cuvettes. 
 
3.2 Room-Temperature and 77 K Fluorescence Measurements with Commercial 
Instrumentation 
Fluorescence excitation and emission spectra were acquired with a spectrofluorometer from 
Photon Technology International. The excitation source was a continuous wave 75-W xenon 
lamp with broadband illumination from 200 to 2000 nm. Detection was made with a 
photomultiplier tube (model 1527) with spectral response from 185 to 650 nm. The excitation 
and emission monochromators had the same reciprocal linear dispersion (4 nm.mm-1) and 
accuracy (±1 nm with 0.25-nm resolution). Their 1200 grooves/nm gratings were blazed at 300 
and 400 nm, respectively. Wavelength reproducibility was ~±2 nm. The instrument was 
computer controlled using commercial software (Felix32) specifically designed for the system. 
Excitation and emission spectra were corrected for wavelength dependence of excitation light 
source and detector sensitivity, respectively. Correction was made in the post acquisition mode 
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using the radiometric correction factors included in Felix32 software. Room-temperature 
measurements were made by pouring liquid solutions into 1 cm×1 cm quartz cuvettes. The 77 K 
measurements followed the classic procedure of immersing the sample solution in a quartz tube 
into a nitrogen filled Dewar flask. 
 
3.3 Fluorescence and Absorption Measurements at 4.2K 
Measurements at 4.2K were carried out with the aid of the FOP and the MLS shown in 
Figure 2.6 and 2.7, respectively. The complete description of the MLS and its capabilities with 
regard to fluorescence and phosphorescence measurements have been reported previously.135 
Here we only provide a brief description of the hardware for absorption and fluorescence 
measurements. Excitation energy is generated by directing the output of a Northern Lights 
tunable dye laser (Dakota Technologies, Inc.) through a KDP frequency-doubling crystal. When 
pumped with ~30 mJ from the second harmonic generator of a Nd:YAG Q-switched laser 
(Quanta Ray), it produces more than 5 mJ at peak of rhodamine 6G in a spectral bandwidth less 
than 0.03 nm. The minimum wavelength step of the tunable dye laser is 0.1 nm. The 
multichannel detector consists of a front illuminated ICCD (Andor Technology). The intensifier 
in front of the CCD chip acts as a superfast shutter, capable of operating on nanosecond time 
scale. The minimum gate time (full width at half-maximum) is 2 ns. The CCD has the following 
specifications: active area, 690×256 pixels (26 μm2 pixel size at photocathode); dark current, 
0.002 electrons pixel-1 s-1; and readout noise, 4 electrons at 20 kHz. The ICCD is mounted at the 
exit focal plane of a spectrograph (SPEX 270M) equipped with a 1200 grooves/mm grating 
blazed at 500 nm. The distance between collection probe and the entrance slit of the spectrograph 
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was optimized to completely illuminate the diffraction grating area. The system is operated in the 
external trigger mode. A trigger signal from the Nd:YAG laser prepulse trigger is sent to the 
delay generator (Stanford Research System DG535) 140 ns before the laser fires to account for 
inherent delays in the electrical cables and components.  
Data acquisition parameters (gate delay and gate width) are entered on the control computer 
with the Andor software and the appropriate control signals are sent via a GPIB interface to the 
pulse generator. Once triggered by the laser, the pulse generator uses this information to 
determine when the image intensifier in the detector head is gated on (gate delay) and for how 
long it is gated on (gate width). When the intensifier is gated off, the acquired data are 
transferred from the detector head to the controller card (32-bit Intelligent Bus-Mastering PCI 
card) in the computer. Complete instrument control was carried out with LabView (National 
Instruments, version 6.0) based software developed in our laboratory.  
All spectra were recorded by tuning the grating of the spectrograph to the central 
wavelength of the spectral range of interest. For each position of the grating, the spectrograph 
covered a 40-nm spectral range. If a larger spectral range were of interest, the spectrograph 
would have to be tuned to the central wavelength of the new spectral range and the process 
repeated. Unless otherwise noted, each spectrum corresponds to the accumulation of 100 laser 
pulses. A 0-ns delay and a 10-ns gate allowed the CCD to acquire laser scatter during the 
duration of the pulse (full width at half-maximum (fwhm) ~5 ns). The 10-ns gate width provided 
satisfactory signal-to-noise ratios with minimum fluorescence interference. Fluorescence spectra 
were recorded using a minimum delay of 10 ns, which was sufficient to avoid the need to 
consider convolution of the laser pulse with the analyte signal. The gate width varied with the 
fluorescence lifetime of the PAH. Gates equivalent to ~ 4× or 5× the lifetime of the PAH were 
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sufficient to collect most of the PAH fluorescence and still avoid instrumental noise.  
For absorption measurements, the limiting resolution of the instrumental system was 
determined by the laser scanning rate, i.e., 0.1 nm/data point. For fluorescence measurements, 
the limiting resolution was determined by the multichannel detection system. The limiting 
resolution of the spectrograph/ICCD was determined with the Hg lamp placed at the analysis end 
of the fiber-optic probe. The experimental value (0.42 nm) of the fwhm for the Hg line at ~313 
nm was within the theoretical value calculated from the spectral range of an individual pixel in 
the CCD array. Considering the reciprocal linear dispersion (RL = 3.1 nm/mm) of the 
spectrograph, the number of active pixels (690×256) in the array, and the dimensions (18×6.7 
mm) of the active area of the CCD chip, the spectral range of 1 pixel should give a 0.08-nm 
limiting resolution. Because of the detector cross talk and the intensifier, the factual limiting 
resolution corresponds to 4-5 pixels (5), i.e., 0.32-0.40 nm. 
 
3.4 HPLC Analysis 
PAH were analyzed using a computer controlled HPLC system from Hitachi (San Jose, CA) 
equipped with the following basic components: a pump (L-7100), a UV detector (L-7400 UV), a 
fluorescence detector (L-7485), and an online degasser (L-761). Separation was carried out on a 
Supelco (Bellefonte, PA) Supelcosil TM LC-PAH column with the following characteristics: 15-
cm length, 4-mm diameter, and 5-μm average particle diameters. Laboratory reagent blanks were 
run in conjunction with each series of samples using identical conditions of glassware, 
equipment, solvents, and analysis to ensure absence of interfering contamination. Complete 
chromatographic separation of EPA-PAH was first monitored via ultraviolet-visible (UV-VIS) 
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absorption spectroscopy. Satisfactory resolution of the 16 PAH was achieved with a 
methanol/water mobile-phase gradient. The settings and conditions of the analysis included 1.5 
mL/min flow rate, isocratic elution with 60/40 methanol/water for 5 min, and then linear gradient 
to 99% methanol over 20 min. The total separation time was 50 min. All sample injections 
were held constant at 20 μL using a fixed volume injection loop.  
Analytical figures of merit (AFOM) in the fluorescence detection mode were obtained using 
the following time-programmed excitation/emission wavelengths: 0 min, 240/330 nm; 11 min, 
234/320 nm; 16.5 min, 252/320 nm; 18 min, 252/370 nm; 20.5 min, 252/402 nm; 22.5 min, 
252/402 nm; 23.6 min, 238/398 nm; 26.0 min, 278/ 395 nm; 31 min, 268/398 nm; 39 min, 
304/421 nm; 45 min, 300/ 466 nm; and 50 min, 300/466 nm. In cases where contiguous PAH 
elution was too fast for individual wavelength optimization, a compromise was made among the 
maximum excitation/emission wavelengths of the contiguous PAH. Acenaphthylene was the 
only PAH to present no RTF under the experimental conditions of this study. Its determination 
via UV-VIS absorption detection was not attempted.  
 
3.5 Capillary Electrophoresis (CE) 
CE was carried out with a GPA100 system purchased from Groton Biosystems. Its detection 
unit consisted of a variable, single wavelength absorption spectrometer (Model VUV 9022-0000; 
JMST Systems) equipped with a deuterium lamp and a silicon photodiode detector. The capillary 
consisted of a single fused-silica tube, 82 cm in length and 50 mm id acquired from Polymicro 
Technologies. Its polyamide coating was removed with a window maker (MicroSolv-CE) to 
provide an UV transparent detection window of approximately 2 mm long. Complete instrument 
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control was performed via PC with customized software (WinPrinCE, PrinCE CE systems). 
Sample injection was accomplished via hydrodynamic pressure.  
Electrophoretic measurements were made with the aid of an 82cm ×50μm I.D. (375μm O.D.) 
fused-silica capillary (Polymicro Technologies). The polyamide coating was removed with a 
window maker (MicroSolv-CE) to provide an UV transparent detection window with an 
approximate length of 2 mm. The center of the optical window was located at 58cm from the 
injection port. Each day the capillary was rinsed for 30min with 1M NaOH followed by a 5min 
rinse with buffer to the beginning of data collection. The capillary was rinsed for 30min at the 

















CHAPTER 4 DETERMINATION OF POLYCYCLIC AROMATIC 
HYDROCARBONS IN DRINKING WATER SAMPLES BY SOLID-
PHASE NANO-EXTRACTION AND HIGH-PERFORMANCE 
LIQUID CHROMATOGRAPHY 
 
H. Wang and A. D. Campiglia*, Analytical Chemistry, 2008, 80, 8202 – 8209. 
 
4.1 Introduction 
In this chapter, we present a novel alternative for the extraction and pre-concentration of 
PAH. Our approach, which we have named solid-phase nano-extraction (SPNE), takes advantage 
of the physico-chemical affinity that exists between PAH and gold nanoparticles (Au NPs). 
Carefully optimization of experimental parameters has led to an SPNE-HPLC method with 
excellent analytical figures of merit (AFOM). Its most significant figure correlates to the small 
volume of water sample one needs for complete PAH analyses. 500μL of water sample are 
sufficient to obtain outstanding precision of measurements at the parts-per-trillion to parts-per-
billion concentration level. The limits of detection (LOD) are excellent as well and range from 
0.9 ng.L-1 (anthracene) to 58ng.L-1 (fluorene). The relative standard deviations at medium 
calibration concentrations varied from 3.2% (acenaphthene) to 9.1% (naphthalene). The 
analytical recoveries of the six regulated WHO-PAH varied from 83.3 ± 2.4% 
(benzo[k]fluoranthene) to 90.8 ± 1.2% (benzo[g,h,i]perylene). The outstanding relative standard 
deviations of the recoveries demonstrate the superior performance of Au NPs over C18 extraction 




4.2 Experimental Section  
4.2.1 Chemicals  
HPLC grade methanol was purchased from Fisher Scientific (Pittsburgh, PA, USA). 
Analytical grade 1-pentanethiol and n-octane were from Acros Organics (Atlanta, GA, USA).  
Otherwise specified, Nanopure water from a Barnstead Nanopure Infinity water system 
(Massachusetts, USA) was used throughout. Au NPs were purchased from Ted Pella, Inc. 
(Redding, CA, USA). All PAH standards were acquired from Sigma-Aldrich (Milwaukee, WI, 
USA) at their highest available purity (>98%) and used with no further purification.  
Note: use extreme cautions when handling PAH that are known to be extremely toxic. 
 
4.2.2 Solution Preparation 
 Stock PAH solutions were prepared in pure methanol and kept in the dark at 4°C. 
Possible PAH degradation was monitored via RTF spectroscopy. PAH working solutions were 
prepared by serial dilution with the appropriate solvent. Commercial solutions of Au NPs were 
kept in the dark at 4°C. The physical integrity of colloids was monitored via UV-VIS absorption 
spectroscopy. Working solutions of Au NPs were prepared by diluting commercial solutions with 
nanopure water. An AccuStandard PAH mixture (Product M-610A) was used as a reference 
standard for HPLC analysis of 16 EPA-PAH. For PAH identification, a working standard was 





4.2.3 Sample Mixing and Centrifugation for PAH Extraction with Gold Colloids 
Sample mixing was carried out with a Maxi Mix III Rotary Shaker (Type M65800, 
Barnstead-Thermolyne) equipped with a PT500X6A Vortex Mixer accessory. Centrifugation was 
performed with a MiniSpin centrifuge (Eppendorf) with maximum rotational speed of 13,400 
rotations per minute (rpm).  
 
4.2.4 UV-VIS Absorption Spectroscopy 
See section 3.1 for instrumental details. 
 
4.2.5 RTF Spectroscopy 
 See section 3.2 for instrumental details. 
 
4.2.6 HPLC Analysis 








4.3 Results and Discussion 
4.3.1 Preliminary Studies on the Interaction of PAH with Au NPs 
The commercial Au NPs solutions used in these studies were synthesized through a citric 
acid reduction reaction.153 Trace amounts of residual citrate ions coexist on the surface of Au 
NPs and act as electrostatic stabilizing agents. Electrostatic stabilization arises from the mutual 
repulsion between neighboring NPs carrying citrate layers with negative surface charges. The 
possibility to extract PAH with Au NPs was first investigated in the absence of citrate ions. Au 
NPs were generated in our laboratory via laser ablation. This is a well-known process that creates 
Au NPs without the presence of counterions or surfactants in the final solution. 154-156  A 10 mm 
× 10 mm Au foil substrate (purity >99.99%) was placed at the bottom of a quartz cuvette 
partially filled with 1 mL of Nanopure water. The output of the second harmonic (520 nm) of a 
10-Hz Nd:YAG Q-switched solid-state laser (Big Sky Laser Technologies) was directed toward 
the metallic surface. After 5 min of sample irradiation, the appearance of a dark red color in the 
supernatant indicated the presence of Au NPs. Absorption spectra recorded from the supernatants 
showed the characteristic Plasmon resonance structure at 520 nm, confirming the presence of 
Au NPs. PAH extraction was immediately tested using benzo[a]pyrene as the model compound. 
The 990 μL of the Au NPs solution was mixed with 10 μL of a 1 μg ·mL-1 benzo[a]pyrene 
methanol solution. After sample shaking for 5 min and centrifugation for additional 20 min, the 
precipitate was separated from the supernatant with a micropipet. RTF spectra of the liquid 
solution confirmed the absence of benzo[a]pyrene in the supernatant and, therefore, its 
adsorption to the surface of Au NPs. Complete extraction of benzo[a]pyrene was also observed 
with commercial solutions of Au NPs. Because the presence of citrate ions does not prevent the 




4.3.2 Centrifugation Time for Au NPs Precipitation 
 Quantitative extraction of PAH requires an appropriate centrifugation time for complete 
collection of Au NPs precipitate. This parameter was investigated via UV-VIS absorption 
spectroscopy. Au NPs solutions with average particle diameters of 5, 10, 20, 40, 60, 80 and 100 
nm were prepared in 1% methanol-water (v/v). This methanol volume was added to facilitate the 
eventual dissolution of trace levels of PAH. Centrifugation was carried out in 2 mL micro-plain 
glass tubes at the maximum rotational speed (13,400 rpm) of our centrifuge. Centrifuged 
solutions of Au NPs with particle diameters equal to or larger than 20 nm presented a clear 
aqueous phase (supernatant) and a reddish solid phase due to the precipitation of Au NPs. Au 
NPs with smaller diameters than 20 nm showed no apparent precipitation at the maximum speed 
of our centrifuge as evidenced by a reddish aqueous phase.  
Absorption spectra were recorded after removing the supernatant from the Microplain 
tube with a glass micro-pipette. Signal intensities were monitored at the maximum absorption 
wavelengths of the Au surface plasmon resonance bands, which varied between 520.3 nm (20 nm 
Au NPs diameter) and 566.7 nm (100 nm Au NPs diameter). Figure 4.1 summaries the behavior 
of the absorption intensity of the supernatant as a function of centrifugation time for 20-, 40- and 
60-nm Au NPs diameters. The expected correlation between precipitation time and particle size 
is clearly observed as the larger (or heavier) Au NPs required shorter centrifugation times for 
complete precipitation. Further studies were then carried out with 20 min of centrifugation time 






















































Figure 4.1 Absorbance intensity of Au NPs as a function of centrifugation time. 
Average diameter of Au NPs was as follows: (●) 20nm, (▲) 40nm and (■) 60nm. The insert shows the 




4.3.3 PAH Precipitation in the Absence of Au NPs  
The possibility of PAH adhesion to the walls of the centrifugation vessels or PAH 




RTF spectroscopy. Working solutions were prepared in 1% methanol-water (v/v). Centrifugation 
was carried out in 2mL Microplain glass tubes for 20 min at 13,400 rpm. Fluorescence intensities 
were monitored before (INC) and after centrifugation (IC) at the maximum excitation and 
emission wavelengths of each PAH. A complete set of RT excitation and fluorescence spectra of 
EPA PAH is presented in Appendix A. The statistical comparisons of INC and IC were based on 
their average values from triplicate measurements of three individually centrifuged aliquots, i.e. 
NNC = NC = 9. Working solutions that had statistically equivalent INC and IC were considered free 
from PAH precipitation. Table 4.1 summaries the maximum concentrations free from PAH 
precipitation along with their statistical comparison. All maximum values are well above PAH 


















Table 4.1 Maximum PAH concentration free from precipitation. 
PAH a 
Maximum 
Ex /Em (nm) 
PAH concentration b 
(ng.mL-1) t exp c 
    
Naphthalene 278/322 30 2.38 
Acenaphthene 292/322 50 1.76 
Fluorene 279/306 30 1.02 
Phenanthrene 294/347 200  2.53 
Anthracene 251/378  40 2.66 
Fluoranthene 288/450 200 0.68 
Pyrene 334/371 75 0.85 
Benzo[a]anthracene 287/386 20 2.54 
Chrysene 269/361 20 1.08 
Benzo[b]fluoranthene 300/445  10  2.14 
Benzo[k]fluoranthene 307/413 30 1.29 
Benzo[a]pyrene 298/404 30 1.83 
Dibenz[a,h]anthracene 300/469 50 1.20 
Benzo[g,h,i]perylene 305/420 10 2.60 
Indeno[1,2,3-cd]pyrene 302/510 30 0.96 
a PAH solutions were made in 1% methanol-water (v/v). b Maximum concentration 
free from PAH precipitation. c t-test of experimental average before ( INC ) and after 












4.3.4 Efficiency of PAH Extraction as a Function of Particle Diameter 
 Four model PAH, namely phenanthrene, chrysene, benzo[a]pyrene and indeno[1,2,3-
cd]pyrene were  selected as representative cases of EPA-PAH containing 3, 4, 5 and 6 rings, 
respectively. All PAH were extracted at the 10ng.mL-1 concentration from standard solutions 
with the same solvent composition, i.e. 1% methanol/water (v/v). All extracting solutions were 
prepared by diluting an appropriate volume of commercial colloid solution with appropriate 
volumes of water and methanol to provide a 1% methanol/water (v/v) final solvent composition. 
The final concentration of Au NPs was the same (5.54 x 109 particles per milliliter) for all 
particle diameters and so it was their final solvent composition (1% methanol/water (v/v)). 
Extracting solutions for each particle diameter were prepared from three different commercial 
batches to account for possible batch-to-batch variations. The extraction procedure consisted of 
shaking 0.95 mL of PAH solution with 0.05 mL of NPs solution for 5min followed by 20 min of 
mixture centrifugation. The shaking time was found to be long enough to achieve maximum 
PAH extraction at 1400rpm mixing speed. Table 4.2 summaries the extraction efficiencies as a 
function of average particle size diameter calculated from RTF signals of PAH standards before 
and after centrifugation. The signal intensities from the supernatants, i.e. PAH solutions after 
centrifugation, were measured in the absence of Au NPs to avoid potential fluorescence 
quenching. As expected, the number of PAH molecules extracted per particle increased with 
particle diameter and total surface area of Au. More interesting to note, however, was the inverse 
trend we observed from both the number of extracted molecules per gram of Au and the number 
of extracted molecules per nm2 of surface area of Au. Because the smaller particles appear to be 












molec.c 1020molec.d molec.e 
particle          g                nm2 
Chrysene a
molec.c    1020 molec.d  molec.e 
particle            g                nm2 
Benzo[a]pyrene a
molec.c    1020 molec.d  molec.e 
particle           g               nm2 
Indeno[1,2,3-cd]pyrene a 
molec.c    1020 molec.d  molec.e 
particle         g                nm2 
      
      
20 0.070      752           93.0        0.598    698             86.3         0.555   551              68.2        0.436    550             68.1         0.436 
40 0.279   1,585           24.5        0.315 1,297             20.1         0.258   994              15.4        0.198 1,010             15.6         0.201 
60 0.627   3,201           14.7        0.283 2,658             12.2         0.235 1,971               9.0        0.174 2,179             10.0         0.194 
80 1.115   3,987             7.7        0.198 3,309               6.4         0.165 2,651               5.1        0.132 2,692               5.2         0.134 
100 1.742   5,368             5.3        0.171 4,832               4.8         0.154 3,779               3.7        0.120 3,651               3.6         0.116 
 
a Initial PAH concentration was 10ppb. All working solutions were prepared in 1% methanol/water (v/v). b Surface area of one particle was calculated 
according to the formula 4r2, where r is the radius of the particle. Total surface area of Au in each working solution was calculated according to the 
formula: [No. of Au NPs in working solution] × [surface area of one particle].c Average number of extracted molecules per Au particle = [number of 
PAH molecules in 1mL of working solution] × [extraction efficiency] / 5.544 x 109 particles. Number of PAH molecules in 1mL of working solution 
were calculated according to the formula: [10x10-9g.mL-1x1mL / formula weight of PAH (g/mol)] x [6.02x1023 molecules/mol]. d Average number of 
extracted molecules per gram of Au = [ average molecules per particle] / [ mass of one particle in gram]. The density of Au is 19.3g/mL.e Average 








4.3.5 Maximum Amount of Extractable PAH and its Correlation to the Volume of 
Commercial Solution for Complete PAH Extraction 
 The extraction procedure was the same as the one previously described. The 
concentration of 20nm Au NPs was kept constant in all extracting solutions (3.5 x 1010 particles 
per milliliter) while PAH concentrations were varied within their respective linear dynamic 
ranges. PAH extraction was monitored via RTF spectroscopy by comparing the RTF intensities 
of supernatants to those recorded from “control” solutions, i.e. PAH standard solutions submitted 
to the same experimental procedure but in the absence of Au NPs.  
Figure 4.2 shows the experimental results obtained for the model PAH. All linear fittings 
were made via the least squares method. The straight lines correlating the data points labeled as 
(▲) represent the fluorescence intensities of PAH standard solutions in the absence of Au NPs. 
The straight line segments representing data points labeled as (●) and (■) correspond to the 
fluorescence intensities of supernatants after centrifugation with Au NPs. Statistical comparison 
showed that the fluorescence intensities within the (●) segments were statistically equivalent to 
the blank signals (α = 0.05, N1 = N2 = 3).157 This fact accounts for the absence of PAH in the 
supernatants and complete PAH extraction within the concentration ranges represented as (●). 
Fluorescence intensities within the (■) segments were statistically different from blank signals 
and increased linearly with PAH concentrations. The signal intensities in the (■) segments were 
lower than the intensities in the (▲) segments as a result of the lower PAH concentrations in the 
supernatants. The lower concentrations reflect the amount of PAH extracted with Au NPs. The 
intercepts of (●) and (▲) segments provide an estimate of the maximum concentration of 
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Figure 4.2 Fluorescence intensity as a function of PAH concentration (ng.mL-1): (A) = phenanthrene; (B) = 
chrysene; (C) = benzo[a]pyrene; (D) = indeno[1,2,3-cd]pyrene. 
Signal intensities were recorded from PAH standard solutions prepared in 1% methanol/water (v/v)  (▲) and 
from supernatants of PAH standards previously extracted with 5% 20nm Au NPs solutions (●/■). Best linear 

















Naphthalene 4.54 ± 0.11 1.30 ± 0.03 
Acenaphthene 6.08 ± 0.15 1.74 ± 0.04 
Fluorene 6.09 ± 0.13 1.74 ± 0.04 
Phenanthrene 6.98 ± 0.28  1.99 ± 0.08 
Anthracene 5.71 ± 0.13 1.63 ± 0.04 
Fluoranthene 6.93 ± 0.29 1.98 ± 0.08 
Pyrene 5.67 ± 0.03 1.62 ± 0.01 
Benzo[a]anthracene 6.61 ± 0.23 1.89 ± 0.07 
Chrysene 6.50 ± 0.06 1.86 ± 0.02 
Benzo[b]fluoranthene 7.48 ± 0.27  2.14 ± 0.08 
Benzo[k]fluoranthene 6.36 ± 0.32 1.82 ± 0.09 
Benzo[a]pyrene 7.46 ± 0.61 2.13 ± 0.17 
Dibenz[a,h]anthracene 6.12 ± 0.13 1.75 ± 0.04 
Benzo[g,h,i]perylene 6.55 ± 0.08 1.87 ± 0.02 
Indeno[1,2,3-cd] pyrene 6.58 ± 0.03 1.88 ± 0.01 
 
a All working solutions were prepared in 1% methanol/water (v/v).  Reported 
values are the averages of 3 independent extractions from the same PAH solution. 
b Maximum concentration of extracted PAH; it was calculated as shown in figure 
2. c MEMPAH = Maximum mass of extracted PAH per Au NP unit; it was 




Table 4.3 lists the maximum PAH concentration that a 5% 20 nm Au NP solution can 
extract from individual PAH standard solutions.  The maximum extractable mass of PAH per Au 
NP (MEMPAH) was calculated dividing the maximum extracted concentration by the number of 
Au NPs in the extracting solution (3.5x1010). The minimum number of Au NPs (mN Au NPs) 
necessary to completely extract a certain mass of PAH in a given volume of water sample (VH2O) 
can then be estimated with the following equation: 




where [PAH] refers to the PAH concentration (ng.mL-1) in the water sample. Based on this 
expression, the co-extraction of a multi-PAH mixture should lead to the following total minimum 
number of Au NPs (TmN Au NPs):  
              n 
TmN Au NPs = ∑ [PAH]i  VH2O / MEMPAHi  (4.2) 
                  i = 1 
 
where i refers to each type of PAH in the mixture. The volume of commercial solution (VCS) with 
known concentration of Au NPs (CCS) can be adjusted to match the total minimum number of Au 
NPs, i.e. TmN Au NPs = CCS x VCS. As such, the minimum volume of commercial solution (mVCS) 
necessary to completely extract a multi-PAH mixture can then be estimated as follows: 
              n                                                            n 
mVCS = ∑ [PAH]i x VH2O / CCS x MEMPAHi = (∑ [PAH]i / MEMPAHi)(VH2O / CCS)   (4.3)  
             i = 1                                                                                    i = 1 
  
Because Eq. (4.1-4.3) do not account for the potential co-extraction of sample concomitants and 
the resulting up-take of particle surface, the analyst should always use a larger extracting volume 
than its minimum value, i.e. VCS > mVCS. Considering that PAH contamination in drinking water 
usually occurs at the sub-nanogram.mL-1 concentration levels, we arbitrarily set VH2O = 0.5mL 
and VCS = 0.95mL for all further experiments. Based on Eq. (4.3), 0.95mL of a 20nm Au NPs 
solution with CCS = 7.0 x 1011 particles.mL-1 should account for the complete extraction of the 15 
EPA-PAH at the individual concentration level of ~ 1.6 x 104 ng.L-1. This concentration is well 
above PAH concentrations usually encountered in drinking water samples. 
 
4.3.6 Releasing PAH for HPLC Analysis  




use an organic solvent with strong binding affinity for Au colloids which, upon its binding to the 
metallic surface, would release PAH to the surrounding medium. Several solvents were 
attempted for this purpose including alcohols (methanol, ethanol, 1-propanol, 1-butanol, 1-
pentanol, 1-hexanol, 1-heptanol and 1-octanol), alkanes (hexane, heptane and octane) and alkane 
thiols (1-pentanethiol, 1-hexanethiol, 1-heptanethiol and 1-octanethiol).  
PAH extractions were carried out from 500μL aliquots of Nanopure water previously 
spiked with 15 EPA-PAH at the 1 x 103 ng.L-1 concentration level. This concentration (CPAH) is 
five times higher than the highest MCL (200ng.L-1) of regulated PAH. After sample 
centrifugation, the supernatant (supernatant A) was removed from the vial and saved for HPLC 
analysis. Micro-litter volumes of releasing solvent were added to the precipitate and mixed with 
48μL of n-octane to favor PAH partitioning into a non-polar environment. The new mixture was 
shaken for 5min at 1400 rpm and centrifuged for 20min at 13,400rpm. Its supernatant 
(supernatant B) was separated from the precipitate and saved for HPLC analysis.  
PAH concentrations in supernatants A ([PAH]A) and B ([PAH]B) were determined via the 
calibration curve method. Their values were used in Eq. 4.4 and 4.5 to calculate the overall 
recovery of SPNE-HPLC (OR) analysis and the extraction efficiency (E) of SPNE:  
 
OR = 100 [PAH]B x VB / CPAH x VW   (4.4) 
E = 100(CPAH x VW - [PAH]A x VA) / CPAH x VW (4.5) 
 
where VW refers to the volume of extracted water and VA and VB to the volumes of supernatants 
A and B, respectively. The releasing efficiencies (RE) of the studied solvents were calculated 





RE = 100([PAH]B x VB / CPAH x VW – [PAH]A) (4.6) 
The best releasing efficiencies were obtained with alkane thiols, more specifically with 2 
to 4μL of 1-pentanethiol. As shown in Figure 4.3, RE varied from ~ 50 (fluorene) to ~ 90% 
(anthracene, benzo[b]fluoranthene, dibenz[a,h]anthracene and benzo[g,h,i]perylene). The 
observed differences among PAH reflect the relative affinity of PAH toward the surface of Au 
NPs and their surroundings. Because no much difference was observed within this volume range, 
all further studies were performed with 2μL of 1-pentanethiol. Table 4.4 summarizes the OR, E 








Figure 4.3 Effect of 1-pentanethiol on the releasing efficiency of extracted PAH with 20nm Au NPs.  































































Table 4.4 Recoveries for the three-step SPNE procedure. 
PAH a OR (%）b E (%) 
c RE (%) d 
Naphthalene 64.7 ± 3.3 82.2 ± 0.8 78.7 ± 4.1 
Acenaphthene 71.6 ± 2.1 96.3 ± 2.3 74.4 ± 2.8 
Fluorene 55.7 ± 3.1 98.1 ± 1.2 56.8 ± 3.2 
Phenanthrene 88.4 ± 1.8 98.8 ± 0.4 89.5 ± 1.9 
Anthracene 94.6 ± 1.6 99.3 ± 0.4 95.3 ± 1.7 
Fluoranthene 85.0 ± 3.0 97.1 ± 0.3 87.5 ± 3.1 
Pyrene 85.8 ± 2.5 95.6 ± 0.3 89.7 ± 2.6 
Benzo[a]anthracene 68.4 ± 2.8 98.6 ± 1.5 69.4 ± 3.0 
Chrysene 74.9 ± 2.1 97.1 ± 0.3 77.1 ± 2.2 
Benzo[b]fluoranthene 88.5 ± 1.4 98.3 ± 1.1 90.0 ± 1.7 
Benzo[k]fluoranthene 83.3 ± 2.4 94.1 ± 0.8 88.5 ± 2.7 
Benzo[a]pyrene 88.6 ± 2.3 96.3 ± 0.6 92.0 ± 2.5 
Dibenz[a,h]anthracene 87.9 ± 0.8 89.0 ± 1.0 98.8 ± 1.4 
Benzo[g,h,i]perylene 83.1 ± 1.8 86.8 ± 2.8 95.7 ± 4.1 
Indeno[1,2,3-cd]pyrene 85.0 ± 2.5 97.5 ± 0.4 86.7 ± 2.6 
 
a All PAH were prepared in 1% (v/v) methanol. b Overall recovery. PAH were extracted 
by 20nm gold nanoparticles from water solution and released by 2 µL 1-pentanethiol in 
48µL octane. c Extraction efficiency of 20nm gold nanoparticles. d Release efficiency is 
the percent of PAH released from the surface of 20nm nanoparticles by 1-pentanethiol. 










4.3.7 Analytical Figures of Merit 
Table 4.5 summaries the AFOM obtained via SPNE-HPLC analysis.  Aqueous standards 
were prepared by spiking milliliters of Nanopure water with micro-litters of PAH solutions in 1% 
methanol-water (v/v). SPNE was carried out with 500μL water aliquots as previously described. 
All linear dynamic ranges are based on the average intensities of at least five PAH concentrations. 
The average intensities correspond to a minimum of nine HPLC measurements made from 
triplicate aliquots collected from three complete experimental trials. No efforts were made to 
reach the upper concentration limits of the calibration curves. The lowest linear concentrations 
correspond to the limits of quantitation, which were calculated as 10SB/m, where SB is the 
standard deviation of 16 blank determinations at the peak base and m is the slope of the 
calibration curve.157 The excellent correlation coefficients (R) demonstrate the existence of linear 
relationships in all cases. The limits of detection – which were calculated as 3SB/m - varied from 
0.9 (phenanthrene) to 58ng/L (fluorene). Although there is a wide range of values – which 
probably reflects the differences in both overall recoveries and fluorescence intensities of the 
studied PAH - all LOD are well below the MCL of regulated PAH. The relative standard 
deviations (RSD) demonstrate excellent precision of measurements at the parts-per-trillion 









Table 4.5 Analytical figures of merit via SPNE-HPLC. 





(  ng.L-1) 




Naphthalene   9.11 240/330    160 -1000 0.9921 48 9.1 
Acenaphthene 15.07 234/320        7 -1000 0.9972 2.1 3.2 
Fluorene 16.98 252/320    193 -1000 0.9764 58 5.6 
Phenanthrene 18.79 252/370        3 -1000 0.9983 0.9 7.0 
Anthracene 20.99 252/402      22 -1000 0.9965 6.6 4.3 
Fluoranthene 22.83 284/464    126 -1000 0.9869 38 3.9 
Pyrene 23.78 238/398        6 -1000 0.992 1.6 5.7 
Benzo[a]anthracene 29.11 278/395        5 -1000 0.9916 1.3 4.8 
Chrysene 30.29 278/395      14 -1000 0.9893 4.2 4.1 
Benzo[b]fluoranthene 33.13 268/398      37 -1000 0.9958 11 5.3 
Benzo[k]fluoranthene 35.35 268/398      25 -1000 0.9937 7.5 6.1 
Benzo[a]pyrene 36.45 268/398        4 -1000 0.996 1.1 3.6 
Dibenz[a,h]anthracene 41.51 304/421      94 -1000 0.9943 28 3.7 
Benzo[g,h,i]perylene 42.53 304/421        8 -1000 0.9905 2.3 4.9 
Indeno[1,2,3-
cd]pyrene 
45.96 300/466      87-1000 0.9974 26 4.3 
 
a All working solutions were prepared in 1% methanol/water (v/v). b Excitation and 
emission set for the HPLC fluorescence detector. c Limit of quantitation (LOQ) is 
calculated by equation: 10 Sb / m. d Limit of detection (LOD) estimated as 3 Sb / m. e 
Relative standard deviation (RSD) is calculated according to the medium concentration of 




4.3.8 PAH Determination in Tap Water  
The feasibility to monitor PAH in tap water was investigated with three water samples of 
unknown matrix composition. Each water sample was collected at a different location within the 
city of Orlando, FL, and examined in triplicate. Milliliter volumes of tap water were spiked with 
microliter volumes of PAH standard solutions to provide final concentrations at the MCL of the 
regulated PAH. SPNE-HPLC analysis was carried out with 500μL aliquot samples. Table 4.6 
summaries the average recoveries and their standard deviations for the three tested samples. The 




25%) for regulated PAH.54  Comparison to overall recoveries in Table 4.4 shows no effects from 
the matrix composition of the unknown drinking water samples.  
 


















Naphthalene 55.6 ± 6.26 11.3 53.1 ± 2.66 5.01 54.3 ± 3.64 6.70 
Acenaphthene 77.3 ± 3.81 4.93 71.6 ± 4.16 5.81 74.5 ± 2.75 3.69 
Fluorene 45.4 ± 3.18 7.00 48.6 ± 5.25 10.8 39.8 ± 4.53 11.4 
Phenanthrene 90.1 ± 2.72 3.02 91.2 ± 3.53 3.87 86.5 ± 3.51 4.06 
Anthracene 93.2 ± 3.61 3.87 86.2 ± 4.07 4.72 92.2 ± 2.76 2.99 
Fluoranthene 78.9 ± 6.44 8.16 72.9 ± 4.38 6.01 76.6 ± 5.19 6.78 
Pyrene 83.5 ± 3.06 3.66 78.6 ± 4.32 5.50 77.8 ± 4.72 6.07 
Benzo[a]anthracene 65.9 ± 3.34 5.07 60.1 ± 1.56 2.60 55.8 ± 7.28 13.0 
Chrysene 67.5 ± 4.39 6.50 61.5 ± 2.48 4.03 67.2 ± 3.11 4.63 
Benzo[b]fluoranthene 85.3 ± 3.25 3.81 80.9 ± 5.44 6.72 83.3 ± 4.84 5.81 
Benzo[k]fluoranthene 85.8 ± 3.62 4.22 89.8 ± 2.63 2.93 85.1 ± 6.55 7.69 
Benzo[a]pyrene 87.8 ± 4.26 4.85 81.8 ± 3.13 3.83 85.8 ± 3.52 4.10 
Dibenz[a,h]anthracene 88.1 ± 5.05 5.73 81.2 ± 3.52 4.33 86.2 ± 4.31 5.00 
Benzo[g,h,i]perylene 86.9 ± 4.68 5.39 79.7 ± 3.62 4.54 86.6 ± 1.88 2.17 
Indeno[1,2,3-
cd]pyrene 
82.4 ± 4.96 6.02 75.6 ± 2.57 3.40 78.8 ± 4.56 5.78 
a All working solutions were prepared in 1% methanol/water (v/v). With the exception of 
benzo[a]pyrene, which was spiked at the 10 ng · L-1. concentration, all remaining PAH were 





SPNE is still in its infancy, and further studies are certainly needed to fully understand 
the adsorption of PAH on Au colloids. But the facts presented in this chapter make this approach 
extremely attractive for the problem at hand. Within the 20-100-nm particle diameter range, the 
20-nm Au NPs showed the best PAH extraction efficiencies. Independent of the size of the 
studied PAH, i.e., 3-6 rings, the 20-nm particles extracted more PAH molecules per gram of Au 
than their larger counterparts.  
Although a straightforward LOD comparison to those reported in the literature via HPLC 
is difficult as different instrumental setups, experimental and mathematical approaches have been 
used for their calculation,151,158-164 our LOD compare favorably. This comparison becomes 
relevant mainly if one considers the small water volume (500 μL) one needs for complete PAH 
analysis. To the extent of our literature search, there are no methods capable to detect these levels 
of PAH in microliters of water sample. This feature makes SPNE well suited for routine analysis 
of numerous samples as the small sample volume facilitates the implementation of simultaneous 
sample extraction. The entire extraction procedure consumes less than 100 μL of organic solvents 
per sample, which makes it environmentally friendly. The small volume of extracting solution - 
i.e., 0.95 mL of 20-nm Au NPs per water sample - adds US $2.25 to the total analysis cost, 









CHAPTER 5 SOLID-PHASE NANO-EXTRACTION AND LASER-
EXCITED TIME-RESOLVED SHPOL’SKII SPECTROSCOPY FOR 
THE ANALYSIS OF POLYCYCLIC AROMATIC HYDROCARBONS 
IN DRINKING WATER SAMPLES 
 
H. Wang, S. Yu and A. D. Campiglia*, Analytical Biochemistry, 2009, 385, 249 – 256. 
 
5.1 Introduction 
New instrumental developments for chromatography165-169 and spectroscopy,138,170-172 as 
well as sensors,173-177  have made PAH analysis more selective and sensitive. Despite the 
sophisticated arsenal of analytical tools, PAH monitoring via simple and cost effective methods 
of analyses still remains an analytical challenge. 151,158-160-25 the basis for standard PAH 
identification and determination.164 Particularly challenging is the analysis of PAH in drinking 
water samples. 52-54 The ideal approach should provide fast analysis time via a selective and 
sensitive method for individual PAH determination. Additional desirable features should include 
low analysis cost and rather low usage of organic solvents via an environmentally friendly 
experimental procedure.  
This chapter presents methodology with significant advances on all fronts. We combine 
SPNE to LETRSS for the direct analysis of 15 EPA-PAH without previous chromatographic 
separation. The analytical performance of SPNE-LETRSS is demonstrated with the analysis of 
three tap water samples of unknown composition. The entire experimental procedure – including 
SPNE and LETRSS measurements – takes less than 40min per sample. The method is well suited 
for routine analysis of numerous samples as the small volumes of water sample (500μL) and 




environmentally friendly experimental procedure. Limits of detection are at the parts-per-trillion 
level. Analytical recoveries are similar to those obtained via HPLC. The simplicity of the 
experimental procedure, use of micro-liters of organic solvent, short analysis time, selectivity, 
and excellent analytical figures of merit demonstrate the advantages of this approach for routine 
analysis of numerous samples. 
 
5.2 Experimental Section 
5.2.1 Reagents 
HPLC grade methanol was purchased from Fisher Scientific (Pittsburgh, PA, USA). 
Analytical grade 1-pentanethiol and n-octane were from Acros Organics (Atlanta, GA, USA).  
Nanopure water from a Barnstead Nanopure Infinity water system (Massachusetts, USA) was 
used throughout. Gold nanoparticles (Au NPs) were purchased from Ted Pella, Inc. (Redding, 
CA, USA). All PAH standards were acquired from Sigma-Aldrich (Milwaukee, WI, USA) at 
their highest available purity (>98%) and used with no further purification.  
Note: use extreme cautions when handling PAH that are known to be extremely toxic. 
 
5.2.2 Solution Preparation  
Stock PAH solutions were prepared in pure methanol and kept in the dark at 4°C. 
Possible PAH degradation was monitored via room temperature fluorescence spectroscopy. PAH 
working solutions were prepared by serial dilution with the appropriate solvent. Commercial 




monitored via ultraviolet 9UV)-visible absorption spectroscopy. Working solutions of Au NPs 
were prepared by diluting commercial solutions with nanopure water. An AccuStandard PAH 
mixture (Product M-610A) was used as a reference standard for HPLC analysis of 16 EPA-PAH. 
For PAH identification, a working standard was prepared by diluting 1 ml of the AccuStandard 
mix to a final volume of 10 ml in acetonitrile.  
 
5.2.3 SPNE of PAH from Water Samples  
Figure 5.1 shows a schematic diagram of the SPNE procedure. The shaking and 
centrifugation times were optimized for maximum PAH extraction and minimum analysis time.1 
Sample mixing was carried out at 1400-rpm mixing speed with a Maxi Mix III Rotary Shaker 
(Type M65800, Barnstead-Thermolyne) equipped with a PT500X6A Vortex Mixer accessory. 
Centrifugation was performed in 2 mL micro-plain glass tubes at the maximum rotational speed 
of our centrifuge, which consisted of a MiniSpin centrifuge (Eppendorf) with maximum 
rotational speed of 13,400 rotations per minute (rpm). The volumes of 1-pentanethiol and n-
octane were optimized to provide maximum PAH release into the supernatant with the minimum 
possible usage of organic solvents. PAH determination in the final supernatant was carried out 
either via HPLC or LETRSS analysis.  
 
5.2.4 HPLC Analysis  





Figure 5.1 Schematic diagram with the experimental steps of the SPNE procedure for the analysis of PAH in 
drinking water samples. 
VH2O refers to the volume of extracted water sample (500μl), and VCS and CCS refer to the volume (0.95ml) 
and concentration (7×1011 particle.ml-1) of Au NPs in the extracting solution, respectively. 
 
 
5.2.5 Survey of 77K-Excitation and Fluorescence Spectra  
See section 3.2 for instrumental and experimental details. 
5.2.6 Instrumentation for LETRSS Analysis  
See section 3.3 for instrumental details. 
5.2.7 Spectral Acquisition with the MLS 




5.2.8 Lifetime Acquisition with the MLS  
Fluorescence lifetimes were measured via the WTM procedure, which consists of the 
following three steps: (i) full sample and background WTM collection; (ii) background decay 
curve subtraction from the fluorescence decay curve at a wavelength of maximum emission for 
each PAH, and (iii) fitting of the background corrected data to single exponential decays. In 
cases of unknown sample composition where the formulation of a correct blank for lifetime 
background correction was not possible, the fluorescence decay at the base of the target peak was 
used for background subtraction at the target wavelength.  All fluorescence lifetimes were 
recorded using 5ns minimum delay. This delay was sufficient to avoid the need to consider 
convolution of the dye laser pulse with the analytical signal. The accuracy of this procedure has 
been confirmed previously.148 Origin software (version 7.5, Micronal Software) was used for 
curve fitting of fluorescence decays. Fluorescence lifetimes were obtained from decay curves 
fitted to y = y0 + A1e[-(x-x0))t1] were obtaining by fixing x0 and y0 at a value of zero. 
5.2.9 77K and 4.2K Sample Procedures  
77K measurements with the spectrofluorimeter followed the classic procedure of 
immersing the sample solution in a quartz tube into a nitrogen filled Dewar flask. 4.2 K 
measurements were carried out as follows. After transferring a known volume (typically 100–
200 μl) of undegassed sample solution with a pipette into the sample vial of the cryogenic probe, 
the tip of the fiber-optic bundle was positioned and held constant with the screw cap above the 
solution surface. Sample freezing was accomplished by lowering the copper tubing into the 
liquid helium, which was held in a Dewar flask with 60 L storage capacity. The liquid helium 




sample freezing took less than 90 s per sample. Replacing the frozen sample involved removing 
the sample vial from the cryogen container and melting the frozen sample with a heat gun. 
Because no physical contact between the tip of the fiber-optic bundle and the sample ever 
occurred during measurements, probe cleanup between measurements was not necessary. The 
entire freeze, thaw, and sample replacement cycle took no longer than 5 min. 
 
5.3 Results and Discussion 
5.3.1 HPLC Analysis of EPA PAH 
For the purpose of comparison, Table 5.1 combines the information previously presented 
in Table 4.4 and 4.6 for the analysis of EPA-PAH in Nanopure and drinking water via SPNE-
HPLC, respectively. Comparison among the recoveries from Nanopure and tap water samples 
shows no clear trend that indicates possible matrix interference from the tap water samples. In 
both cases, the observed differences among overall recoveries probably reflect the relative 
affinity of PAH towards the surface of Au NPs and their surroundings, which include water, 1-
















Recovery (%) b 
Nanopure water c Tap water d 
Naphthalene 9.11 ± 0.08 64.7 ± 3.3 54.3 ± 1.3 
Acenaphthene 15.07 ± 0.05 71.6 ± 2.1 74.5 ± 2.9 
Fluorene 16.98 ± 0.06 55.7 ± 3.1 44.6 ± 4.5 
Phenanthrene 18.79 ± 0.09 88.4 ± 1.8 89.3 ± 2.5 
Anthracene 20.99 ± 0.08 94.6 ± 1.6 90.5 ± 3.8 
Fluoranthene 22.83 ± 0.11 85.0 ± 3.0 76.1 ± 3.0 
Pyrene 23.78 ± 0.07 85.8 ± 2.5 80.0 ± 3.1 
Benzo[a]anthracene 29.11 ± 0.03 68.4 ± 2.8 60.6 ± 5.1 
Chrysene 30.29 ± 0.06 74.9 ± 2.1 65.4 ± 3.4 
Benzo[b]fluoranthene 33.13 ± 0.07 88.5 ± 1.4 83.2 ± 2.2 
Benzo[k]fluoranthene 35.35 ± 0.12 83.3 ± 2.4 86.9 ± 2.5 
Benzo[a]pyrene 36.45 ± 0.09 88.6 ± 2.3 85.1 ± 3.1 
Dibenz[a,h]anthracene 41.51 ± 0.02 87.9 ± 0.8 85.2 ± 3.6 
Benzo[g,h,i]perylene 42.53 ± 0.05 83.1 ± 1.8 84.4 ± 4.4 
Indeno[1,2,3-cd]pyrene 45.96 ± 0.11 85.0 ± 2.5 78.9 ± 3.4 
 
a All work solution were made in 1% (v/v) methanol. b Overall recovery. PAH were 
extracted by 20nm gold nanoparticles from water solution and released by 2 µL 1-
pentanethiol in 48µL octane. c Overall recoveries obtained with nanopure water 
samples. d  Overall recoveries obtained with three tap water samples. 
 
 
Figure 5.2 compares the fluorescence intensities of two chromatograms recorded from the 
same water sample via HPLC and SPNE-HPLC. EPA-PAH concentrations were adjusted to 
provide a spiked sample with final concentrations at the parts-per-trillion level. Clearly, the pre-
concentration afforded by SPNE makes possible PAH analysis at the concentration levels below 
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Figure 5.2 Chromatograms of 15 EPA PAH obtained by SPNE-HPLC (A) and HPLC (B). 
I) naphthalene 250 ng.L-1; II) acenaphthene 50 ng.L-1 ; III) fluorene 250 ng.L-1; IV) phenanthrene 50 ng.L-1; V) anthracene 100 ng.L-1; VI) fluoranthene 
250 ng.L-1; VII) pyrene 50 ng.L-1; VIII) benzo[a]anthracene 50 ng.L-1; IX) chrysene 25 ng.L-1; X) benzo[b]fluoranthene 50 ng.L-1; XI) 
benzo[k]fluoranthene 40 ng.L-1; XII) benzo[a]pyrene 20 ng.L-1; XIII) dibenz[a,h]anthracene 100 ng.L-1; XIV) benzo[g,h,i]perylene 25 ng.L-1; XV) 




5.3.2 4.2K LETRSS of EPA-PAH 
For the specific case of EPA-PAH, the solvent matching criterion for Shpol’skii 
Spectroscopy leads to one of the following five n-alkanes: n-pentane (naphthalene, acenaphthene, 
and acenaphthylene), n-hexane (phenanthrene and pyrene), n-heptane (fluorene, fluoranthene, 
benzo[g,h,i]perylene, benzo[b[fluoranthene and anthracene), n-octane (benzo[a]pyrene, 
dibenz[a,h]anthracene, chrysene and benz[a]anthracene), and n-nonane (indeno[1,2,3-cd]pyrene 
and benzo[k]fluoranthene). Considering the use of five organic solvents per sample practically 
unattractive, previous work in our lab demonstrated the feasibility to determine the 15 EPA-PAH 
under generic Shpol’skii conditions, this is with only one n-alkane (either n-hexane or n-octane) 
and one excitation wavelength (283.2nm).138 Using a generic excitation wavelength simplify 
instrumental manipulation because it allows the analyst to operate the tunable dye laser with only 
one organic dye. 
Table 5.2 summarizes the 4.2K excitation and fluorescence wavelengths and 4.2K 
fluorescence lifetimes recorded from undegassed PAH solutions in n-octane. Appendix C 
compiles a complete set of 77K excitation and fluorescence of the 15 EPA-PAH in n-octane. 
Appendix D presents a complete set of 4.2K fluorescence spectra and lifetimes for the 15 EPA-
PAH in n-octane.  Excitation spectra were first recorded at 77K with the commercial 
spectrofluorimeter and the maximum wavelengths for each excitation peak were then confirmed 
at 4.2K with the MLS and the fiber optic probe. With the exception of acenaphthylene, all the 
other PAH showed 4.2K fluorescence emission in n-octane. The lack of fluorescence from 
acenaphthylene persisted after sample de-oxygenation (15min of nitrogen bubbling prior to 




Currently, we have no explanation for acenaphthylene behavior. The remaining PAH showed 













Table 5.2 Excitation and emission of 15 PAH in n-octane at 4.2K. 
PAH a λex (nm) b λem (nm) c τ (ns) d
Naphthalene 225, 269, 280, 288, 291 315.3, 320.4, 322.8, 324.8, 330.8, 338.3, 340.2, 
347.3, 351.6 
200.9 ± 1.7 
Acenaphthene 230, 283, 295 320.3, 325.6, 331.0, 335.8, 342.5, 347.1, 352.2 44.8 ± 0.7 
Fluorene 266, 275, 281, 291, 295, 302 302.7, 304.5, 309.3, 316.7 6.9 ± 0.2 
Phenanthrene 259, 270, 285, 293, 296 346.5, 351.5, 356.8, 363.4, 364.5, 366.5, 383.1 46.8 ± 0.4 
Anthracene 256, 327, 343, 362, 365 378.6, 406.2 5.8 ± 0.2 
Fluoranthene 279, 285, 290, 325, 344, 363 407.8, 415.4, 434.6, 436.8, 443.6, 466.4 55.4 ± 1.1 
Pyrene 243, 256, 277, 309, 322, 334, 338 372.0, 372.8, 377.5, 378.5, 382.0, 383.4, 384.3, 
387.6, 388.7, 392.5, 393.6 
516.2 ± 4.4 
Benzo[a]anthracene 272, 282, 293, 316, 331, 347, 392 383.6, 396.4, 405.3 52.5 ± 1.6 
Chrysene 262, 273, 287, 298, 310, 323 360.8, 372.6, 380.7, 392.5, 401.1 57.8 ± 2.3 
Benzo[b]fluoranthene 292, 304, 351, 385 397.5, 405.0, 414.8, 424.1, 430.1, 449.3 43.8 ± 1.1 
Benzo[k]fluoranthene 254, 287, 299, 310, 327, 362, 374, 
382, 396 
404.1, 405.3, 407.6, 413.0, 421.9, 426.4, 429.3 8.9 ± 0.3 
Benzo[a]pyrene 269, 288, 298, 348, 370 402.8, 404.6, 408.1, 416.8, 423.6, 426.2, 430.2 38.6 ± 0.3 
Dibenzo[a,h]anthracene 290, 301, 324, 335, 352 393.9, 395.3, 396.5, 404.5, 414.5, 416.2, 419.2 41.9 ± 0.5 
Benzo[g,h,i]perylene 293, 305, 330, 350, 368, 390 407.1, 413.2, 415.4, 416.2, 419.7, 422.5, 429.0, 
445.3 
127.2 ± 1.5 
Indeno[1,2,3-cd]pyrene 254, 281, 306, 320, 367, 382, 390 463.0, 466.7, 472.2, 473.4, 474.5, 481.5, 502.3 10.4 ± 0.1 
Underlined wavelength indicates the maximum excitation wavelength. a All PAH solutions were prepared in n-octane. b The 
excitation were measured at 77K. c The emission were measured at 4.k at the excitation of 283nm. d lifetime were measured at 





Careful examination of the excitation ranges of the 15 EPA-PAH confirms the possibility 
to using 283.2nm as a common excitation wavelength. The worst fluorescence overlapping was 
observed between naphthalene and acenaphthene. All the other PAH showed at least one 
fluorescent peak with no spectral overlapping from the other EPA-PAH. Their maximum 
wavelengths, which are reported under target wavelengths in Table 5.2, provide accurate 
determination of each EPA-PAH at the trace concentration level (ng.L-1).  
Spectral purities at target wavelengths were confirmed via lifetime measurements taken 
from synthetic mixtures with the 15 EPA-PAH at concentrations 100x higher than the target PAH. 
Fluorescence lifetimes were obtained via the WTM procedure.  Figure 5.3 shows an example of a 
4.2 K WTM for benzo[a]pyrene. For the 13 PAH with no spectral interference, the lifetime from 
the mixtures at the target wavelengths were single exponential decays. For a confidence interval 
of 95% (α = 0.05) and six determinations (n = 6),157 their lifetime values matched the standard 
lifetimes shown in Table 5.2. In all cases, the agreement between the calculated and observed 
points over the first two lifetimes of the decays agreed to within 1% and the residuals showed no 
systematic trends. The lifetime measurements at the target peaks of naphthalene and 
acenaphthene gave biexponential decays. The short and long components of the biexponential 
decays statistically matched (α = 0.05, n = 6)157 the fluorescence lifetimes of acenaphthene (44.8 
± 0.7 ns) and naphthalene (200.9 ± 1.7 ns), respectively. Their spectral discrimination was 
accomplished on the basis of time resolution with appropriate gate times, that is, 40 ns for 



































































Figure 5.3 (A) 4.2 K WTM recorded with the fiber-optic probe and the MLS. (B) Fluorescence spectrum 
extracted from WTM at 5ns delay. (C) Fluorescence decay obtained from fitting the intensity of fluorescence 
emission at 404 nm as a function of time. 
Instrumental parameters: excitation wavelength = 283.2 nm, initial gate delay = 5ns, gate with = 1000ns, gate 







5.3.3 4.2K LETRSS Analytical Figures of Merit  
Figure 5.4 shows typical examples of calibration curves obtained via SPNE-LETRSS 
analysis. The complete set of calibration curves obtained for the 15 EPA-PAH is shown in 
Appendix E. Table 5.3 summarizes its analytical figures of merit for the 15 EPA-PAH. Aqueous 
standards were prepared by spiking milliliters of nanopure water with microlitters of PAH 
solutions in 1% methanol-water (v/v). SPNE was carried out with 500μL water aliquots as 
previously described in Figure 5.1. All linear dynamic ranges (LDRs) were based on the average 
intensities of at least five PAH concentrations. The average intensities correspond to a minimum 
of nine LETRSS measurements made from triplicate aliquots collected from three complete 
experimental trials. No efforts were made to reach the upper concentration limits of the 
calibration curves. The lowest linear concentrations correspond to the limits of quantitation, 
which were calculated as 10SB/m, where SB is the standard deviation of 16 blank determinations 
at the peak base and m is the slope of the calibration curve.157 The excellent correlation 
coefficients demonstrate the existence of linear relationships in all cases. The limits of detection 
(LODs) – which were calculated as 3SB/m - varied from 0.8ng/L (benzo[a]pyrene) to 88ng/L 
(fluorene). Although there is a wide range of values – probably reflecting the differences in both 
overall recoveries and fluorescence intensities of the studied PAH - all LODs are well below the 
maximum concentration level of regulated PAH. The relative standard deviations demonstrate 










































































Figure 5.4 Low concentration ranges of calibration curves obtained via SPNE-LETRSS. 
 (A) anthracene, (B) pyrene,  (C) benzo[a]pyrene and (D) benzo[g,h,i]perylene. Excitation = 283nm; 













Table 5.3 Analytical figure of merit of SPNE-LETRSS. 








      
Naphthalene 320.4 66 – 1000 0.9901 20 5.2 
Acenaphthene 320.3 100 – 1000 0.9965 29 4.3 
Fluorene 309.3 200 – 1000 0.9836 88 0.9 
Phenanthrene 346.5  10 – 1000 0.9749 2.5 3.5 
Anthracene 378.6   15 – 1000 0.9941 4.5 2.8 
Fluoranthene 407.8   30 – 1000 0.9776 8.7 2.9 
Pyrene 372.0 11 – 1000 0.9944 3.4 4.2 
Benzo[a]anthracene 383.6   9 – 1000 0.9968 2.5 3.6 
Chrysene 360.8 22 – 1000 0.9968 6.6 3.5 
Benzo[b]fluoranthene 397.5 29 – 1000 0.9849 8.6 3.1 
Benzo[k]fluoranthene 426.4  6 – 1000 0.9574 1.7 6.3 
Benzo[a]pyrene 402.8  3 – 1000 0.9978 0.8 2.1 
Dibenzo[a,h]anthracene 393.9 53 – 1000 0.9755 16 2.8 
Benzo[g,h,i]perylene 419.7  8 – 1000 0.9927 2.3 4.2 
Indeno[1,2,3-cd]pyrene 463.0 24 – 1000 0.9717 7.1 3.8 
  
a All work solution were made in 1% (v/v) methanol.  b Targeted emission wavelength 
upon excitation of naphthalene (200/1000 ns) and acenaphthene (0/40 ns). All PAHs were 
determined using delay/gate times = 0/1000 ns.  c Linear dynamic range (LDR)  are 
calculated from limit of quantitation (LOQ). LOQ is calculated by equation: 10 Sb / m. 













5.3.4 PAH Recoveries from Tap Water Samples via SPNE-LETRSS Analysis  
The feasibility of monitoring PAH via SPNE–LETRSS in tap water was investigated with 
the three water samples previously analyzed via SPNE–HPLC (see Table 5.1 for PAH recoveries). 
Table 5.4 summarizes the average recoveries and their standard deviations obtained via SPNE–
LETRSS. In all cases, the relative standard deviations of the recoveries were lower than 25%, 
which meets the criterion for regulated PAH (≤25%).53,54 Comparison with values in Table 5.1 
reveals no particular trend in the ability of SPNE–LETRSS to provide either lower or higher 
recoveries than SPNE–HPLC. All recoveries are in good agreement and provide PAH 
concentrations within the confidence of the standards. Figure 5.5 shows an example of a two-
dimensional 4.2 K Shpol’skii spectrum recorded at a time window - delay = 5 ns and gate = 1000 
ns - that captures the fluorescence emission of the 15 EPA–PAH. All targeted PAH are clearly 
identified in the water sample with no apparent matrix interference. WTM analyses yielded 
single exponential decays and matching lifetimes to those from the standards, confirming peak 














Nanopure water c Tap water d 
Naphthalene 73.1 ± 5.3 61.9 ± 4.2 
Acenaphthene 68.3 ± 1.9 72.0 ± 3.1 
Fluorene 58.6 ± 2.7 53.5 ± 2.6 
Phenanthrene 90.4 ± 2.3 90.5 ± 3.1 
Anthracene 93.5 ± 2.1 92.6 ± 1.5 
Fluoranthene 85.8 ± 3.2 87.5 ± 2.3 
Pyrene 88.1 ± 3.6 84.1 ± 2.8 
Benzo[a]anthracene 71.2 ± 2.7 66.3 ± 2.5 
Chrysene 72.9 ± 1.8 74.6 ± 4.1 
Benzo[b]fluoranthene 90.3 ± 3.4 87.2 ± 2.1 
Benzo[k]fluoranthene 85.0 ± 3.0 84.3 ± 3.8 
Benzo[a]pyrene 89.9 ± 3.5 90.5 ± 3.6 
Dibenz[a,h]anthracene 87.3 ± 2.8 88.5 ± 3.3 
Benzo[g,h,i]perylene 83.4 ± 2.3 85.6 ± 4.8 
Indeno[1,2,3-cd]pyrene 91.1 ± 1.6 88.3 ± 3.0 
a All work solution were made in 1% (v/v) methanol.  b Overall recovery. PAH were 
extracted by 20nm gold nanoparticles from water solution and released by 2 µL 1-
pentanethiol in 48µL octane. c Overall recoveries obtained with nanopure water 







































Figure 5.5 4.2 K fluorescence spectrum of PAH spiked drinking water sample submitted to SPNE–LETRSS 
analysis. 
Peak assignments and PAH final concentrations are as follows: (I) 200 ng.L-1 flourene; (II) 200 ng.L-1 
naphthalene; (III) 50 ng.L-1acenaphthene; (IV) 50 ng.L-1 phenanthrene; (V) 25 ng.L-1 chrysene; (VI) 50 ng.L-1 
pyrene; (VII) 100 ng.L-1 anthracene; (VIII) 50 ng.L-1 benzo[a]anthracene; (IX) 100 ng.L-1 
dibenz[a,h]anthracene; (X) 50 ng.L-1 benzo[b]fluoranthene; (XI) 20 ng.L-1 benzo[a]pyrene; (XII) 200 ng.L-1 
fluoranthene; (XIII) 25 ng.L-1 benzo[g,h,i]perylene; (XIV) 40 ng.L-1 benzo[k]fluoranthene; (XV) 100 ng.L-1 
indeno[1,2,3-cd]pyrene. Compounds II and III were determined using delay/gate times equal to 200/1000 and 









We have presented the first successful application of SPNE and LETRSS to the analysis 
of PAH in drinking water samples. The new approach presents several desirable features for 
routine monitoring of numerous samples. The precision of measurements at the parts-per-billion 
concentration level is outstanding; relative standard deviations varied from 0.9% (fluorene) to 
6.3% (benzo[k]fluoranthene). The LODs—which varied from 0.8 ng.L-1 (benzo[a]pyrene) to 88 
ng.L-1 (fluorene)—are excellent as well and compare favorably with those reported previously 
with other methods.158-164 The analytical recoveries of the 15 EPA–PAH are in good agreement 
with those obtained via SPNE–HPLC. The wide recovery range probably reflects the relative 
affinity of PAH for the surface of Au NPs and the surrounding solution. For the six regulated 
WHO–PAH, the recovery values varied from 84.3 ± 3.8% (benzo[k]fluoranthene) to 90.5 ± 3.6% 
(benzo[a]pyrene). Their relative standard deviations were lower than 25% and, therefore, met the 
criterion for regulated PAHs (≤25%).53,54 Comparison with higher recoveries reported previously 
with established solid-phase extraction methods151,158,159 should take into consideration the early 
stage of SPNE. Future studies in our group will optimize the polarity of the surrounding solution 
to achieve higher analytical recoveries.  
Similar to SPNE–HPLC,1 complete PAH analysis is possible with only 500 μl of water 
aliquots. This small volume facilitates the implementation of SPNE for simultaneous sample 
extraction of numerous samples. In comparison with HPLC, LETRSS eliminates the need for 
PAH separation. The direct determination of pictograms of PAHs in microliters of water sample 
with no need for previous separation is a tremendous asset for routine analysis of numerous 
samples. This feature reduces both analysis time and the use of organic solvents. Complete PAH 




consumes only 50 μl of organic solvent. The facts that 60 L of liquid helium typically lasts for 3 
weeks of daily use—averaging 15 to 20 samples per day—and that the extracting solution adds 








CHAPTER 6 IMPROVING THE RECOVERY AND THE LIMITS OF 
DETECTION FOR THE ANALYSIS OF MONOHYDROXY-
POLYCYCLIC AROMATIC HYDROCARBONS IN URINE 
SAMPLES VIA SOLID-PHASE NANO-EXTRACTION 
 
H. Wang, W. B. Wilson, A. D. Campiglia*, Journal of Chromatography A, 2009, 385, 249 – 256. 
 
6.1 Introduction 
Because the first step in the metabolic pathway of PAH forms hydroxy-PAH (OH-PAH), 
urine analysis of OH-PAH is recognized as an accurate assessment of human exposure to 
PAH.178,179 The general approach for monitoring OH-PAH in urine samples follows the sequence 
of urine hydrolysis, sample clean-up and pre-concentration, chromatographic separation and 
determination. The hydrolysis step – which can be either enzymatic or acidic - is included to 
dissociate OH-PAH from their glucuronide and/or sulfate conjugates. As previously mentioned, 
popular approaches for sample clean up and pre-concentration are liquid-liquid extraction,180,181 
SPE182 and solid-phase micro-extraction.183 Chromatographic analysis is usually carried out 
either with HPLC - RTF183-185 or GC – MS.186-188  
Research in our lab has been focused on screening methods for monitoring OH-PAH in 
numerous urine samples.189 The development of easy-to-use and cost-effective techniques with 
high sample throughput is becoming increasingly relevant to investigate the uptake of PAH by 
large human populations.187,188 During the course of our experiments we realized that one of the 
main sources of metabolite loss in SPE-HPLC methodology is the evaporation of the eluting 
solvent prior to chromatographic determination. Recoveries as low as 45-48% have been 




benzo[a]pyrene. 81,151   
In a typical SPE-HPLC procedure, OH-PAH are eluted from C18 cartridges with milliliter 
volumes of methanol and pre-concentrated to micro-litters for HPLC determination. Eliminating 
the evaporation step carries with it the obvious deterioration of LOD, which need to be at the 
sub-parts-per-billion (ng.mL-1) concentration levels. This chapter presents an original solution 
for the problem at hand. We substitute the evaporation step with a pre-concentration approach 
that extracts OH-PAH with Au NPs. The analytical potential of SPNE is evaluated with the 
following six metabolites: 9-hydroxyphenanthrene, 2-hydroxyfluorene, 1-hydroxypyrene, 6-
hydroxychrysene, 3-hydroxybenzo[a]pyrene and 4-hydroxybenzo[a]pyrene. We demonstrate that 
the substitution of the evaporation step with the Au NPs procedure improves the overall 
recoveries, the relative standard deviations of the average recoveries and the LOD of SPE-HPLC 
analysis. The overall recoveries of the studied metabolites varied from 59.7 ± 3.6% (2-
hydroxyfluorene) to 92.3 ± 2.5% (6-hydroxychrysene). The relative standard deviations of the 
average recoveries were than 6%. The LOD were at the parts-per-trillion levels and varied from 
~2pgmL-1 (6-hydroxychrysene) to ~18 pg.mL-1 (2-hydroxyfluorene).   
 
6.2 Experimental Section 
6.2.1 Chemicals 
HPLC grade methanol, hydrochloric acid, potassium biphthalate sodium hydroxide buffer, 
and synthetic urine were purchased from Fisher Scientific (Pittsburgh, PA). Analytical grade 1-
pentanethiol was from Acros Organics (Atlanta, GA). Au NP were purchased from Ted Pella, Inc. 




throughout. All OH-PAH were purchased at their highest available purity (>98%) and used with 
no further purification. 9-hydroxyphenanthrene (9-OHphe) and 2-hydroxyfluorene (2-OHflu) 
were acquired from Sigma-Aldrich (Milwaukee, WI). 1-hydroxypyrene (1-OHpyr) and 6-
hydroxychrysene (6-OHchr) were purchased from Accustandard (New Haven, CT). 3-
hydroxybenzo[a]pyrene  (3-OHb(a)p) and 4-hydroxybenzo[a]pyrene (4-OHb(a)p) were obtained 
from Midwest Research -Institute (Missouri, 64110).  
Note: use extreme caution when handling OH-PAH that are known to be extremely toxic. 
 
6.2.2 Solution Preparation 
Stock solutions of OH-PAH were prepared in pure methanol. Their working solutions 
were prepared by serial dilution with 5% methanol (v/v). Possible metabolite degradation was 
monitored daily via fluorescence spectroscopy. Working solutions of Au NPs were prepared by 
diluting their commercial solutions with Nanopure water. The physical integrity of Au NPs was 
monitored daily via absorption spectroscopy. All solutions were kept stored in the dark at 4oC.  
 
6.2.3 Hydrolysis of Urine Samples 
Prior to hydrolysis, urine samples were spiked with micro-litters of metabolite stock 
solutions of appropriate concentration and allowed to equilibrate overnight. Acidic hydrolysis 
(pH = 5.0) of the spiked samples was then carried out by mixing and shaking (30 min, 1400 rpm) 
8mL of urine sample, 500 µL of 0.1 M HCl and 500 µL of 0.05 M potassium biphthalate sodium 




6.2.4 Solid-Phase Extraction of Urine Samples 
 SPE was carried out via an experimental procedure previously optimized in our lab.189 Urine 
samples were processed through a Sep-Pak® C-18 (Waters, Milford, MA) cartridge pre-
conditioned with 15 mL of methanol and 5 mL of water. All solutions were processed through 
the cartridge with the aid of a 10 mL syringe attached to the cartridge. The cartridge was 
sequentially rinsed with 10 mL of water and 10 mL of 20% methanol/water (v/v). OH-PAH were 
eluted with 3 mL of 100% methanol. The eluate was concentrated almost to dryness under a 
gentle stream of nitrogen and then dissolved to 1 mL with methanol for HPLC analysis.  
 
6.2.5 Extraction of OH-PAH with Au NPs   
 A 500 µL aliquot of the methanol eluate were mixed with 1 mL of 20-nm Au NPs. The 
mixture was shaken for 5 min at 1400 rpm and centrifuged for 20 min at 13,400 rpm. The 
supernatant was separated from the precipitate with a micro-pipette. 2 µL of 1-pentanethiol 
followed by 48 µL of methanol were added to the precipitate. The new mixture was shaken for 5 
min at 1400 rpm and then centrifuged for another 20 min at 13,400 rpm. All mixing and shaking 
times were optimized for best metabolite recovery.  
 
6.2.6 Sample Mixing and Centrifugation for Metabolite Extraction with Au NPs 
Sample mixing was carried out with a Maxi Mix III Rotary Shaker (type M65800, 
Barnstead-Thermolyne) equipped with a PT500X6A Vortex Mixer accessory. Centrifugation was 




rotations per minute (rpm).  
 
6.2.7 pH Measurements 
pH of solutions was measured with the help of an AR-15 pH/mV/°C meter and a glass 
body standard size combination electrodes from Fisher Scientific ( Pittsburgh, PA).  
 
6.2.8 Absorption Spectroscopy 
See section 3.1 for instrumental and experimental details. 
 
6.2.9 RTF Spectroscopy 
 See section 3.2 for instrumental and experimental details. 
 
6.2.10 HPLC Analysis 
 See section 3.4 for instrumental details. OH-PAH separation was carried out on a Supelco 
(Bellefonte, PA) Supelcosil TM LC-OH-PAH column with the following characteristics: 15-cm 
length, 4-mm diameter, and 5-µm average particle diameters. All sample injections were held 
constant at 20 µL using a fixed-volume injection loop. Blank measurements were made in 
conjunction with each series of samples using identical conditions of glassware, equipment, 





6.3 Results and Discussion 
6.3.1 Optimization of HPLC Analysis  
The strategy we used to evaluate the pre-concentration of OH-PAH with Au NPs included 
the four most common features of current SPE-HPLC methodology, namely: (a) extraction of 
OH-PAH from hydrolyzed urine samples with C-18 silica cartridges; (b) elution of metabolites 
from the solid sorbent with methanol; (c) evaporation of the eluting solvent with a gentle N2 gas 
stream; and (d) re-dissolution of the residual solid with methanol prior to chromatographic 
determination.182,185-187,190,191 Metabolite recoveries were monitored via HPLC analysis. Table 6.1 
summarizes the settings and conditions for the complete chromatographic separation of the 
studied metabolites. Their separation was achieved with a linear water–methanol gradient 
varying from 70% to 90% methanol (v/v) and flow rates increasing from 0.5 to 1.5mL.min−1. 
Metabolite detection was carried out in the fluorescence mode using the following time-
programmed excitation/emission wavelengths: 0min, 273/326nm (2-OHflu); 8.9 min, 
252/381nm(9-OHphe); 17.0 min, 345/386nm(1-OHpyr); 21.0 min, 270/381nm (6-OHchry); 26.0 
min, 372/419nm (4-OHb(a)p); and 33.0 min, 381/432nm(3-OHb(a)p). The measurement 
wavelengths were programmed to match the maximum excitation and emission wavelengths of 
the studied OH-PAH. Figure 6.1 compares their excitation and fluorescence spectra in methanol–
water mixtures with relative volume/volume (v/v) compositions of 30–70% and 10–90%. 
Because the spectral features of the studied metabolites did not vary significantly with the 
composition of the mobile phase, the accurate monitoring of their analytical concentrations was 







Table 6.1 HPLC parameters for the separation of OH-PAH. 




Flow rate  
(mL/min) 
0.0 30 70 0.5 
15.0 30 70 0.8 
20.0 20 80 1.0 
25.0 20 80 1.0 
30.0 10 90 1.5 
41.0 10 90 1.5 
























































Figure 6.1  Excitation and fluorescence spectra in methanol-water 30-70(v/v) (solid line) and 10-90(v/v) 






Figure 6.2 shows a typical chromatogram with the complete separation of the six 
metabolites. Three chromatographic runs of the same standard mixture recorded from three 
independent injections of 20μL aliquots provided the following average retention times (min): 
8.49±0.13 (2-OHflu), 9.46±0.09 (9-OHphe), 19.00±0.06 (1-OHpyr), 22.50±0.15 (6-OHchr), 
29.99±0.20 (4-OHb(a)p) and 37.80±0.10 (3-OHb(a)p). The distinct values of the experimental 
averages show the possibility to identify the six metabolites from their retention times. 
Comparison of spectral features in Figure 6.1 shows the potential for unambiguous identification 
of closely related metabolites – such as 3-OHb(a)p and 4-OH-b(a)p) – on the bases of excitation 
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Figure 6.2 Typical HPLC chromatogram of metabolite synthetic mixture containing 50 ng.mL-1 (A) 2-OHflu; 
(B) 9-OHphe; (C) 1-OHpyr; (D) 6-OHchr; (E) 4-OHb(a)p; (F) 3-OHb(a)p. 
 
6.3.2 OH-PAH Precipitation in the Absence of Au NPs 
Quantitative extraction of OH-PAH via the SPNE procedure requires an appropriate 
centrifugation time for the complete collection of Au NPs precipitate. Previous studies in our lab 
have investigated this parameter as a function of average particle diameter.1 For 20 nm Au NPs, 
i.e. the average particle diameter arbitrarily chosen for the present studies, 20 min of 
centrifugation time was sufficient to completely precipitate the colloidal particles. The possibility 
of OH-PAH adhesion to the walls of the centrifugation vessels or metabolite precipitation in the 
absence of NPs – i.e. solely due to metabolite precipitation – was then investigated up to 20 min 




eluting solvent of our SPE procedure. Centrifugation was carried out at 13,400rpm in 2mL 
polypropylene graduated tubes equipped with locking lids. OH-PAH concentrations were 
monitored via RTF spectroscopy. Fluorescence intensities were measured before (INC) and after 
centrifugation (IC) at the maximum fluorescence excitation and emission maxima of each 
metabolite. Working solutions that had statistically equivalent INC and IC were considered free 
from OH-PAH precipitation. The statistical comparisons were based on average values taken 
from three triplicate measurements of three individually centrifuged aliquots, i.e. NNC =NC =9. 
Table 6.2 summarizes the concentration ranges of OH-PAH free from precipitation along with 
the statistical comparison for the highest tested concentration. Because concentration levels of 
OH-PAH in urine samples are usually below 30 ng.mL−1 ,178,179 no efforts were made to 
investigate higher concentration values. 
 












2-OHflu 273, 302 300, 326 30 2.23 
9-OHphe 252, 274, 298 371, 381 30 1.78 
1-OHpyr 242, 279, 333, 345, 363s 386, 406, 427s 30 0.51 
6-OHchr 270, 336 381, 398 30 2.52 
4-OHb(a)p 266, 301, 372 419, 441s 30 0.22 
3-OHb(a)p 267, 293, 362, 381, 400 432, 453s 30 1.16 
 
a  All metabolite standard solutions were prepared in methanol. b Excitation (λexc) and 
emission (λem) wavelength of OH-PAH at room temperature. Underlined wavelengths 
indicate the maximum excitation and emission wavelength; s = shoulder. c OH-PAH 
concentrations range free from precipitation due to centrifugation. d t-test of fluorescence 
intensity before and after centrifugation fo [OH-PAH] = 30ng. mL-1. tcritical = 2.78 (a = 0.05; 






6.3.3 Complete Metabolite Extraction 
The minimum volume of Au NPs solution (mVCS) that one needs to completely extract a 





/ CS                             (6.1) 
where [COM]i is the concentration (mass/volume) of any given component in the sample, VS is 
the volume of extracted sample, CCS is the concentration of Au NPs in the extracting solution 
(particles/volume), and MEMCOMi is the maximum extracted mass of any given component of the 
mixture per Au NP. The MEMCOMi values were experimentally obtained via an original method 
developed in our lab.1 OH-PAH were individually extracted from methanol standard solutions 
with 100μL of 20 nm colloidal solutions containing 7.0×1011 particles mL−1. The SPNE 
procedure consisted of mixing 500μL of metabolite standard solution, 900μL of water and 100μL 
of Au NPs solution in a 2 mL polypropylene tube followed by 5 min of mechanical shaken at 
1400rpm and 20 min of centrifugation at 13,400 rpm. Metabolite extractions were monitored via 
RTF spectroscopy by comparing the fluorescence intensities of the supernatants to those 
recorded from pure standards submitted to the same experimental procedure in the absence of Au 
NPs. All extractions were carried out within the linear dynamic ranges of the RTF calibration 
curves. 
Figure 6.3 shows the experimental results obtained for four of the studied metabolites. All 
linear fittings were calculated via the least-squares method. The straight lines correlating the data 
points labeled as (▼) represent the fluorescence intensities of metabolites standard solutions in 




represent the fluorescence intensities of the supernatants after centrifugation with Au NPs. 
Statistical comparison showed that the fluorescence intensities within the (●) segments were 
statistically equivalent to the blank signals (α = 0.05, N1 = N2 = 3).157 This fact accounts for the 
absence of OH-PAH and complete metabolite extraction within the concentration ranges 
represented as (●). Fluorescence intensities within the (■) segments were statistically different 
from blank signals and increased linearly with metabolite concentrations. The signal intensities 
in the (■) segments were lower than the intensities in the (▼) segments as a result of the lower 
metabolite concentrations in the supernatants. The lower concentrations reflect the amount of 
OH-PAH extracted with Au NPs. The intercepts of (●) and (▼) segments provide the MEMCOMi 











































































y = 1031.3x + 10996.9
R2=0.9739
y = 11810.7x + 14048.8
R2=0.9996
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R2=0.9908
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Figure 6.3 Fluorescence intensity as a function of OH-PAH concentration (ng.mL-1): (A) 2-OHflu; (B) 1-
OHpyr; (C) 6-OHchry; (D) 3-OHb(a)p. 
Single intensity were recorded from OH-PAH standard solutions prepared in methanol (▼) and from 
supernatant of OH-PAH standards previously extracted with 10% 20-nm Au NPs solution (●/■). Best linear 








Table 6.3 Maximum amount of extracted OH-PAH with 100μL commercial 20-nm Au NPs. 
OH-PAH a Max conc b (ng·mL-1) MEMCOMi c ( 10-10 ng/particle) 
2-OHflu 8.98 ± 0.35 1.92 ± 0.07 
9-OHphe 8.78 ± 0.26 1.88 ± 0.06 
1-OHpyr 8.76 ± 0.41 1.88 ± 0.09 
6-OHchr 9.59 ± 0.24 2.06 ± 0.05 
4-OHb(a)p 9.01 ± 0.22 1.93 ± 0.05 
3-OHb(a)p 8.69 ± 0.23 1.86 ± 0.05 
 
a All metabolite standard solutions were prepared in methanol. b Maximum concentration 
of extracted OH-PAH with 100μL of 20-nm Au NPs (7.0 x 1011 particles.mL-1). c 
MEMCOMi: maximum mass of extracted OH-PAH per particle unit; it was  calculated 




According to Eq. (6.1), 1mL of a 20 nm Au NPs solution with CCS =7.0×1011 
particles.mL−1 should account for the complete extraction of the six metabolites at individual 
concentration levels of ~4.5×104 ng L−1. This concentration level is much higher than the OH-
PAH concentration levels usually encountered in urine samples.1,2,182-191 Because Eq. (6.1) does 
not account for the potential co-extraction of concomitants in the sample and the resulting uptake 
of particle surface, we kept VCS at 1mL for all further experiments. 
 
6.3.4 Releasing Metabolites from Au NPs 
Previous studies in our lab investigated the efficiency of alcohols, alkanes and 
alkanethiols to release PAH adsorbed to the surface of Au NPs.1,2 The best recoveries were 
obtained with 1-penthanethiol. This solvent was then used here to release OH-PAH from Au 




previously mixed with 1000μL of a 20 nm Au NPs commercial solution (7.0×1011 particles). 
After sample centrifugation, the supernatant (supernatant A) was separated from the precipitate 
and saved for further analysis via RTF spectroscopy. 2μL of 1-pentanethiol were added to the 
precipitate and mixed with 500μL of methanol to favor OH-PAH partitioning into the liquid 
solution. The new mixture was shaken for 5 min at 1400rpm and centrifuged for 20 min at 
13,400 rpm. Its supernatant (supernatant B) was separated from the precipitate and saved for 
further analysis via RTF spectroscopy. 
The concentrations of metabolites in supernatants A ([OHPAH]A) and B ([OH-PAH]B) 
were determined with the calibration curve method. Their values were substituted in Eqs. (6.2)–
(6.4) to calculate the extraction efficiency (E), the releasing efficiency (RE) and the overall 
recovery (OR) of each metabolite: 
E 100 COH PAH M  OH PAH A A
COH PAH VM
             (6.2) 
 
RE 100  OH PAH B B
COH PAH M  OH PAH A
                    (6.3) 
 
OR 100  OH PAH B B
COH PAH M
                                     (6.4) 
where COH-PAH refers to the metabolite concentration in the original sample, VM to the extracted 
volume of methanol, and VA and VB to the volumes of supernatants A and B, respectively. 
Figure 6.4 shows the RE values as a function of micro-liter volumes of 1-pentanethiol. 
Larger volumes than 2μL caused fluorescence quenching in all cases. Within a confidence 




were statistically equivalent (N1 =N2 =3). Table 6.4 summarizes the E, RE and OR values 
obtained for the six metabolites. With the exception of 2-OHflu, all the other OH-PAH were 
extracted from the eluting solvent (methanol) with an efficiency statistically equivalent to 100% 
(˛α= 0.05, N=3). As a result, the OR variations predominantly reflect the observed differences 
among RE values. The different RE values can be attributed to the physical–chemical affinity 





























Figure 6.4 Effect of 1-pentanethiol on the releasing efficiency of extracted OH-PAH with 20-nm Au NPs; from 
left to right: 0, 0.2, 0.5, 1, 2μL.  






Table 6.4 Overall recovery of SPNE. 
OH-PAH a Ex/Emb E (%) c RE (%) d OR (%) e
2-OHflu 273/321 90.9 ± 0.8 94.7 ± 2.4 86.1 ± 2.0 
9-OHphe 253/381 98.9 ± 1.9 88.0 ± 3.1 87.0 ± 2.5 
1-OHpyr 347/384 98.4 ± 0.5 97.6 ± 1.9 96.0 ± 1.8 
6-OHchr 270/378 97.6 ± 2.1 98.3 ± 2.3 95.9 ± 0.9 
4-OHb(a)p 371/419 98.8 ± 2.0 94.7 ± 2.3 93.6 ± 1.2 
3-OHb(a)p 308/430 99.6 ± 1.1 92.4 ± 2.7 92.0 ± 2.3 
 
a Standard solutions were prepared in methanol. b Fluorescence excitation and emission 
wavelengths at which intensity measurements were made. All calculations are based on three 
independent extractions made with 1000 µL of a 20-nm Au NPs commercial solution (7.0 x 
1011 particles). c Extraction efficiency of OH-PAH. d Releasing efficiency of OH-PAH with 




6.3.5 Comparison of the Evaporation Step to the Au NPs Procedure 
Table 6.5 summarizes the metabolites recoveries obtained via the SPE procedure and 
compares the OR of the SPE – evaporation procedure to those obtained with the SPE – Au NPs 
procedure. Standard mixtures of the six metabolites were prepared in pure methanol and spiked 
in 8mL of synthetic urine sample to provide final individual concentrations of 2 ng.mL−1. The 
metabolites concentrations in the SPE eluting solvent (methanol) and the final extract of the 
SPE–evaporation and SPE–Au NPs procedures were monitored via HPLC analysis using 
calibration curves built with a minimum of five standard solutions. The average intensities 
plotted in the calibration graphs corresponded to a minimum of nine HPLC measurements made 
from triplicate aliquots collected from three complete experimental trials. Although a general 
improvement of the OR values is observed with the SPE–Au NPs procedure, their statistical 




significant improvements only for five of the six studied OH-PAH. 2-OHflu showed statistically 
equivalent recoveries because the OR improvement via the SPE–Au NPs procedure was not 
enough to overcome the rather large standard deviation of the OR obtained via the SPE–
evaporation procedure. Keeping in mind that the SPE step was the same for both types of 
procedures, our data clearly shows the considerable improvement of reproducibility of 
measurements that one can achieve with the Au NPs step.  
 
Table 6.5 Metabolites recoveries from synthetic urine samples via SPE-HPLC, SPE-evaporation-HPLC and 







Rec (%) RSD(%) OR (%)c RSD(%) OR  (%) RSD(%)
d
2-OHflu 65.3 ± 4.2 6.43  44.5 ± 11.5 25.8  59.7 ± 3.6 6.03 
9-Ohphe 86.9 ± 3.5 4.03  62.0 ± 9.1 14.7  80.7 ± 3.1 3.84 
1-OHpyr 83.2 ± 2.6 3.12  63.1 ± 6.7 10.6  80.8 ± 2.0 2.48 
6-OHchr 93.5 ± 3.0 3.21  67.7 ± 10.5 15.5  92.3 ± 2.5 2.71 
4-OHb(a)p 71.3 ± 3.7 5.19  57.5 ± 7.1 12.3  68.1 ± 3.1 4.55 
3-Ohb(a)p 68.5 ± 4.0 5.84  53.2 ± 6.8 12.8  64.1 ± 2.8 4.37 
a Mixture of six OH-PAH spiked into 8 mL of synthetic urine sample to reach final 
individual concentration equal to 2 ng.mL-1. b Percent of recovery obtained via SPE. HPLC 
analysis was made in the SPE eluting solvent (methanol) prior to its pre-concentration step or 
the Au NPs step. c Percent of overall recovery (OR) obtained via SPE and evaporation (SPE-
evaporation) or SPE and the Au NPs step (SPE-Au NPs). HPLC analysis was carried out 
after pre-concentration the SPE eluting solvent via the evaporation or the Au NPs step. d 
Relative standard deviation based on average values obtained from triplicate measurements 






Figure 6.5 – which compares the fluorescence intensities of three chromatographs recorded from 
individual aliquots of the same urine sample – confirms the excellent reproducibility of 
measurements of the SPE–Au NPs procedure at the low parts-per-billion concentration levels. 
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Figure 6.5 Chromatograms recorded from individual aliquots of the same urine sample pre-concentrated 
with Au NPs. 
All metabolites were spiked at the 2ng.mL-1 concentration. Peak assignment: (I) 2-OHflu; (II) 9-OHphe; (III) 
1-OHpyr; (IV) 6-OHchr; (V) 4-OHb(a)p; (VI) 3-OHb(a)p. 
 
Table 6.6 summarizes the AFOM of the two approaches obtained from synthetic urine 
samples containing the six studied metabolites. Standard OH-PAH mixtures were prepared in 
pure methanol and spiked in synthetic urine samples. The excellent variances (R2) from the linear 




in all cases. No efforts were made to reach the upper concentration limits of the calibration 
curves. The lowest linear concentrations correspond to the limits of quantitation (LOQ), which 
were calculated as 10 SB/m. The LOD were calculated as 3 SB/m. In both cases, SB was the 
standard deviation of 16 blank determinations at the peak base and m was the slope of the 
calibration curve. A head-to-head comparison of our data in Table 6.6 shows the clear advantage 
of substituting the evaporation with the Au NPs step. LOD improvements varied from5.7× (2-
OHflu) to 14.05× (3-OHb(a)p). The observed range of LOD most likely reflects the differences 






































2-OHflu 8.49 ± 0.13    227/330 0.343-10 0.103 0.9893  0.059-2 0.0178 0.9859 
9-OHphe 9.46 ± 0.09 244/370 0.153-10 0.046 0.9967  0.023-2 0.0070 0.9771 
1-OHpyr 19.00 ± 0.06 242/388 0.083-10 0.025 0.9993  0.0073-2 0.0022 0.9990 
6-OHchr 22.50 ± 0.15 269/378 0.070-10 0.021 0.9884  0.0060-2 0.0018 0.9998 
4-OHb(a)p 29.99 ± 0.20 248/433 0.720-10 0.216 0.9991  0.049-2 0.0147 0.9918 
3-OHb(a)p 37.80 ± 0.10 248/433 0.543-10 0.163 0.9903  0.038-2 0.0116 0.9894 
 
a All working solutions were synthetic urine samples previously spiked with micro-litters of metabolite standard solutions of 
appropriate concentrations. b Fluorescence excitation and emission wavelengths for HPLC analysis. c SPE followed by 
evaporation of eluting solvent. d SPE followed by SPNE. e Linear dynamic range (LDR). f Limits of detection (LOD) were 
calculated by the equation: LOD = 3 SB /m, where SB is the standard deviation of 16 blank determinations and m is the slope of 











Our studies have devised a unique approach to improve the AFOM of SPE-HPLC for the 
analysis of OH-PAH in urine samples. The use of Au NPs to pre-concentrate metabolites from 
the SPE eluting solvent provided OR improvements (ORAu NPs − OREvaporation) varying from ~10.6% 
(4-OHb(a)p) to ~24.6% (6-OHchr). The significant improvements observed in the standard 
deviations of the OR values via the SPE–Au NPs procedure provided relative standard deviations 
lower than 6%. Significant improvements were also observed in the LOD. Because the Au NPs 
step improved the LOD by at least one order of magnitude, the minimum detection levels of all 
the studied metabolites were at parts-per-trillion (pg.mL−1) level.  
Numerous SPE-HPLC methods have been published for the analysis of OH-PAH 
metabolites in human urine samples. A wide range of OR and relative standard deviations have 
been reported for the metabolites investigated in this chapter. These include 41±5% (12.2%) for 
3-OHb(a)p,182 53±13% (24.5%) for 2-OHflu,182 67±1% (1.5%) for 9-OHphen,182 and 57±10.3% 
(18%)185 and 62±14% (22.6%)182 for 1-OHpyr. The same is true for the reported LOD, which 
include 0.72 ng.mL−1 for 2-OHflu,182 0.16 ng.mL−1 for 9-OHphe,182 0.004 ng.mL−1,182 0.005 
ng.mL−1 and 40 ng.mL−1 for 1-OHpy185,190 and 0.006 ng.mL−1, 0.121ng.mL−1 and 0.161 ng.mL−1 
for 3-OHb(a)p.182,185,190  
A straightforward comparison to our data is rather arguable because our experiments 
were carried out with synthetic urine samples. However, the fact that our SPE-HPLC results 
from synthetic urine samples are consistent with previously reported data on human urine 
samples provides a general prospective of the excellent potential of the new approach for the 










CHAPTER 7 GOLD NANOPARTICLES DEPOSITED CAPILLARIES 
AS PRE-CONCENTRATION DEVICES FOR IN-CAPILLARY 
MICRO-EXTRACTION CAPILLARY ELECTROPHORESIS: 
APPLICATION TO THE URINE ANALYSIS OF MONOHYDROXY 
METABOLITES OF POLYCYCLIC AROMATIC HYDROCARBONS 
 
7.1 Introduction 
Capillary Electrophoresis (CE) is a separation technique based on the differential 
migration rate of charged species in a dc electric field applied across a capillary tube.  A 
particular strength of CE is its unique ability to separate a large variety of charged species, 
including peptides and proteins,192,193 nucleic acids (DNA and RNA),194-196 lipids,197 low-
molecular weight drugs,198,199 and even inorganic ions.200,201 This versatility makes CE an 
extremely attractive technique in biochemical, biological and biomedical research as well as in 
the biotechnology industry. Similar to high-performance liquid chromatography (HPLC), the 
simplicity and wide applicability of ultraviolet and visible absorption spectroscopy (UV-VIS) 
makes this technique the most common detection mode in CE. The main disadvantage of CE-
UV-VIS in bio-analysis is its rather poor concentration sensitivity. The unsatisfactory limits of 
detection (LOD) mainly result from the short optical path length of on-capillary absorption 
measurements and the small sample injection volumes (10 – 100nL). Several strategies exist to 
improve the LOD of CE. These include measuring absorption through longer optical path lengths 
with the aid of Z- or U-shaped detection cells202,203 or bubble cells;204,205 using more sensitive 
detectors, which could be based on laser induced fluorescence spectroscopy110,206-208 or mass 
spectroscopy,209,210 or performing sample pre-concentration prior to CE.211-216  





electrophoresis-based approaches.218 Chromatographic pre-concentration using solid-phase 
extraction (SPE) appears to be widely accepted due to its general applicability and relatively high 
pre-concentration factors.219-221 The simplest way to combine SPE and CE is to perform the two 
steps separately via an off-line approach. At-line approaches use a robotic or a similar system to 
transfer the samples from SPE to the CE system. In both off-line and at-line systems there is no 
direct stream of liquid between SPE and CE. The integration of the two steps into a single system 
provides the advantages of minimum sample handling and possible automation. Two types of 
integrated SPE-CE systems exist. On-line coupling requires a physical connection for continuous 
flow from the SPE column to the separation capillary. Valves222-225, flow injection analysis 
systems226-231 and T-splits232,233 have been used for this purpose with various degrees of success.  
Ideal coupling is achieved with in-line SPE-CE systems, were the SPE column is placed inside 
the separation capillary.219  Pre-concentration and separation within the same capillary requires 
the use of an eluting solvent chemically compatible with the elctrophoretic mobile phase. For 
those cases where the eluting solvent is chemically incompatible with the separation medium, a 
new procedure was recently developed with the name of in-capillary micro-extraction.234,235 The 
new method is easy to implement and does not require micro-valves, external connectors or T-
splits. In-capillary micro-extraction CE uses two different capillaries, one for sample pre-
concentration and the other for electrophoretic separation. Both steps are carried out in the CE 
system with minimum sample handling. Pre-concentration is made with the aid of a chemically 
modified capillary that is also used for sample elution. The eluted sample is collected into the 
injection vial for elctrophoretic separation, which is then carried out with a second silica 
capillary. This approach was successfully applied to the analysis of several carbamate pesticides 





polymeric sorbent synthesized in a silica capillary. Using a polydivinylbenzene monolith of 
16cm length, an average pre-concentration factor of 60 was obtained for the studied pesticides.  
Only a few reports exist on the analyses of PAH metabolites via CE. Table 7.1 correlates 
the name of the metabolite to the method of analysis used for its determination. Smith and co-
workers206 reported the separation of twelve OH-PAH via cyclodextrin-modified micellar 
electrokinetic chromatography (CD-MEKC) using a buffer consisting of 40mM γ-CD, 60mM 
sodium dodecyl sulfate (SDS) and 30mM borate. Metabolite detection was carried out via laser 
induced fluorescence (LIF). A UV-transmitting fiber optic cable was used to couple the 325nm 
laser light from a He-Cd to the detection window in the separation capillary. The inner diameter 
of the capillary tube provided a detection window with optical path-length (effective path-length) 
equal to 50μm. Fluorescence was collected into a commercial spectrofluorimeter for intensity 
and spectra recording. LOD at the sub-parts-per-million level (sub-μg/mL) were obtained for all 
the studied metabolites. Xu and Hurtubise236,237 demonstrated the successful separation of nine 
PAH metabolites via capillary zone electrophoresis (CZE) using a 100mM 3-cyclohexylamino-1-
propanesulfonic acid (CAPS) buffer solution (pH 10.4) with 40% (v/v) methanol. The studied 
metabolites - which included tetrols, benzo[a]pyrene diols and OH-PAH – were detected via UV 
absorption spectroscopy. This detection approach was useful for the optimization of 
electrophoretic parameters but not sensitive enough for metabolite detection at trace 
concentration levels. Kuijt and co-workers110 separated 5 OH-PAH via CD-MECK using a 
30mM borate buffer (pH 9.0) containing 60 mM SDS and 12.5mM γ-CD. Their quantitation was 
carried out via both conventional fluorescence and LIF. The best LOD (low ng/mL concentration 
range) were obtained with LIF home-made set-up. Open path sample excitation was carried out 





window with a 75 μm effective path-length) was detected with single channel system consisting 







Table 7.1  Overview of the CE analysis of PAH metabolites. 
PAH Metabolites CE Electrophoretic Medium Detection Mode LOD Ref. 
2-OHnaphthalene CD-MEKC γ-CD/SDS/borate buffer CF/LIF 40/4 ng/ml [110] 
1-OHphenanthrene CD-MEKC γ-CD/SDS/borate buffer CF/LIF 7/2 ng/ml [110] 
1-OHbenzo[a]pyrene CD-MEKC γ-CD/SDS/borate buffer LIF ~ 270ng/ml [206] 
3-OHbenzo[a]pyrene CD-MEKC γ-CD/SDS/Na2B4O7/H3BO3 UV / [238] 
CD-MEKC γ-CD/SDS/borate buffer LIF ~ 270ng/ml [206] 
CD-MEKC γ-CD/SDS/borate buffer CF/LIF 2/2 ng/ml [110] 
CZE CAPS/MeOH/H2O (40% v/v) UV / [236] 
7-OHbenzo[a]pyrenep CD-MEKC γ-CD/SDS/borate buffer LIF ~ 270ng/ml [206] 
CZE CAPS/MeOH/H2O (40% v/v) UV / [236] 
9-OHbenzo[a]pyrene CD-MEKC γ-CD/SDS/borate buffer LIF ~ 270ng/ml [206] 
CZE CAPS/MeOH/H2O (40% v/v) UV / [236] 
12-OHbenzo[a]pyrene CZE CAPS/MeOH/H2O (40% v/v) UV / [236] 
1-OHbenzo[a]anthracene CD-MEKC γ-CD/SDS/borate buffer LIF ~ 250ng/ml [206] 
3-OHbenzo[a]anthracene CD-MEKC γ-CD/SDS/borate buffer LIF ~ 250ng/ml [206] 
CZE CAPS/MeOH/H2O (40% v/v) UV / [236] 
8-OHbenzo[a]anthracene CD-MEKC γ-CD/SDS/Na2B4O7/H3BO3 UV / [238] 
1-OHchrysene CD-MEKC γ-CD/SDS/borate buffer CF/LIF 35/6 ng/ml [110] 
3-OHchrysene CD-MEKC γ-CD/SDS/borate buffer LIF ~ 250ng/ml [206] 
4-OHchrysene CD-MEKC γ-CD/SDS/Na2B4O7/H3BO3 UV / [238] 
1-OHpyrene CD-MEKC γ-CD/SDS/borate buffer LIF 17.6ng/ml [206] 
CZE CAPS/MeOH/H2O (40% v/v) UV / [236] 









Table 7.1 Overview of the CE analysis of PAH metabolites (continue). 
PAH Metabolites CE Electrophoretic Medium Detection Mode LOD Ref. 
1-OHbenzo[b]fluoranthene CD-MEKC γ-CD/SDS/borate buffer LIF ~ 270ng/ml [206] 
12-OHbenzo[b]fluoranthene CD-MEKC γ-CD/SDS/Na2B4O7/H3BO3 UV / [238] 
2-OHindeno[1,2,3-cd]pyrene CD-MEKC γ-CD/SDS/borate buffer LIF ~ 300ng/ml [206] 
benzo[a]pyrene-trans-4,5-
dihydrodiol 
CD-MEKC γ-CD/SDS/Na2B4O7/H3BO3 UV / [238] 
benzo[a]pyrene-trans-7,8-
dihydrodiol 
CZE CAPS/MeOH/H2O (40% v/v) UV / [236] 
benzo[a]pyrene-trans-9,10-
dihydrodiol 
CZE CAPS/MeOH/H2O (40% v/v) UV / [236] 
benzo[a]pyrene-r-7-trans-8,9-
cis-10-tetrahydrotetrol 
CZE CAPS/MeOH/H2O (40% v/v) UV / [236] 
Abbreviation: CD-MEKC: cyclodextrin modified micellar electrokinetic capillary chromotagraphy; CZE: capillary zone 










 In this chapter, we present the first application of gold nanoparticles (Au NPs) deposited 
capillaries as sample pre-concentration devices for in-capillary micro-extraction electrophoresis 
and their use for the analysis of OH-PAH in synthetic urine samples. We demonstrate the 
feasibility to obtain competitive UV absorption LOD (S/N = 3) with commercial instrumentation. 
1-hydroxypyrene (1-OHpyr), 9-hydroxyphenanthrene (9-OHphe), 3-hydroxybenzo[a]pyrene (3-
OHbap), 4-hydroxybenzo[a]pyrene (4-OHbap) and 5-hydroxybenzo[a]pyrene (5-OHbap) were 
separated via CZE using a 100mM CAPS buffer solution (pH  10.4) 40% (v/v) methanol. Sample 
pre-concentration with Au NPs deposited capillaries provided enrichment factors ranging from 
87 (9-OHphen) to 100 (3-OHbap) and made possible to reach UV absorption LOD from 9ng.mL-
1 (9-OHphen and 3-OHbap) to 14ng.mL-1 (4-OHbap).  
 
7.2  Experimental Section 
7.2.1 Chemicals and Materials 
HPLC grade methanol, hydrochloric acid, potassium biphthalate sodium hydroxide buffer 
and synthetic urine were purchased from Fisher Scientific (Pittsburgh, PA). CAPS and 3-
mercaptopropyl- trimethoxysilane (MPTMS) were purchased from Sigma–Aldrich (Milwaukee, 
WI). Analytical grade 1-pentanethiol was from Acros Organics (Atlanta, GA). Au NPs were 
purchased from Ted Pella, Inc. (Redding, CA). Nanopure water from a Barnstead Nanopure 
Infinity water system was used throughout. All OH-PAH were purchased at their highest 
available purity (>98%) and used with no further purification. 9-OHphe was acquired from 
Sigma–Aldrich (Milwaukee, WI). 1-OHpyr was purchased from Accustandard (New Haven, CT). 





64110). Fused-silica capillary with 50μm internal diameter and 375μm outer diameter were 
purchased from Polymicro Technologies. The polyamide coating was removed with a window 
maker (MicroSolv-CE) to provide an UV transparent detection window with an approximate 
length of 2 mm. The center of the optical window was located at 58cm from the injection port of 
the CE instrument.  
Note: use extreme caution when handling OH-PAH that are known to be extremely toxic. 
 
7.2.2  Solution preparation 
Stock solutions of OH-PAH were prepared in pure methanol. Working metabolite 
solutions were prepared by serial dilution with 5% methanol (v/v). Possible metabolite 
degradation was monitored daily via fluorescence spectroscopy. All solutions were stored in the 
dark at 4 ◦C. The buffer solution for OH-PAH separation was prepared daily by adding 1.107g of 
CAPS to 60mL of Nanopure water (18.1MΩ) and 40mL of HPLC grade methanol. Its final pH 
was adjusted to 10.4 using a 1M NaOH solution. The 10mM MPTMS we used to coat the inner 
walls of the pre-concentration capillary tube was prepared in ethanol.  
 
7.2.3 Instrumentation 
Solution mixing was carried out with a Maxi Mix III Rotary Shaker (Type M65800, 
Barnstead-Thermolyne) equipped with a PT500X6A Vortex Mixer accessory. pH measurements 
were made with an AR-15 pH/mV/C meter and a glass body standard size combination 





recorded with a Zeiss scanning electron microscope (Ultra 55, Carl Zeiss SMT AG, Germany). 
Prior to imaging, capillaries were sputter coated with a uniform layer of Au-Pd (5nm thick) using 
an SPI bench-top module spotter coater (Structure Probe, West Chester, PA, USA). 
Instrumentation for absorption, fluorescence and CE measurements was previously described in 
sections 3.1, 3.2 and 3.5, respectively.    
 
7.2.4 Fabrication of Au NPs deposited capillaries 
Fabrication of Au NPs deposited capillaries followed the method published in the 
literatures.239-246 All reagents were pumped through the capillaries with the aid of our CE 
instrument. All coated capillaries had the same length (100cm) and square internal channel 
(74μm x 74μm) dimensions. With the aim of exposing the surface silanol groups on their inner 
walls, capillaries were first etched by pressure rinsing (1000mbar) with 1M NaOH (30min), de-
ionized water (10min) and 0.1 M HCl (30min). Upon rinsing with DI water again, the capillary 
was placed in an oven and dried at 100˚C for 1h to remove all moisture. The organosilane 
derivatization step was carried out with a 10mM MPTMS solution. The coupling agent was 
introduced into the capillaries by pressure (1000mbar) for a period of 2h and left it to stand 
overnight. The modified capillary was then rinsed with ethanol and annealed at 110˚C in the 
oven for 10 min. After rinsing the capillaries with de-ionized water, 2mL of a Au NPs aqueous 
solution (20nm particles at a 7 × 1011 particle/mL concentration) was pressure introduced into the 
capillaries at 500mbar. The excess of Au NPs was removed by pressure rinsing the capillaries 






7.2.5 In-capillary micro-extraction procedure 
Metabolites were retained in the coated capillary by pressuring through 1mL of sample 
solution at 1000mbar. The same CE pressure was used to release the metabolites with micro-
litters of 1-pentanethiol. The eluting solution was collected in 300μL glass vials (Analytical Sales 
and Services Inc.; Pompton Plains, NJ) for subsequent electrophoretic separation.  
 
7.2.6 Analysis of Urine Samples 
Prior to hydrolysis, urine samples were spiked with micro-litters of metabolite stock 
solutions of appropriate concentration and allowed to equilibrate overnight. Acidic hydrolysis 
(pH = 5.0) of the spiked samples was then carried out by mixing and shaking (30 min, 1400 rpm) 
8mL of urine sample, 500 µL of 0.1 M HCl and 500 µL of 0.05 M potassium biphthalate sodium 
hydroxide buffer. SPE was carried out via an experimental procedure previously optimized in our 
lab.189 Urine samples were processed through a Sep-Pak® C-18 (Waters, Milford, MA) cartridge 
pre-conditioned with 15 mL of methanol and 5 mL of water. All solutions were processed 
through the cartridge with the aid of a 10 mL syringe attached to the cartridge. The cartridge was 
sequentially rinsed with 10 mL of water and 10 mL of 20% methanol/water (v/v). OH-PAH were 
eluted with 3 mL of 100% methanol and submitted to CE analysis. 
 
7.3 Results and discussion 
7.3.1  CZE separation of the studied metabolites  





class separation of nine PAH metabolites, including tetrols, benzo[a]pyrene diols, 3-OHbap and 
1-OHpyr.236,237 To the extent of our literature search, the CZE separation of 9-OHphen, 4-OHbap 
and 5-OHbap has not been reported yet. The HPLC analysis of 9-OHphen in urine samples has 
been already published182,247 but the chromatographic separation of 4-OHbap and 5 OH-bap has 
not been reported yet.   HPLC studies carried out in our lab have shown the difficulty to achieve 
a single set of optimum chromatographic conditions for the separation of 3-OHbap, 4-OHbap 
and 5-OHbap.248  Table 7.2 lists the five OH-PAH in increasing order of migration time using a 
100mM CAPES buffer solution (pH 10.4) 40% (v/v) methanol. The number of theoretical plates, 
N, was calculated from the equation N = 16(tr/w)2 where tr denotes the migration time and w the 
width at the base peak.249 Under these buffer conditions, the separation efficiency of CZE 

















Table 7.2 CE separation parameters for the 5 OH-PAH. 
 
OH-PAH 





9-OHphe 31.16 ± 0.27 33,269 / 
5-OHbap 33.72 ± 0.31 83,537 4.45 
4-OHbap 34.37 ± 0.35 75,603 1.34 
3-OHbap 38.87 ± 0.58 96,696 9.01 
1-OHpyr 39.87 ± 0.44 108,872 2.03 
a CE analysis conditions for the 5 OH-PAH: buffer, 100mM CAPS with 40% (v/v) 
methanol; apparent pH 10.1; voltage, 26kV; temperature, 25ºC. b The number of 
theoretical plates were calculated from the equation N = 16(tr/w)2 where tr denotes the 
migration time and w the width at the base peak. c The resolution of two metabolites (A 




7.3.2 Characterization of Au NPs deposited capillaries 
Figure 7.1a compares the UV-Vis absorption spectra of a 20nm Au NPs solution that were 
recorded before and after coating of the inner walls of a capillary tube. Both spectra show the 
characteristic Plasmon resonance structure of Au NPs at 525 nm. The intensity drop observed 
in the spectrum after the capillary coating correlates to the immobilization of Au NPs in the inner 
surface of capillary tube and the lower concentration of Au NPs in solution.  Figures 7.1b – d 
compare the scanning electron microscopy (SEM) images recorded from a 50mm un-coated 
capillary segment (7.1b) to those recorded from 50mm Au NPs deposited capillaries segments 
(7.1c and 7.1d). Similar images recorded from different segments of numerous capillary tubes 










Figure 7.1 UV absorption spectra of Au NPs solution before and after coating to the capillary and SEM 
images of the inner surface of capillary. 
(a) UV absorption of 20nm Au NP commercial solutions before and after deposition. (b) untreated capillary; 
(c) and (d) coated with 20nm Au NP.  
 
 
7.3.3 Sample flow rate for in-capillary pre-concentration of OH-PAH  
The retention capacity of OH-PAH metabolites increased with the length of the pre-
concentration capillary tube. An inverse correlation was observed between the flow rate of the 
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sample solution and the length of the capillary tube.  The resistance to the passage of fluids 
increased with the length of the capillary tube and slowed down the sample flow rate. Because 
the use of rather short capillary tubes and relatively high sample flow rates prevented the 
adequate retention of OH-PAH, we optimized the sample flow rate for capillaries 100cm in 
length. Metabolite retention was monitored via fluorescence spectroscopy, a technique sensitive 
enough to monitor OH-PAH at trace concentration levels.3 Fluorescence intensities were 
measured at the maximum fluorescence excitation and emission maxima of each metabolite. All 
measured intensities were within the linear dynamic ranges of the calibration curves. All 
calibration curves were built with a minimum of five OH-PAH linear concentrations. Each point 
in the calibration graphs corresponded to the average value of a at least three intensity 
measurements. The best straight lines were obtained via the least squares method. All extractions 
were made by pressuring 1mL OH-PAH solution through the pre-concentration capillary tube. 
All calculations were based on average values taken from triplicate measurements of three 
independent metabolite extractions carried out with three coated capillaries. The percent of 
extracted metabolite (%E) was calculated according to equation (7.1): 
%E = 100(COH-PAH  – [OH-PAH]A) / COH-PAH  (7.1) 
Where COH-PAH corresponds to the original metabolite concentration in the sample and [OH-
PAH]A is the concentration of OH-PAH remaining in the extracted solution. The sample flow rate 
(F) was controlled by varying the pressure of the CE injection pump from 200 to 2000mbar. F 
was calculated according to the equation F = 1,000μL/t, where t was the time it took 1,000μL to 
flow through the capillary tube. Figure 7.2 correlates the extraction efficiency of 3-OHbap to the 
pump pressure and the sample flow rate. As the pump pressure was varied from 200 to 





7.8μL/min (1,000mbar), the extraction efficiency of 3-OHbap remained statistically equivalent 
(N1 = N2 = N3 = 3; P = 0.05).157 Considerable drops of the %E values were observed at 1,500 and 
2,000mbar pump pressures. The same trend was observed for the remaining OH-PAH. Because 
the pre-concentration time is inversely proportional to the pump pressure, we adopted 1,000mbar 




































Figure 7.2 Effect of CE pump pressure on the flow rate and extraction efficiency of 3-OHbap. 
 
7.3.4 Releasing OH-PAH from Au NPs deposited capillaries 
Previous studies in our lab investigated the efficiency of alcohols, alkanes and 





recoveries for OH-PAH were obtained with a 4% 1-penthanethiol-methanol (v/v) solution. This 
mixture was then used here to release OH-PAH from Au NPs deposited capillaries. Metabolites 
were individually pre-concentrated from 1,000μL aliquots of 20ng.mL-1 OH-PAH standard 
solutions. This metabolite concentration (COH-PAH) is within the concentration range of OH-PAH 
in urine samples. All extractions were made by pressuring 1mL OH-PAH solution through the 
pre-concentration capillary tube at 1,000mbar. The releasing solvent was then pumped through 
the coated capillary under the same sample pressure and the eluted solution was collected for 
further dilution with methanol. The dilution step provided appropriate aliquot volumes (500μL) 
for the smallest cuvettes available in our lab. Metabolite concentrations were then determined via 
fluorescence spectroscopy and the calibration curve method. The percent of extracted metabolite 
(%E) was calculated according to equation (7.1). The overall recovery of OH –PAH (%OR) was 
calculated according to equation (7.2): 
%OR = 100[OH-PAH]BVB/COH-PAHVS  (7.2) 
Where [OH-PAH]B corresponds to the metabolite concentration released from the pre-
concentration capillary, VB = 500μL, COH-PAH is the metabolite concentration in the sample and 
VS =1mL. The percent of released metabolite (%RE) was calculated with the following equation:  
%RE = 100([OH-PAH]B VB / (COH-PAH VS – [OH-PAH]A VA) (7.3) 
Several volumes of releasing solvent (4, 6, 8, 10 and 15μL) were investigated for best releasing 
efficiencies and overall recoveries. The best percentages were obtained with 8 and 10μL of 4% 
1-penthanethiol-methanol (v/v). Table 7.3 summarizes the %E, %RE and %OR values obtained 
for the five OH-PAH with 8μL of releasing solvent. The statistical comparison of the tabulated 
values (N1 = N2 = 3; P = 0.05)157 shows no difference on the extraction efficiencies of the studied 





indication that possible differences among the physical-chemical affinities OH-PAH might have 
towards the inner surfaces of coated capillaries and their surroundings are within the precision of 
our measurements.   
 
 Table 7.3 Overall recovery of in-capillary micro-extraction. 
OH-PAH a Ex/Emb E (%) c RE (%) d OR (%) e
9-OHphe 253/381 76.5 ± 5.9 91.2 ± 5.1 69.8 ± 5.5 
5-OHbap 305/429 89.4 ± 5.0 84.7 ± 6.3 75.7 ± 6.2 
4-OHbap 371/419 84.5 ± 4.5 85.6 ± 4.3 72.4 ± 3.2 
3-OHbap 308/430 87.1 ± 4.1 92.5 ± 3.7 80.6 ± 5.3 
1-OHpyr 347/384 85.8 ± 3.5 88.9 ± 4.9 76.3 ± 4.8 
 
a Standard solutions were prepared in methanol. b Fluorescence excitation and emission 
wavelengths at which intensity measurements were made. All calculations are based on three 
independent extractions. c Extraction efficiency of OH-PAH. d Releasing efficiency of OH-
PAH with 4% (v/v) of 1-pentanethiol/methanol. e Overall recovery of OH-PAH  
 
7.3.5 Analytical figures of merit (AFOM) 
The AFOM of in-capillary micro-extraction CZE were compared to those obtained via 
CZE. Calibration curves were built with standard mixtures containing known concentrations of 
the five metabolites in methanol. Sample pre-concentration via in-capillary micro-extraction was 
carried out processing 1mL of the standard mixture at 1,000mbar pressure. Metabolites release 
was accomplished passing 8μL of a 4% 1-penthanethiol – methanol solution (v/v) through the 
pre-concentration capillary at 1,000mbar pressure. CZE was carried out with 8μL of sample 
using 100mM CAPS buffer solution (pH 10.4) in 40% methanol (v/v). Table 7.4 compares the 
AFOM of the two approaches. All linear dynamic ranges were based on the average intensities of 





correspond to a minimum of three measurements made from triplicate aliquots submitted to three 
complete experimental trials. No efforts were made to reach the upper concentration limits of the 
calibration curves. The excellent correlation coefficients (R) demonstrate the existence of linear 
relationships in all cases. The main significant difference between the AFOM of the two 
approaches resides on the LOD. Their values – which were calculated according to S/N = 3 – 
clearly show the advantage of using Au NPs deposited capillaries for pre-concentration in-
capillary micro-extraction CZE. Concentration factors of approximately two orders of magnitude 
provided UV absorption LOD considerably lower or of the same order of magnitude as those 







Table 7.4 Comparison of the analytical figures of merit of the CE method and in-capillary micro-extraction CE method. 
 
OH-PAH 













9-OHphe 31.16 ± 0.27 1 - 10 0.9938 0.61  10 - 30 0.9890 8.85 87 
5-OHbap 33.72 ± 0.31 1 - 10 0.9981 0.86  10 - 30 0.9869 12.5 94 
4-OHbap 34.37 ± 0.35 1 - 10 0.9939 1.08  10 - 30 0.9839 14.4 90 
3-OHbap 38.87 ± 0.58 1 - 10 0.9894 0.75  10 - 30 0.9909 9.62 100 
1-OHpyr 39.87 ± 0.44 1 - 10 0.9898 0.94  10 - 30 0.9878 11.8 95 
a LDR: linear dynamic range; bLOD were calculated according to S/N = 3, where S is the intensity of the signal and N is intensity 
of noise; c Concentration factor were calculated according to the equation: C-fator = (Analyte desorption efficiency × Analyte 












7.3.6 Urine Analysis 
Table 7.5 lists the metabolites absorption intensities recorded from electropherograms of 
three spiked urine samples and three methanol standard mixtures. For comparison purposes, all 
samples had the metabolites at the same parts-per-billion concentration level. Because urine 
matrix constituents showed to degrade free Au NPs in aqueous solutions,3 we decided to first 
extract the metabolites from the spiked urine samples and then perform their in-capillary micro-
extraction from the methanol extract. SPE was carried out via an experimental procedure 
previously developed in our lab.3 SPE methanol extracts and methanol standard mixtures (No 
SPE) were submitted to in-capillary micro-extraction using one Au NPs deposited capillary per 
sample. In-capillary micro-extraction was carried out by pressuring through the capillary 1mL of 
solution at 1,000mbar. Comparison of SPE to No SPE values show lower absorption intensities 
for all the samples previously submitted to SPE. This was expected as the SPE procedure 
provides overall recoveries lower than 100% for all the studied metabolites.3 The comparison of 
the relative standard deviations (RSD) consistently shows better precision of measurements for 
the No SPE samples. The No SPE RSD values correspond to the precision of measurements 
obtained via the in-capillary micro-extraction procedure. Because their averages were calculated 
from three electrophoretic runs using three different capillaries, the reported values also reflect 









Table 7.5 Reproducibility of In-Capillary Micro-Extraction CZE for the Analysis of OH-PAH (Absorption intensities ×10-4). 
 
OH-PAH 
Capillary 1 and 2  Capillary 3 and 4  Capillary 5 and 6 Average (RSD) 
SPE No SPE SPE No SPE SPE No SPE  SPE No SPE 
9-OHphe 2.70 3.44  2.34 3.23  2.27 3.08  
 
2.44 ± 0.23 
(9.5%) 
3.25 ± 0.18 
(5.6%) 
5-OHbap 2.35 2.94  1.87 3.05  2.16 2.67  
 
2.12 ± 0.24 
(11.4%) 
2.89 ± 0.20 
(6.8%) 
4-OHbap 1.27 1.59  1.12 1.48  1.05 1.35  
 
1.15 ± 0.11 
(9.8%) 
1.47 ± 0.12 
(8.2%) 
3-OHbap 2.88 3.75  2.36 3.72  2.22 3.36  
 
2.49 ± 0.35 
(14.0%) 
3.61 ± 0.22 
(6.0%) 
1-OHpyr 1.33 1.89  1.19 1.74  1.14 1.63  
 
1.22 ± 0.10 
(8.1%) 













Figure 7.3 displays the electropherograms of three standard mixtures recorded under the 
same CZE conditions. Comparison of electropherograms 7.3a and 7.3b show the advantage of 
using in-capillary micro-extraction to pre-concentrate the sample prior to CZE analysis. 
Although the concentration of individual metabolites in the pre-concentrated sample (7.3b) is 
50x lower than their concentration in the no pre-concentrated sample (7.3a), the signal intensities 
in 7.3b are approximately 2x higher than those in 7.3a. Furthermore, the presence of 1-
penthanethiol in the separation buffers - which appears as peak I in 7.3b - shows no effect on the 
migration times of the studied OH-PAH. Comparison of electropherograms 7.3b and 7.3c 
demonstrates no effect of the possible presence of urine matrix components in the separation 
buffer. Because the migration times of the studied metabolites and their peak widths remain 
approximately the same, we can state that the use of Au NPs deposited capillaries as pre-















































 Figure 7.3 Electropherogram of a mixture of 5 OH-PAH and 1-pentanethiol. 
a) 1.5 μg/mL standard solution; b) 0.03μg/mL OH-PAH solution after in-capillary micro-extraction; c) 
0.01μg/mL OH-PAH urine sample after SPE and in-capillary micro-extraction. I)EOF marker (Methanol); 
II) 1-pentanethiol; III) 9-OHphen; IV) 5-OHbap; V) 4-OHbap; VI) 3-OHbap; VII) 1-OHpyr. CE analysis 
conditions for the 5 OH-PAH: buffer, 100mM CAPS with 40% (v/v) methanol; apparent pH 10.1; voltage, 









We have developed a novel and sensitive method for the analysis of OH-PAH via CZE. It 
is possible now to obtain UV absorption LOD at the low parts-per-billion level with commercial 
CE instrumentation. Our LOD are comparable to those previously reported via CE-LIF. 110,206  
The main original component of our method is the use of Au NPs deposited capillaries for the 
pre-concentration of samples prior to CE analysis. Their application to the pre-concentration of 
OH-PAH provides concentration factors of approximately two orders of magnitude. The 
reproducibility of measurements is excellent as well. The second original component 
demonstrates the CZE separation of 3-OHbap, 4-OHbap and 5OH-bap using a 100mM CAPES 
buffer solution (pH 10.4) with 40% (v/v) methanol. The pre-concentration of OH-PAH with Au 
NPs deposited capillaries requires the use of 1-pentanethiol for subsequent metabolite release. 
Our studies show that this releasing solvent has no effect on the successful CZE separation of the 













CHAPTER 8 ANALYSIS OF POLAR METABOLITES OF 
POLYCYCLIC AROMATIC HYDROCARBONS VIA LASER-
EXCITED TIME-RESOLVED SHPOL’SKII SPECTROSCOPY IN 
FROZEN ALCOHOL MATRIXES 
 
8.1 Introduction 
Previous articles have shown that room-temperature excitation and fluorescence spectra 
of PAH metabolites and PAH-DNA adducts do not have sufficient resolution to distinguish 
among closely related species.250-253 Similar findings have been reported at low-temperature, 
which have shown very broad spectra with bandwidths of several hundreds of reciprocal 
centimeters.99,100,253 The nature of band broadening is well known and thoroughly discussed in 
chapter 2 of this dissertation. For amorphous matrixes in the condensed phase, characterized by 
their lack of long-range order, the local conditions (microenvironments) that influence the 
transition energies of the solute molecules (predominantly through electron-electron interactions) 
differ from one solute molecule to another. The resulting differences in electronic transition 
energies lead to a Gaussian broadening of excitation and emission spectra. This type of band 
broadening is called inhomogeneous band broadening. Homogeneous broadening affects all 
molecules to the same extent. It arises from vibronic coupling to the rapidly fluctuating 
surrounding matrix and from the limited lifetimes of the states involved in the electronic 
transition. In an ideal situation, i.e. when all solute molecules experience exactly the same 
environment, the only remaining source of band broadening (apart from instrumental 
contributions) is homogeneous.99,100 





inhomogeneous band broadening is fluorescence line narrowing spectroscopy. Similar to 
Shpol’skii spectroscopy, fluorescence line narrowing spectroscopy deals with cryogenic 
temperatures where samples are frozen to 77K or below. In fluorescence line narrowing 
spectroscopy, inhomogeneous broadening is suppressed with the aid of a narrow-band tunable 
laser that excites a small selection of analyte molecules in the frozen sample. Excitation can be 
accomplished within the 0-0 transition wavelength region or into the vibronic region of the first 
excited state S1-S0.When the conformations of the analyte molecules and the orientations of the 
surrounding matrix molecules do not change substantially during the lifetime of the excited state, 
only the small sub-selection (isochromat) of analyte molecules is excited and their fluoresce line-
narrowed spectrum is observed. The freedom in solvent choice has prompted the application of 
fluorescence line narrowing spectroscopy to a variety of problems. In particular, for chemical 
identification, conformational analysis, and/or probing the micro-environment of DNA (or 
protein) - adducts.99,253 Unfortunately, fluorescence line narrowing spectroscopy is distinctly less 
sensitive than Shpol’skii spectroscopy because the excited isochromat only comprises a small 
fraction of the total number of analyte molecules in the frozen matrix.253 On the other end, the 
requirement of a specific analyte-solvent combination has confined Shpol’skii spectroscopy to 
the analysis of parent PAH.254 The research presented here has the potential to remove this 
limitation and extend the applicability of Shpol’skii Spectroscopy to the analysis of polar PAH 
metabolites. 
The determination of PAH metabolites prior to DNA damage fills an important niche to 
prevent extreme body burdens and minimize cancer risk. One would certainly prefer an early 
warning parameter over a toxicological endpoint – such as DNA-adducts - that indicates the 





PAH metabolites are relatively rare. Reviewing the early Russian literature, Nurmukhametov 
states that “Attempts to obtain an effectively resolved structure for the electronic bands of 
aromatic alcohols…in n-hydrocarbon solution did not give positive results”.255 Nevertheless, a 
few years later Khesina et al.256 observed quasi-line spectra for two phenolic benzo[a]pyrene 
(B[a]P) metabolites, 3-hydroxy-B[a]P (3-OHB[a]P) and 6-OHB[a]P, in frozen n-octane. 
Garrigues and Edwald254 reported quasi-line spectra for 9-OHB[a]P. Among the hydroxyl-PAH 
included in Karcher’s spectral atlas, a Shpol’skii spectrum was included only for 3-OHB[a]P.257 
Ariese and co-workers258 noted that the sensitivity of the Shpol’skii method for  monohydroxy 
(phenolic) metabolites of B[a]P is more than one order of magnitude poorer in comparison with 
the parent compound B[a]P, although at room temperature the fluorescence quantum yields of 
the two compounds are similar. In the case of 1-hydroxypyrene the difference in sensitivity is 
even larger. Experimental evidence suggests that this phenomenon is caused by the limited guest-
host compatibility due to the polar hydroxyl group, the later having a stronger influence in the 
case of the five ring B[a]P derivative. In principle two effects can occur, resulting from either the 
poorer solubility in n-alkanes or the poorer compatibility with the n-alkane crystal lattice. The 
first is the formation of aggregates during the cooling procedure, leading to precipitation and 
reduced quantum yields. The second concerns freezing out of the analyte molecules, at the point 
of matrix solidification, from the crystalline phase being formed into the amorphous phase, 
resulting in broad-band emission at the expense of the intensity of the Shpol’skii lines.259 As a 
result, the direct Shpol’skii analysis of phenolic metabolites can only be applied if trace-level 
sensitivity is not required. 
As a tentative means of improving the compatibility of PAH metabolites with typical n-





monohydroxybenz[a]anthracenes into less polar methoxy derivatives, which could subsequently 
be analyzed by means of Laser-Excited Shpol’skii Spectroscopy. The methylation procedure was 
later extended to several other types of B[a]P metabolites, including monohydroxy-B[a]P 
derivatives, B[a]P-dihydrodiols, B[a]P-dihydrodiolepoxide, and B[a]P-tertahydrotetrol.258,261 
The approach was found to be suitable only for phenolic metabolites. The fluorescence intensity 
of 3-methoxy-B[a]P and 1-methoxy-B[a]P - i.e. the derivatives of 3-OHB[a]P and 1-OHB[a]P, 
respectively – in n-octane was found to be comparable to that of B[a]P.258 Good results were also 
obtained for phenolic metabolites when other derivatizing agents were used; narrow Shpol’skii 
spectra and good detection limits were obtained for acetylated 6-OHB[a]P and for octyl 
derivatives of 3-OHB[a]P, 6-OHB[a]P, and 9-OHB[a]P.261 Unfortunately, derivatization of 
polyhydroxylated metabolites proved to be much more complicated. In the case of methylation 
of B[a]P dihydrodiol metabolites a mixture of products was obtained.258 For instance, B[a]P 
9,10-dihydrodiol yielded 9-methoxy-B[a]P, 10-methoxy-B[a]P, as well as the expected 
dimethylated product 9,10-dihydrodimethxy-B[a]P. Their relative concentration ratios depended 
critically on the derivatization conditions, which made the reproducibility of measurements poor. 
Other problems were related to the limited sensitivity of Shpol’skii spectra of methylated 
polyhydroxy metabolites. The detection limits found for permethylated B[a]P diols, B[a]P 
diolepoxide, and B[a]P tetrol were many orders of magnitude poorer than those observed for 
methylated phenolic B[a]P metabolites, although the same instrumental set up was used. In 
summary, Shpol’skii spectroscopy, after derivatization, is a well suited approach for 
monohydroxy metabolites but falls short for polyhydroxylated metabolites for reasons of both 






8.2  Experimental Section  
8.2.1 Chemicals  
HPLC grade methanol was purchased from Fisher Scientific (Pittsburgh, PA, USA). N-
Alkanes and alcohols were acquired from Acros Organics (Atlanta, GA, USA).  Otherwise 
specified, Nanopure water from a Barnstead Nanopure Infinity water system (Massachusetts, 
USA) was used throughout. Commercial standards of the PAH metabolites were acquired from 
the Midwest Research Institute (Kansas City, Missouri) at their highest purity available and used 
with no further purification.  
 
8.2.2 Solution Preparation 
Stock metabolite solutions were prepared daily and kept in the dark at 4°C. Possible 
metabolite degradation was monitored via RTF spectroscopy. Metabolite working solutions were 
prepared by serial dilution with the appropriate solvent.  
8.2.3 UV-VIS Absorption Spectroscopy 
See section 3.1 for instrumental details. 
8.2.4 RTF Spectroscopy 
 See section 3.2 for instrumental details. 
8.2.5 Instrumentation for LETRSS Analysis  





8.2.6 Spectral Acquisition with the MLS 
See section 3.3 for experimental details. 
 
8.2.7 Lifetime Acquisition with the MLS  
Fluorescence lifetimes were measured via the WTM procedure, which consists of the 
following three steps: (i) full sample and background WTM collection; (ii) background decay 
curve subtraction from the fluorescence decay curve at a wavelength of maximum emission for 
each PAH, and (iii) fitting of the background corrected data to single exponential decays. In 
cases of unknown sample composition where the formulation of a correct blank for lifetime 
background correction was not possible, the fluorescence decay at the base of the target peak was 
used for background subtraction at the target wavelength.  All fluorescence lifetimes were 
recorded using 5ns minimum delay. This delay was sufficient to avoid the need to consider 
convolution of the dye laser pulse with the analytical signal. The accuracy of this procedure has 
been confirmed previously.148 Origin software (version 7.5, Micronal Software) was used for 
curve fitting of fluorescence decays. Fluorescence lifetimes were obtained from decay curves 
fitted to y = y0 + A1e[-(x-x0))t1] were obtaining by fixing x0 and y0 at a value of zero. 
 
8.2.8 77K and 4.2K Sample Procedures  
77K measurements with the spectrofluorimeter followed the classic procedure of 
immersing the sample solution in a quartz tube into a nitrogen filled Dewar flask. 4.2 K 





200 μl) of undegassed sample solution with a pipette into the sample vial of the cryogenic probe, 
the tip of the fiber-optic bundle was positioned and held constant with the screw cap above the 
solution surface. Sample freezing was accomplished by lowering the copper tubing into the 
liquid helium, which was held in a Dewar flask with 60 L storage capacity. The liquid helium 
would typically last 3 weeks with daily use, averaging 15 to 20 samples per day. Complete 
sample freezing took less than 90 s per sample. Replacing the frozen sample involved removing 
the sample vial from the cryogen container and melting the frozen sample with a heat gun. 
Because no physical contact between the tip of the fiber-optic bundle and the sample ever 
occurred during measurements, probe cleanup between measurements was not necessary. The 
entire freeze, thaw, and sample replacement cycle took no longer than 5 min. 
 
8.3  Results and Discussion 
Preliminary studies in our lab support a rather simple solution for the problem at hand. As 
a way of improving the solubility of PAH metabolites in frozen matrixes, we tested a series of 
primary alcohols (RCH2OH) as solvent hosts. By optimizing the length of the alkyl group (R), 
our expectation was to minimize the number of crystallographic sites occupied by metabolite 
molecules in the crystal lattice of the frozen alcohol. We thought that the combination of these 
two effects should lead to spectral narrowing and strong fluorescence emission for trace 
determination of PAH metabolites.  
A criterion often employed for solvent selection in Shpol’skii Spectroscopy is to match 
the length of the n-alkane molecule to the effective length of the parent PAH.100 The same 





We selected 1-hexanol for 1-hydroxypyrene, 2-hydroxyfluorene and 9-hydroxyphenanthrene and 
1-octanol for 3-OHB[a]P. Table 1 compares their 77K-fluorescence intensities to those obtained 
in their corresponding n-alkane solutions. Fluorescence enhancements in the presence of the 
primary alcohols were observed in all cases.  
 
Table 8.1 77K Fluorescence Intensities of PAH Metabolites in Alcohol and n-Alkane Matrixes. 
Monohydroxy-PAH a IAlcohol b IAlkane b IAlcohol / IAlkane 
1-hydroxypyrene (1.80 ± 0.08) × 106 (6.74 ± 0.06) × 105 2.67 ± 0.12 
2-hydroxyfluorene (3.71 ± 0.06) × 105 (1.08 ± 0.03) × 105 3.44 ± 0.11 
3-OHB[a]P (6.97 ± 0.08) × 105 (3.83 ± 0.05) × 105 1.82 ± 0.03 
9-hydroxyphenanthrene (7.49 ± 0.05) × 105 (2.36 ± 0.10) × 105 3.17 ± 0.13 
 
a All metabolite concentrations were 1ng.mL-1. b IAlcohol and IAlkane = fluorescence intensities in 
the frozen alcohol and n-alkane matrixes, respectively: 1-hexanol and n-hexane (1-
hydroxypyrene, 2-hydroxyfluorene and 9-hydroxyphenanthrene) and 1-octanol and n-octane 
(3-OHB[a]P). All fluorescence intensities represent an average of three independent 




Although the Shpol’skii effect is significant at liquid nitrogen temperature, fluorescence 
excitation and emission spectra only become extremely sharp at temperatures below 20 K. Figure 
8.1 compares the 4.2K fluorescence spectra of 1-hydroxypyrene and 3-OHB[a]P in primary 
alcohols with various alkyl chain lengths. A drastic improvement of spectral narrowing is 
observed for both metabolites as the length of the RCH2- group approaches the length of the n-
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Figure 8.1 4.2K fluorescence emission spectra recorded upon laser excitation at 347.9nm (1-OHpyrene,) 
311.2nm (3-OHB[a]P). 
10ns delay and 1000ns gate times, and  spectral band-pass of 0.32nm. Both spectra represent the 





The spectra of 1-OHpyrene in 1-hexanol and 3-OHB[a]P in 1-octanol show the quasi-line 
structure expected from Shpol'skii systems. Another peculiar feature of these spectra is the 
presence of featureless fluorescence bands underlying the quasi-line fluorescence spectra. Broad 
emission bands in the spectra of PAH/n-alkane systems have been attributed to the presence of 
disordered groups of solute molecules or pre-aggregates in the frozen matrix. We should mention 
that we did not attempt site-selective excitation or sample excitation near the 0-0 transition 
region of PAHs metabolites. Bearing in mind that both approaches usually improve spectral 
resolution in Shpol’skii matrixes, it is reasonable to expect even narrower spectra from PAHs 
metabolites.  
 The effect of site-selective excitation is clearly noted in Figure 8.2. Upon fast cooling to 4.2K  
in 1-octanol, B[a]P-trans-9,10-dihydrodiol occupies predominantly two crystallographic sites 
that yield two distinctive fluorescence spectra slightly shifted by small wavelength differences. 
Under multi-site excitation conditions (λexc = 347.6nm), the maximum wavelengths of the 
doublet emissions from the 0-0 transitions appear at 399.6nm (site 1) and 402.6nm (site 2). Site-
selective excitation of “site 1” at 346.9nm removes the fluorescence contribution of site 2 and 












Figure 8.2 4.2K fluorescence spectrum of 10ng.mL-1 B[a]P -trans-9,10-dihydrodiol in 1-octanol. 
 Both spectra represent the accumulation of 100 laser pulses per data point. Other parameters are: 10ns delay 
and 1000ns gate times, and spectral band-pass of 0.32nm. 
 
 
Table 8.2 summaries the 77K and 4.2K fluorescence quantum yields of B[a]P-r-7,t-8-
dihydrodiol-c-9,10-poxide(±), (syn) and B[a]P-r-7,t-8-dihydrodiol-t-9,10-poxide(±), (anti) in n-
octane and 1-octanol. In comparison to 1-octanol, lowering the temperature to 4.2K caused 
relatively small improvements in the fluorescence quantum yields. Similar results were observed 
for 3-OHB[a]P, 4-OHB[a]P, 5-OHB[a]P, B[a]P-trans-9,10-dihydrodiol and B[a]P-trans-7,8-
dihydrodiol (±). As such, the strong fluorescence emission observed at 77K and 4.2K can be 





Table 8.2 Fluorescence Quantum Yields a of anti-BPDE (±) and syn-BPDE (±). 
 Solvent 77K 4.2K 
anti-BPDE (±)  n-octane 0.046 ± 0.006 0.048 ± 0.008 
1-octanol 0.29 ± 0.05 0.35 ± 0.04 
syn-BPDE (±)  n-octane 0.075 ± 0.007 0.081 ± 0.011 
1-octanol 0.23 ± 0.06 0.28 ± 0.06 
a All values represent an average of three independent measurements; anti-BPDE (±) = B[a]P-r-




Table 8.3 summaries the analytical figures of merit for B[a]P metabolites in this solvent. 
The LOD were calculated using the formula 3sB / m; where sB is the standard deviation of 16 
blank (1-octanol) and m is the slope of the LDR of the calibration curve. The relative standard 
deviations of three fluorescence measurements at medium linear concentrations varied between 3% 
(4-OHBaP) and 6% (B[a]P-trans-7,8-dihydrodiol (±)). Clearly, using 1-octanol as the Shpol’skii 
matrix makes the quantitative analysis of B[a]P metabolites at trace concentration levels possible.  
 
Table 8.3 4.2K Fluorescence analytical figures of merita of B[a]P metabolites in 1-Octanol. 
B[a]P metabolite λexc / λem (nm) LDR (ng.mL-1) R LOD (ng.mL-1) 
3-OHB[a]P 311.5 / 433.5 2.4 - 100 0.9980 0.8 
4-OHB[a]P 309.1 / 418.6 0.6 - 100 0.9978 0.2 
5-OHB[a]P 309.1 / 422.3 1.8 - 100 0.9956 0.6 
B[a]P-trans-7,8-dihydrodiol (±) 347.7 / 394.5 0.9 - 100 0.9993 0.3 
B[a]P-trans-9,10-dihydrodiol 347.7 / 402.6 0.6 - 100 0.9974 0.2 
anti-BPDE (±) 348.3 / 379.6 0.3 - 100 0.9997 0.1 
syn-BPDE (±) 347.9 / 377.4 0.9 - 100 0.9990 0.3 
 
a Lower limit of LDR corresponds to the limit of quantitation, i.e. 3 x LOD. No efforts were made 






When frozen in 1-octanol, the 4.2K fluorescence spectra of anti- and syn-BPDE (±) 
present the predominant contribution of four and two crystallographic sites, respectively. Figure 
8.3 shows the effect of wavelength excitation on the spectral features of both racemic mixtures. 


























Figure 8.3 4.2K fluorescence emission spectra of anti-BPDE (±) and syn-BPDE (±) in 1-octanol. 
Sample excitation (ex) was within the wavelength range of site selective excitation of anti-BPDE (±). All 
spectra represent the accumulation of 100 laser pulses per data point. Other parameters are: 10ns delay and 







Table 8.4 summarizes the fluorescence lifetimes of the racemic mixtures measured at the 
maximum emission wavelength of each crystallographic site. Our observations are consistent 
with the well known sensitivity of fluorescence lifetimes to the microenvironment of the 
fluorophor. It is generally accepted that the multiplet structure of fluorescence spectra arise from 
the different orientations of guest molecules in the Shpol’skii matrix. The different orientations 
lead to nonequivalent crystal field effects and hence wavelength shifts. Most likely, the field 
effects are also sensed by the fluorescence lifetimes of the metabolites. We should mention that 
we were the first to report the dependence of fluorescence lifetimes on the crystallographic sites 
of parent PAHs.134 The comparison of values in Table 8.4 shows that the lifetime difference from 
site to site is larger than their wavelength difference. This fact enhances the specificity of site-
selective excitation because it facilitates time-resolution of partially overlapped spectra. Time-
resolution makes it possible to select appropriate delay and gate times to either minimize or 
enhance the spectral contribution of one site over the contribution of the remaining sites.  
 
Table 8.4 4.2K Fluorescence Lifetimesa of BPDE (±) Metabolites Occupying Different Crystallographic Sites 
in 1-Octanol. 
 376.4nm 377.4nm 377.9nm 379.nm 
anti-BPDE (±) 142.7 ± 3.3 189.9 ± 3.4 177.1 ± 2.3 132.7 ± 5.2 
syn-BPDE (±) 224.6 ± 2.5 201.8 ± 1.3 No site No site 
 
a Fluorescence lifetimes are in nanoseconds. Reported values represent the averages of three 









Figure 8.4 overlaps the fluorescence spectra of the two racemic mixtures recorded upon 
sample excitation at 347.5nm, i.e. an excitation wavelength that promotes multi-site excitation of 
the two mixtures.  A delay time of 200ns and a gate time of 500ns reduce the fluorescence 
intensity of anti-BPDE (±) to approximately 25% of its original value. If the direct determination 
of syn-BPDE (±) were of interest, the contribution of the residual fluorescence of anti-BPDE (±) 
could be eliminated by tuning the excitation wavelength to an excitation wavelength that mainly 
promotes the fluorescence emission of syn-BPDE (±). Similarly, if the direct determination of 
anti-BPDE (±) were of interest, it could be achieved via site selective excitation of its site at 
379.5nm. The combination of multiple fluorescence sites with narrow peaks and different 
fluorescence lifetimes associated to site-selective excitation holds tremendous potential for the 


















Figure 8.4 Effect of delay (200ns) and gate (500ns) times on the 4.2K fluorescence spectra of syn-BPDE (±) (---
-) and anti-BPDE (±) (—) in 1-octanol. 
Sample excitation (ex) was within the wavelength range of site selective excitation of anti-BPDE (±). All 
spectra represent the accumulation of 100 laser pulses per data point. Other parameters are: 10ns delay and 
1000ns gate times, and spectral band-pass of 0.32nm.  
 
 
8.4 Conclusion and Future Studies 
The outstanding selectivity and sensitivity for the direct analysis of PAHs at trace 
concentration levels has made Shpol’skii spectroscopy a leading technique in environmental 
analysis. Unfortunately, the requirement of a specific guest-host combination - typically a non-





analytical chemistry. The research presented in this chapter takes the first steps in removing this 
limitation with the direct analysis of polar PAH metabolites in alcohol matrixes.  
Finding the most appropriate Shpol’skii matrix for the fluorophor under investigation is 
not always evident and requires some trial an error. The properties of the fluorophor play an 
important role, in particular the three dimensional shape of the molecule, its rigidity, and the 
number (and positions) of polar substituent groups. In general, the difficulty in achieving 
Shpol’skii spectra increases with the number of polar groups present in the fluorophor since they 
reduce the solubility in n-alkanes and tend to promote the formation of aggregates and clusters 
during cooling. It has been reported that in a 10K n-octane Shpol’skii matrix, addition of a 
hydrogen bonding impurity like water, methanol or diethyl ether to the sample does not affect the 
high resolution of 3-hydroxyflavone.262 The reason for this is that 3-hydroxyflavone fits tightly 
into the matrix so there is no space available for an additional hydrogen-bonding molecule; upon 
cooling the added polar solvent is simply frozen out and a phase separation is obtained. If, on the 
contrary, a hydrogen bonding impurity is added that can replace a particular octane molecule of 
the crystalline surrounding of a 3-hydroxyflavone molecule, a different effect is observed. 
Adding a minor amount of 2-octanol to the octane matrix of 3- hydroxyflavone resulted in the 
appearance of a new site at 507.2nm. Addition of a much larger amount of 3-octanol results in a 
new site further shifted to the blue, i.e., at 504.7nm. On the other end, the addition 1-octanol or 
4-octanol showed no effect.262  
Under this prospective, we expect the position of the hydroxyl group in the alcohol 
molecule to affect both the spectral resolution of PAH metabolites and the number of sites in the 
Shpol’skii matrix. We also expect the position of the hydroxyl group in the alcohol molecule to 





of the metabolite. We will investigate these possibilities monitoring the spectral properties of 
PAH metabolites in several types of solvent systems. For the particular case of B[a]P, we will 
investigate (a) 1-heptanol, 2-heptanol, 3-heptanol and 4-heptanol; (b)1-octanol, 2-octanol, 3-
octanol and 4-octanol; and (c) 1-nonanol, 2-nonanol, 3-nonanol, 4-nonanol and 5-nonanol. We 
will also investigate the titration of a metabolite in an n-alkane solution with small amounts of an 
alcohol that best matches the molecular length of both the n-alkane and the metabolite. The best 
choice will be made on the bases of spectral narrowing, signal intensities and number of 
crystallographic sites. 
Analytical methods to elucidate the initial phase of carcinogenesis are extremely relevant 
to our society. Covalent binding of PAHs metabolites to DNA appears to be the first critical step 
in the initiation of the tumor formation process. Under this prospective, the determination of 
PAH metabolites prior to DNA damage fills an important niche to prevent extreme body burdens 
and minimize cancer risk. A plethora of analytical techniques are currently needed to determine 
its metabolites in biological matrixes. We propose a single but powerful approach to track down 
trace concentration levels of all PAH major metabolites. The ability to directly determine the 
presence and the amounts of optical isomers even if closely related stereo-isomers are present in 
far higher concentrations would be a huge breakthrough. The long term aim of our research is to 







APPENDIX A: EXCITATION AND FLUORESCENCE SPECTRA OF 15 



























Figure A-1 Excitation and fluorescence spectra of naphthalene 20ppb in 1% 
methanol/water at RT. 



















Figure A-2 Excitation and fluorescence spectra of acenaphthene 10ppb in 1% 

























Figure A-3 Excitation and fluorescence spectra of fluorene 10ppb in 1% methanol/water at 
RT. 























Figure A-4 Excitation and fluorescence spectra of phenanthrene 10ppb in 1% 

























Figure A-5 Excitation and fluorescence spectra of anthracene 10ppb in 1% methanol/water 
at RT. 




















Figure A-6 Excitation and fluorescence spectra of fluoranthene 20ppb in 1% 



























Figure A-7 Excitation and fluorescence spectra of pyrene 10ppb in 1% methanol/water at 
RT. 
























Figure A-8 Excitation and fluorescence spectra of benzo[a]anthracene 10ppb in 1% 
























Figure A-9 Excitation and fluorescence spectra of chrysene 10ppb in 1% methanol/water at 
RT. 



















Figure A-10 Excitation and fluorescence spectra of benzo[b]fluoranthene 20ppb in 1% 































Figure A-11 Excitation and fluorescence spectra of benzo[k]fluoranthene 10ppb in 1% 
methanol/water at RT. 





















Figure A-12 Excitation and fluorescence spectra of benzo[a]pyrene 10ppb in 1% 



























Figure A-13 Excitation and fluorescence spectra of dibenz[a,h]anthracene 10ppb in 1% 
methanol/water at RT. 



























Figure A-14 Excitation and fluorescence spectra of benzo[g,h,i]perylene 20ppb in 1% 




























Figure A-15 Excitation and fluorescence spectra of indeno[1,2,3-cd]pyrene 30ppb in 1% 















Figure B-1 Fluorescence intensity as a function of naphthalene concentration after 
extracted by 5% 20-nm Au NPs.(Ex/Em = 285/320nm) 
 
Figure B-2 Fluorescence intensity as a function of acenaphthene concentration after 
extracted by 5% 20-nm Au NPs. (Ex/Em = 292/322nm) 
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Figure B-3 Fluorescence intensity as a function of fluorene concentration after extracted by 
5% 20-nm Au NPs. (Ex/Em = 279/306nm) 
 
Figure B-4 Fluorescence intensity as a function of phenanthrene concentration after 
extracted by 5% 20-nm Au NPs. (Ex/Em = 294/347nm) 
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Figure B-5 Fluorescence intensity as a function of anthracene concentration after extracted 
by 5% 20-nm Au NPs. (Ex/Em = 252/380nm) 
 
Figure B-6 Fluorescence intensity as a function of fluoranthene concentration after 
extracted by 5% 20-nm Au NPs. (Ex/Em = 288/450nm) 
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Figure B-7 Fluorescence intensity as a function of pyrene concentration after extracted by 5% 
20-nm Au NPs. (Ex/Em = 336/373nm) 
 
Figure B-8 Fluorescence intensity as a function of benzo[a]anthracene concentration after 
extracted by 5% 20-nm Au NPs. (Ex/Em = 289/387nm) 
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Figure B-9 Fluorescence intensity as a function of chrysene concentration after extracted 
by 5% 20-nm Au NPs. (Ex/Em = 269/363nm) 
 
Figure B-10 Fluorescence intensity as a function of benzo[b]fluoranthene concentration 
after extracted by 5% 20-nm Au NPs. (Ex/Em = 305/426nm) 
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Figure B-11 Fluorescence intensity as a function of benzo[k]fluoranthene concentration 
after extracted by 5% 20-nm Au NPs. (Ex/Em = 307/412nm) 
 
Figure B-12 Fluorescence intensity as a function of benzo[a]pyrene concentration after 
extracted by 5% 20-nm Au NPs. (Ex/Em = 297/405nm) 
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Figure B-13 Fluorescence intensity as a function of dibenz[a,h]anthracene concentration 
after extracted by 5% 20-nm Au NPs. (Ex/Em = 304/396nm) 
 
Figure B-14 Fluorescence intensity as a function of benzo[g,h,i]perylene concentration after 
extracted by 5% 20-nm Au NPs. (Ex/Em = 305/420nm) 
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Figure B-15 Fluorescence intensity as a function of indeno[1,2,3-cd]pyrene concentration 
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APPENDIX C: EXCITATION AND FLUORESCENCE SPECTRA OF 15 




























Figure C-1 Excitation and fluorescence spectra of naphthalene 0.5ppm in n-octane at 77K. 





















































Figure C-3 Excitation and fluorescence spectra of fluorene 0.5ppm in n-octane at 77K. 
























































Figure C-5 Excitation and fluorescence spectra of anthracene 0.5ppm in n-octane at 77K. 
























































Figure C-7 Excitation and fluorescence spectra of pyrene 0.5ppm in n-octane at 77K. 



















































Figure C-9 Excitation and fluorescence spectra of chrysene 0.5ppm in n-octane at 77K. 




























Figure C-10 Excitation and fluorescence spectra of benzo[b]fluoranthene 0.5ppm in n-





























Figure C-11 Excitation and fluorescence spectra of benzo[k]fluoranthene 0.5ppm in n-
octane at 77K. 






















































Figure C-13 Excitation and fluorescence spectra of dibenz[a,h]anthracene 0.5ppm in n-
octane at 77K. 






















































Figure C-15 Excitation and fluorescence spectra of indeno[1,2,3-cd]pyrene 0.5ppm in n-








APPENDIX D: FLUORESCENCE SPECTRA AND LIFETIME DECAY 














































Figure D-1 Fluorescence spectra of naphthalene 0.5ppm in n-octane at 4.2K. Ex = 283nm 



















Figure D-2 Fluorescence decay of naphthalene in n-octane at 4.2K. Ex/Em = 283/318.5nm; 




























Figure D-3 Fluorescence spectra of acenaphthene 0.5ppm in n-octane at 4.2K. Ex = 283nm 




















Figure D-4 Fluorescence decay of acenaphthene in n-octane at 4.2K. Ex/Em = 283/320.1nm; 

























Figure D-5 Fluorescence spectra of fluorene 0.5ppm in n-octane at 4.2K. Ex = 283nm 




















Figure D-6 Fluorescence decay of fluorene in n-octane at 4.2K. Ex/Em = 283/301.8nm; td = 




























Figure D-7 Fluorescence spectra of phenanthrene 0.5ppm in n-octane at 4.2K. Ex = 283nm 



















Figure D-8 Fluorescence decay of phenanthrene in n-octane at 4.2K. Ex/Em = 283/363.4nm; 
































Figure D-9 Fluorescence spectra of anthracene 0.5ppm in n-octane at 4.2K. Ex = 343nm 



















Figure D-10 Fluorescence decay of anthracene in n-octane at 4.2K. Ex/Em = 343/384.4nm; 





























Figure D-11 Fluorescence spectra of fluoranthene 0.5ppm in n-octane at 4.2K. Ex = 283nm 



















Figure D-12 Fluorescence decay of fluoranthene in n-octane at 4.2K. Ex/Em = 283/436.8nm; 






























Figure D-13 Fluorescence spectra of pyrene 0.5ppm in n-octane at 4.2K. Ex = 283nm 






















Figure D-14 Fluorescence decay of pyrene in n-octane at 4.2K. Ex/Em = 283/372.0nm; td = 
































Figure D-15 Fluorescence spectra of benzo[a]anthracene 0.5ppm in n-octane at 4.2K. Ex = 
283nm 





















Figure D-16 Fluorescence decay of benzo[a]anthracene in n-octane at 4.2K. Ex/Em = 


























Figure D-17 Fluorescence spectra of chrysene 0.5ppm in n-octane at 4.2K. Ex = 283nm 



















Figure D-18 Fluorescence decay of chrysene in n-octane at 4.2K. Ex/Em = 283/380.7nm; td 





























Figure D-19 Fluorescence spectra of benzo[b]fluoranthene 0.5ppm in n-octane at 4.2K. Ex 
= 283nm 


















Figure D-20 Fluorescence decay of benzo[b]fluoranthene in n-octane at 4.2K. Ex/Em = 





























Figure D-21 Fluorescence spectra of benzo[k]fluoranthene 0.5ppm in n-octane at 4.2K. Ex 
= 283nm 




















Figure D-22 Fluorescence decay of benzo[k]fluoranthene in n-octane at 4.2K. Ex/Em = 





























Figure D-23 Fluorescence spectra of benzo[a]pyrene 0.5ppm in n-octane at 4.2K. Ex = 
283nm 



















Figure D-24 Fluorescence decay of benzo[a]pyrene in n-octane at 4.2K. Ex/Em = 




























Figure D-25 Fluorescence spectra of dibenz[a,h]anthracene 0.5ppm in n-octane at 4.2K. Ex 
= 283nm 





















Figure D-26 Fluorescence decay of dibenz[a,h]anthracene in n-octane at 4.2K. Ex/Em = 

































Figure D-27 Fluorescence spectra of benzo[g,h,i]perylene 0.5ppm in n-octane at 4.2K. Ex = 
283nm 





















Figure D-28 Fluorescence decay of benzo[g,h,i]perylene in n-octane at 4.2K. Ex = 






























Figure D-29 Fluorescence spectra of indeno[1,2,3-cd]pyrene 0.5ppm in n-octane at 4.2K. Ex 
= 283nm 

















Figure D-30 Fluorescence decay of indeno[1,2,3-cd]pyrene in n-octane at 4.2K. Ex/Em = 







APPENDIX E: LOW CONCENTRATION RANGES OF CALIBRATION 











































Figure E-1 Calibration curve obtained via SPNE-LETRSS for naphthalene (Ex = 283nm). 
 















































Figure E-3 Calibration curve obtained via SPNE-LETRSS for fluorene (Ex = 283nm). 














































Figure E-5 Calibration curve obtained via SPNE-LETRSS for anthracene (Ex = 283nm). 













































Figure E-7 Calibration curve obtained via SPNE-LETRSS for pyrene (Ex = 283nm). 















































Figure E-9 Calibration curve obtained via SPNE-LETRSS for chrysene (Ex = 283nm). 













































Figure E-11 Calibration curve obtained via SPNE-LETRSS for benzo[k]fluoranthene (Ex = 
283nm). 
















































Figure E-13 Calibration curve obtained via SPNE-LETRSS for dibenz[a,h]anthracene (Ex 
= 283nm). 
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